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PREFACE
In this cumulative PhD thesis, I combine three original papers comprising my work on histone 
variants, namely H2A.Z.2.2, macroH2A, and H3.X and H3.Y. In addition, a review article entitled 
“Chromatin proteomics and epigenetic regulatory circuits”, which I partially wrote, constitutes the 
more general part of the introduction section. In this review, we summarize the vast field of chromatin 
biology and epigenetics including post-translational modifications of histones, histone variants, DNA 
methylation, ATP-dependent chromatin remodeling, non-coding RNAs and nuclear architecture as 
well as their functional interplay. 
The centerpiece of this thesis is the first original paper: “H2A.Z.2.2 is an alternatively spliced histone 
H2A.Z variant that causes severe nucleosome destabilization”. In this paper, we identified and 
characterized both biochemically and biophysically, a novel, putatively primate-specific histone 
H2A.Z splice variant named H2A.Z.2.2. Our study provides compelling evidence that H2A.Z.2.2 is 
highly expressed in human brain and strongly destabilizes nucleosomes. 
During the process of writing and assembling this PhD thesis, my supervisor Priv.-Doz. Dr. Sandra 
Hake had the interesting and challenging idea to write the more specific part of the introduction and 
the discussion of this thesis in form of a review article. Prof. Dr. Peter Becker and Prof. Dr. Heinrich 
Leonhardt supported the idea from the beginning. Based on my own work on nucleosome stability and 
mobility presented in the original paper on H2A.Z.2.2, I decided to write a comprehensive review 
concerning the influence of histone H2A variants on nucleosome as well as chromatin structure and 
stability. The more specific part of the introduction summarizes the literature on H2A variants and 
their biological function; the discussion focuses on their influence on nucleosome structure, stability 
and higher-order chromatin structure. I decided, in accordance with the guide lines for cumulative 
dissertations, to put the discussion subsequent to the introduction. In order to keep the space between 
text and references minimal, the references appear after the discussion section and are followed by the 
results section, constituted by the three original papers mentioned above. Soon after the submission of 
this PhD thesis, a review article based on both introduction and discussion parts presented here will be 
submitted to Nucleic Acids Research; whose editor strongly encouraged us to do so. 
This thesis does not contain an additional materials and methods section as all relevant information is 
presented in the here included original papers and corresponding supplementary materials and method 
sections. Moreover all working protocols and information on plasmids as well as DNA and RNA 
oligonucleotides will be kept in the laboratory of Priv.-Doz. Dr. Sandra Hake and are available upon 
request.
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SUMMARY
In the eukaryotic nucleus, DNA is packaged into chromatin, a nucleoprotein complex with the 
nucleosome as its basic subunit. The nucleosome consists of approximately 150 bp of DNA wrapped 
around an octamer of core histones with two copies of each H2A, H2B, H3 and H4. Chromatin is 
highly dynamic and allows DNA compaction to different degrees, thereby permitting or prohibiting 
accessibility to factors regulating DNA-related processes. Structural alterations of chromatin are 
strictly controlled and involve various interconnected mechanisms including the exchange of canonical 
histones with histone variants. 
This work comprises three original papers all dealing with histone variants and their biological 
implications. The centerpiece is the identification and characterization of H2A.Z.2.2 (Z.2.2), a novel, 
putatively primate-specific splice isoform of the extensively studied histone variant H2A.Z. Z.2.2 
mRNA is present in all human tissues analyzed although at lower levels when compared to the major 
splice isoform, Z.2.1. In the brain however, Z.2.2 mRNA is abundant and constitutes up to 50% of 
transcripts originating from the H2A.Z.2 locus. Moreover, characterization of Z.2.2´s mobility in vivo 
and stability in vitro demonstrated that this variant strongly destabilizes nucleosomes; to an extent at 
least as pronounced as H2A.Bbd, the prime example of a destabilizing H2A variant thus far. Z.2.2 is 
identical to Z.2.1 in most of its sequence but has an altered docking domain/C-terminal sequence, 
which is shorter and has a stretch of six unique amino acids. Interestingly, by analysis of deletion 
mutants and chimeric proteins, we could show that Z.2.2´s characteristic properties are dependent on 
its unique docking domain sequence and structure, and that mere shortening of Z.2.1 to the same 
length as Z.2.2 does not restore Z.2.2´s high mobility in vivo. Taken together, these findings suggest a 
possible exciting role of Z.2.2 in conferring unique structural properties to chromatin in primate 
brains, thereby distinguishing them from those of other mammals. 
The second paper describes the role of ATRX in regulating macroH2A´s chromatin association. 
MacroH2A is well characterized as a transcriptional repressor however the mechanisms by which it is 
targeted to its chromatin sites have remained elusive. We found that ATRX interacts with soluble 
macroH2A in chromatin free extracts, suggesting a possible role in macroH2A targeting. The findings 
that ATRX knock down leads to increased macroH2A incorporation at telomeric regions and the -
globin gene cluster, concurrent with reduced -globin gene expression, support its function in 
negatively regulating macroH2A chromatin association. Notably, this study is only the second study 
pointing towards histone variant targeting by negatively influencing their chromatin association. 
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In the third paper, we report the identification of H3.X and H3.Y, two novel primate-specific H3 
variants. These variants are, in contrast to Z.2.2, only expressed in a subset of cell lines and tissues 
(including some brain tissues), but H3.Y expression is significantly upregulated under metabolic stress 
coupled with high cell density in the human osteosarcoma cell line U2OS. Furthermore, knock down 
of H3.Y impairs cell proliferation by deregulation of cell cycle-specific gene expression. Since H3.Y 
was expressed only in a subset of neuronal cells in hippocampus, it is possible that this novel variant 
plays an important role in fine-tuning proliferation of some specialized cell types upon certain stimuli
Zusammenfassung 
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ZUSAMMENFASSUNG 
DNA liegt in Eukaryoten in Form von Chromatin vor, einem Nukleoproteinkomplex dessen 
Grundbaustein das Nukleosom darstellt. Das Nukleosom besteht aus ca. 150 bp DNA, die um ein 
Histonoktamer aus jeweils zwei Kopien der Histone H2A, H2B, H3 und H4 gewunden sind. Die 
Chromatinstruktur ist sehr dynamisch und ermöglicht eine DNA-Kompaktierung in verschiedenen 
Ausmaßen, was wiederum die Zugänglichkeit von Faktoren, die in DNA-bezogene Prozessen 
involviert sind, entweder  erlaubt oder verhindert. Änderungen der Chromatinstruktur sind 
hochreguliert und werden durch etliche, miteinander verknüpfte Prozesse kontrolliert, wie z.B. durch 
den Austausch von kanonischen Histonen mit Histonvarianten. 
Diese Dissertation enthält drei Originalartikel, die sich alle mit Histonvarianten und deren 
biologischen Implikationen beschäftigen. Das Herzstück dieser Doktorarbeit stellt die Identifizierung 
und Charakterisierung von H2A.Z.2.2 (Z.2.2), einer neuen, mutmaßlich primaten-spezifischen 
Spleißisoform der ausgiebig untersuchten Histonvariante H2A.Z dar. Die mRNA von Z.2.2 kommt in 
allen untersuchten menschlichen Geweben vor, allerdings in wesentlich geringeren Mengen als die 
Haupt-Spleißisoform, Z.2.1. Im Gehirn hingegen ist die Z.2.2 mRNA sehr abundant und macht bis zu 
50% der Transkripte des H2A.Z.2 Locus aus. Darüberhinaus zeigte die Charakterisierung der 
Mobilität von Z.2.2 in vivo und seiner Stabilität in vitro, dass es Nukleosomen signifikant 
destabilisiert; in einem mindestens genauso großen Ausmaß wie H2A.Bbd, dem bisherigen 
Paradebeispiel einer destabilisierenden H2A Variante. Z.2.2 ist fast vollständig identisch mit Z.2.1 mit 
Ausnahme des C-terminus („docking domain“). Dieser ist kürzer und enthält eine Sequenz von sechs 
charakteristischen Aminosäuren. Interessanterweise konnten wir mittels Deletionsmutanten und 
chimären Proteinen zeigen, dass die veränderte Aminosäuresequenz und Struktur am C-Terminus von 
Z.2.2 entscheidend für seine charakteristische Eigenschaften sind; das bloße Verkürzen von Z.2.1 auf 
die gleiche Länge wie Z.2.2. führte nicht zu einer vergleichbaren Mobilität in vivo. Zusammengefasst 
lassen diese Ergebnisse vermuten, dass Z.2.2 zu einzigartigen strukturelle Eigenschaften von 
Chromatin im Primatengehirn führt, welche es wiederum von denen anderer Säuger unterscheiden 
könnte. 
Der zweite Artikel beschreibt die Rolle von ATRX in der Regulation der Chromatinassoziation von 
macroH2A. MacroH2A ist charakterisiert worden als Transkriptionsrepressor, jedoch waren die 
Mechanismen wie diese Variante gezielt ins Genom lokalisiert wird bisher unklar. Knock-down von 
ATRX führt zu einem erhöhtem Einbau von macroH2A an Telomeren und am -Globin Gencluster 
mit einer gleichzeitig verringerten Transkription dieser Gene. Diese Ergebnisse lassen stark vermuten, 
dass eine funktionelle Rolle von ATRX darin besteht, die Assoziation von macroH2A mit Chromatin 
negativ zu beeinflussen. Es ist hervorzuheben, dass dieses erst die zweite Studie ist, die den 
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Mechanismus der Lokalisation von Histonvarianten durch eine negative Beeinflussung der 
Chromatinassoziation beschreibt. 
Im dritten Artikel beschreiben wir die Identifizierung und Charakterisierung der primaten-spezifischen 
Histonvarianten H3.X und H3.Y. Diese Varianten sind, anders als Z.2.2, nur in wenigen Geweben und 
Zelllinen exprimiert, darunter auch einigen speziellen menschlichen Gehirngeweben. Die Expression 
von H3.Y kann jedoch durch Nährstoffmangel und erhöhte Zelldichte in der humanen 
Osteosarcomazelllinie U2OS deutlich erhöht werden.  Darüberhinaus konnten wir zeigen, dass der 
Knock-down von H3.Y die Zellproliferation durch eine Deregulation der Expression von Zellzyklus-
spezifischen Genen verringert. Da H3.Y nur in einer Subpopulation von neuronalen Zellen im 
Hippocampus exprimiert wird, ist es denkbar, dass diese neue Histonvariante eine wichtige Rolle in 
der Feinabstimmung der Proliferation von einigen spezialisierten Zelltypen durch äußere Reize spielt.
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1. INTRODUCTION 
In eukaryotes, DNA is organized into chromatin to fit into the constrained space of the nucleus. 
Generally, packaging of DNA into chromatin decreases its accessibility and consequently interferes 
with biological processes based upon DNA such as transcription, replication and repair but protects it 
from damage by different kinds of stress. Despite the immense degree of global compaction, access to 
DNA is achieved by local chromatin decondensation in a highly regulated manner. Chromatin is a 
very dynamic structure; its regulation involves several interconnected mechanisms (1) such as DNA 
methylation (2), ATP-dependent chromatin remodeling (3), histone post-translational modifications 
(PTMs) (4), non-coding RNAs (ncRNAs) (5), arrangement within the three-dimensional nuclear 
architecture (6) and the replacement of canonical histones by histone variants (7). 
Historically, the term chromatin is derived from the Greek chroma (color) and was first coined about 
130 years ago by Flemming who microscopically analyzed nuclei stained with basophilic dyes. He 
stated “The word chromatin may stand until its chemical nature is known, and meanwhile stands for 
that substance in the cell nucleus which is readily stained” (8,9). Although its general chemical nature 
was revealed, the term still stands. The distinction of chromatin into two states, euchromatin (from the 
Greek eu (good)), the part of the chromatin that is stained lightly with basic dyes, and heterochromatin 
(from the Greek hetero (different, other)), which does not, was established in 1928 by Heitz (10). 
Since then, a lot of progress in a more detailed and functional understanding of the chromatin structure 
was made. The identification of DNA as the carrier of the genetic information in 1944 (11), the 
structure of DNA in 1953 (12), the idea of a regular chromatin subunit, the nucleosome, in the 1970s 
(13-15) and the high resolution structure of the nucleosome in 1997 were important scientific hallmark 
events (16). Today, systems biology approaches allow a much more comprehensive analysis of 
chromatin and lead to fascinating new insights. It becomes more and more apparent that chromatin is 
more diverse and complex than the original distinction into euchromatin and heterochromatin 
suggested. Recent studies distinguish five (17) or nine prevalent chromatin states (18), depending on 
the different parameters analyzed. In the future, the combination between highly correlative 
approaches providing us with vast quantities of data, together with mechanistic analyses to understand 
causal relationships, will hopefully help us to understand this fascinating substance more and more.  
The introduction section of this PhD thesis contains two parts. The first, more general, part is the 
review article “Chromatin proteomics and epigenetic regulatory circuits” (1) that summarizes all 
epigenetic mechanisms mentioned above as well as their functional interconnections. The second, 
more specific, part is a summary of the literature on histone H2A variants and their biological 
functions. Here I leave out the roles of H2A variants in manipulating basic nucleosomal properties and 
higher-order chromatin structure, as this is the topic of the discussion section. 
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Many phenotypic changes of eukaryotic cells due to changes in gene expression depend on
alterations in chromatin structure. Processes involved in the alteration of chromatin are
diverse and include post-translational modifications of histone proteins, incorporation of
specific histone variants, methylation of DNA and ATP-dependent chromatin remodeling.
Interconnected with these processes are the localization of chromatin domains within the
nuclear architecture and the appearance of various classes of noncoding regulatory RNAs.
Recent experiments underscore the role of these processes in influencing diverse biological
functions. However, the evidence to date implies the importance of an interplay of all these
chromatin-changing functions, generating an epigenetic regulatory circuit that is still not
well understood.
KEYWORDS: chromatin • chromatin remodeling • DNA methylation • epigenetics • histone • histone variant 
• noncoding RNA • nuclear architecture • post-translational modification • regulatory circuit
Deciphering the genetic code has set the foun-
dation for understanding the biology of life
and how it is determined and regulated in
every living organism. Although DNA is the
hereditary molecule that controls all cellular
functions, pioneering findings in the research
field of epigenetics have revealed many addi-
tional and combinatorial mechanisms that crit-
ically contribute to the regulation of gene
expression and the subsequent defining of the
cellular phenotype. 
In the eukaryotic nucleus, DNA does not exist
as a naked molecule, but adopts a compact for-
mation by the assembly with basic histone pro-
teins in a nucleoprotein complex, known as
chromatin. Four different histone types are
known (H2A, H2B, H3 and H4), which orga-
nize DNA into basic repeating units of chroma-
tin: the nucleosomes. Nucleosomes consist of a
cylindrical octamer core formed from one
H3/H4 tetramer and two H2A/H2B dimers,
surrounded by 147 bp of DNA in a left-handed
superhelix [1]. Further incorporation of the
linker histone H1, as well as other nonhistone
structural proteins, leads to the compaction of
chromatin in higher order structures, generating
interphase chromatin and also highly compacted
mitotic chromosomes. Thus, chromatin is the
template of all DNA-related processes, and the
proper regulation of its conformation is essential
for the performance of many cellular functions. 
Cells have developed several mechanisms to
regulate chromatin structure and the sub-
sequent accessibility of DNA, which can be
broadly divided into four main categories:
• Post-translational modifications of histones
(PTMs)
• Incorporation (or replacement) of histone
variants
• DNA methylation
• ATP-dependent chromatin remodeling
 Furthermore, recent findings also provide
evidence for an important role of noncoding
RNAs (ncRNAs), as well as the distinct localiza-
tion of certain chromatin domains in the con-
text of nuclear architecture in regulating chro-
matin-related processes. In this review, we
introduce the main fields of chromatin research
and give examples of novel results that connect
these different chromatin pathways, which in
turn generate an epigenetic regulatory circuit
(FIGURE 1). We conclude with an outlook of future
key questions concerning this circuit and the
role of epigenetic mechanisms in disease.
Post-translational modifications 
of histones
Histones are subject to numerous PTMs, includ-
ing acetylation and methylation of lysine residues
(mono-, di- and trimethylation), methylation of
106 Expert Rev. Proteomics 5(1), (2008)
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arginine residues (mono-, asymmetrical and symmetrical
dimethylation) and phosphorylation, ubiquitination, sumoyla-
tion and ADP ribosylation of other amino acids [2,3]. The num-
ber and nature of identified histone PTMs is enormous and a
summary of these is reviewed in [4]. Specific enzymes catalyze
both the formation and the removal of these PTMs, suggesting
that they are dynamic. Histone acetyltransferases (HAT) and
deacetylases (HDAC) place and remove acetylation marks,
respectively, while kinases and phosphatases catalyze the phos-
phorylation and dephosphorylation of histones (FIGURE 2).
Methyl marks, established by histone methyltransferases
(HMTs) [5], were considered to be stable and irreversible for a
long time, until enzymes that demethylate histone tails were
reported recently. These enzymes include histone arginine
deiminases, such as PAD4 (which catalyze the conversion to
citrulline [6,7]), arginine demethylases (e.g., JMJD6 [8]) and
lysine-specific demethylases (e.g., LSD1). LSD1, which belongs
to the jumonji family, catalyzes the amine oxidation of mono-
and dimethylated histone H3K4 [9], while other family mem-
bers facilitate the removal of di- and trimethyl groups from
other H3 lysine residues (FIGURE 2) [10,11].
The majority of PTMs has been detected on the flexible
N-terminal tails of histones, which protrude from the nucleo-
some core. Histone tails and their PTMs participate in crucial
interactions necessary for the proper regulation of the chro-
matin structure and can be grouped into three main classes:
intranucleosomal interactions with the underlying DNA, inter-
nucleosomal interactions among adjacent nucleosomes, and
interactions with specific DNA/chromatin-related proteins.
Because of their broad interaction potential, PTMs affect a
variety of processes such as gene regulation, chromatin con-
densation, chromosome segregation, DNA replication and
repair. The influence of PTMs can be ascribed to either the
modification-induced electrostatic changes that influence the
affinity of histone tails to the subjacent DNA and/or other
nucleosomes, or to the generation of high-affinity sites for
the recruitment of specific chromatin modules. Although the
majority of PTMs reside on the tails of core histones, recent
findings highlight the potential of the few characterized
PTMs that occur on the globular core domain of histones
(e.g., H3K56ac) in evoking more effective changes to chro-
matin structure. The drastic nature of these modifications is
mainly due to their localization in the nucleosome structure,
including its lateral surface, where crucial DNA–histone
interactions occur. The latter type of PTMs led to the pro-
posal of a new mechanism for the regulation of nucleosome
positioning, which is summarized by the regulated nucleo-
some mobility model [4,12]. According to this model, the
modification(s) of histone residues that interact with DNA
changes the chemical affinity between histone and DNA,
thereby altering the relative mobility of a nucleosome along
DNA. This model also involves ATP-dependent chromatin
remodeling, the contribution of which
to chromatin structure is described in
‘ATP-dependent chromatin remodeling’.
The “histone-code hypothesis” was pro-
posed to explain the influence of PTMs on
chromatin-related processes [2,13,14]. It sug-
gests that PTMs act in a combinatorial way
that can be read by proteins specifically
recognizing certain PTMs or combinations
thereof, and consequently influence dis-
tinct biological functions. Indeed, many
factors, involved in diverse pathways, have
been found to bind PTMs on histone tails
with specific protein domains (modules),
which recognize methyl-groups (chromo-,
tudor-, malignant brain tumor (MBT)-
domain, WD40 repeats and PHD-finger),
acetyl-groups (bromodomain), phospho
groups (14-3-3) and unmodified histone
residues (SANT-domain and PHD-finger)
(TABLE 1) [15,16]. 
Histone PTMs play an especially impor-
tant role in the regulation of transcription
and have been characterized as either tran-
scriptionally active or repressive (see later).
This classification is not clear cut, because
some marks that are linked with gene acti-
vation are also found, in some cases, to
Figure 1. Epigenetic regulatory circuits play a role in the regulation of almost all 
biological processes in eukaryotes. They are interconnected and involve histone 
modifications (PTMs), histone variants, DNA methylation, chromatin remodeling, ncRNAs and 
the position of the particular chromatin region within the nucleus (nuclear architecture).
ncRNA: Noncoding RNA; PTM: Post-translational modification.
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correlate with heterochromatin and vice versa. In general, acety-
lation of lysines and the phosphorylation of serines and thre-
onines are associated with gene activation, sumoylation appears
to repress gene transcription, while methylation and ubiquitina-
tion have variable effects, depending on the precise residues and
context. On the other hand, ADP ribosylation is considered to
be implicated in several chromatin-related functions, such as
regulation of DNA repair pathways, chromatin structural alter-
ations during apoptossis, regulation of higher order chromatin
structures and imprinting (reviewed in [17]). Besides a single
effect of one PTM on biological processes, it has been shown
that certain PTMs cross-talk with each other, leading to “trans-
histone” pathways. One example is the influence of monoubiq-
uitination of histone H2B (H2Bub) on histone H3 modifica-
tions. This modification is necessary for the methylation of
H3K79 and H3K4, but not for the methylation of H3K36 [18].
Although single PTMs have clearly been demonstrated to be
recognized by proteins containing specialized modules (TABLE 1),
studies have recently reported the existence of patterns of co-
existing PTMs. For example, the repressive marks H3K27me3
and H2AK119ub have been found to occur together on tran-
scriptionally silent [19], whereas the active marks H3K4me2/3
and H4K16ac have been found together on transcriptionally
active homeotic genes, which encode important transcription
factors involved in developmental processes [20]. Interestingly,
bivalent domains, marked simultaneously by activating
(H3K4me3) as well as repressing (H3K27me3) PTMs, have
been found at key developmental genes in embryonic stem cells,
indicating the plasticity of these genes in pluripotent cells [21].
These and other reports led to the generation of a multivalency-
based theory, the so-called “nucleosome code” (reviewed in [22]).
Here, the authors suggest that nuclear proteins known to con-
tain numerous effector domains may recognize distinct PTMs
on the same or different histones. This would lead to the forma-
tion of macromolecular complexes, which would play a role in
translating this multivalent PTM code into biological function.
However, direct evidence supporting this model is still lacking. 
Histone variants
Beside the canonical histones, many variants of the core his-
tones H2A, H2B, H3 and the linker histone H1 have evolved
(FIGURE 2); but no histone H4 variant has been characterized to
date. The existence of histone variants was known as early as
1969; however, extensive research on these proteins is a very
recent development [23]. Histone variants have the potential to
displace the canonical histones from the nucleosomal octamer,
altering its nature either by inducing structural changes or by
changing its interaction with other factors (e.g., remodeling
complexes, transcription machinery or other nucleosomes).
Although this exchange procedure is still not thoroughly under-
stood, it is highly dependent on specific proteins (histone chap-
erones) that deliver histone variants to the DNA. Emerging evi-
dence indicates that there might be specific histone chaperones
for different variants [24]. 
Histone H1 and its variants play an important role in the
compaction of chromatin. Although H1 variants are differen-
tially expressed in a developmental and tissue-specific manner,
Figure 2. Constituents of chromatin and variations therein. Depiction of the components that constitute chromatin; DNA, histones 
(variants) and their respective PTMs. DNA containing methyl groups on certain CpG islands is wrapped around a nucleosome consisting of 
an octamer of histone proteins. Variants of the different core histone families are depicted in green in the nucleosome. (Left) Histone 
PTMs, such as lysine (K) methylation, are set by a writer and deleted by an eraser. PTMs are bound by proteins (readers) that contain 
specific recognition modules. (Top) Listing of mammalian core histone variants and their putative function/location in chromatin.
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they appear to be highly redundant (reviewed in [25,26]). Like the
core histones, H1 is involved in epigenetic regulation, but as H1
research is such a vast field on its own (reviewed in [25]), we want
to focus our attention on the functional differences of core his-
tone variants (FIGURE 2). In recent years, several connections
between histone variants and other epigenetic regulatory mecha-
nisms, particularly variant-specific PTMs, have been discovered.
A selection of these will be summarized in the following section. 
Five H3 variants have been identified in mammals: CENP-A
(centromere specific), H3.1, H3.2, H3.3 and H3.1t (testis spe-
cific); the four latter variants differing from each other in only a
few amino acids. CENP-A demonstrates great sequence differ-
ences to the other H3 variants in its N-terminal tail, which is
also highly divergent among species. CENP-A-containing
nucleosomes localize subjacent to the active kinetochore and are
critical determinants of centromeric chromatin [27]. A CENP-A-
specific PTM is its phosphorylation of serine 7 during mitosis,
which might play a role in cytokinesis [28]. 
The histone H3 variants H3.1 and H3.2 differ in only one
amino acid from each other, and recent analysis of expression
and modification patterns suggest that they might function in
different aspects of gene repression [29].
On the other hand, several studies have demonstrated that
H3.3 is associated with transcriptionally active regions in dif-
ferent organisms [30,31]. Interestingly, in humans, it was demon-
strated that the unique serine residue at position 31 of H3.3 is
phosphorylated during metaphase in a subpopulation of H3.3
located directly adjacent to centromeres. The function of this
H3.3-specific PTM is presently unknown [32]. 
In addition to the canonical H2A, the mammalian H2A fam-
ily contains the variants H2A.X, H2A.Z, MacroH2A
(MacroH2A1.1, MacroH2A1.2 and MacroH2A2) and
H2A.Bbd (Barr body deficient). The H2A variants differ
greatly in their respective functions.
H2A.X contains a unique serine residue (S139 in mammals)
that becomes phosphorylated (γ-H2A.X) at foci of DNA double-
strand breaks (DSBs) and constitutes a docking site for DNA-
repair proteins in many organisms. The mechanisms of recruit-
ment are currently under investigation (see ‘ATP-dependent
chromatin remodeling’) [33].
H2A.Z shows only approximately 60% sequence identity to
the canonical H2A. Multiple studies implicated H2A.Z with
the formation of heterochromatin (in higher eukaryotes) as well
as the prevention of heterochromatin spreading (in yeast), sug-
gesting that H2A.Z might have acquired diverse functions in
different species [34].
H2A.Bbd is an unusually short mammalian H2A variant that
is only 48% identical to H2A and is found on all chromo-
somes, except for the female inactive X chromosome (Xi). It co-
localizes with acetylated histone H4, suggesting an association
with transcriptionally active chromatin [35]. In addition, differ-
ent groups could show that nucleosomes containing H2A.Bbd
rather than canonical H2A are less stable and have a more
relaxed conformation, suggesting that the incorporation of
H2A.Bbd is another mechanism of unfolding chromatin [36–38].
MacroH2A, the longest and most unusual H2A variant, is ver-
tebrate-specific and consists of a N-terminal H2A-like and a large
C-terminal nonhistone region (the macrodomain) [30].
MacroH2A is associated with the Xi and thought to play a role in
maintaining the transcriptionally inactive state of this chromo-
some [39]. Its macrodomain has been shown to constitute a spe-
cific-binding module for ADP-ribose and might even display
enzymatic activity [40]. Additionally, ubiquitination of
MacroH2A seems to be involved in the localization of this variant
to the Xi [41]. Besides its role in X inactivation, recent work
showed that MacroH2A inhibits transcription. Mechanistically,
the macrodomain prevents acetylation of adjacent histone tails
and chromatin remodeling [42], (see ‘Chromatin remodeling’).
Table 1. General histone modifications and their respective protein families that enzymatically catalyze 
the formation of marks (writers), enzymes that remove PTMs (erasers) and proteins that specifically bind 
to histone PTMs (readers).
Post-translational 
modifications
“Writer” families “Eraser” families “Reader” modules
Lysine methylation Set and Non-Set proteins Jumonji Chromodomain, Tudor, MBT, PHD
Arginine methylation PRMT Deiminase, Jumonji WD40 repeat
Acetylation HAT HDAC Bromodomain
Phosphorylation Kinase Phosphatase 14-3-3
Ubiquitination E1, E2, E3 ligases Deubiquitinase ?
SUMOylation SUMO Desumoylase (?) ?
ADP ribosylation PARP ? ?
Unmodified SANT, PHD
HAT: Histone acetyltransferases; HDAC: Histone deacetylases; MBT: Malignant brain tumor; PARP: Poly(ADP-ribose) polymerase; PRMT: Protein arginine 
methyltransferases; SUMO: Small ubiquitin-like modifier.
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MacroH2A incorporation is also influenced by the DNA
methylation status of centromeric heterochromatin. The loss of
DNA methylation leads to increased incorporation of MacroH2A
into pericentric regions and thus to the reorganization of hetero-
chromatin [43]. 
In mammals, only three bona fide H2B variants (hTSH2B,
H2BFWT and spH2B) have been found to date. All of these
variants reside in the testis and their functions are largely
unknown (reviewed in [30]).
Multiple examples for functional connections between his-
tone variants and chromatin remodeling complexes are known
and will be discussed in the following parts. 
DNA methylation
Virtually all vertebrates, many plants and even many inverte-
brates contain chemical modifications on cytosine bases at dis-
tinct positions in the genome that heritably influence the regu-
lation of genetic information (FIGURE 2). DNA methylation,
perhaps the best characterized epigenetic modification, results
in long-term silencing of the underlying sequence and is essen-
tial for many different cellular functions, including cell differ-
entiation, gene regulation, genomic imprinting, X inactivation
and aging [44,45]. Two mechanisms contribute to the inhibition
of gene transcription: 
• DNA methylation inhibits the association of some DNA-
binding factors with their recognition sequence [46] 
• Methylated CpG dinucleotides recruit specific binding factors
involved in gene silencing [47,48] 
DNA methylation patterns are highly dynamic and are
established during early mammalian development with differ-
ences between the paternal and maternal genomes [49,50].
Defects in DNA methylation lead to diverse disorders, ranging
from mental retardation and immune deficiencies to malignant
transformations [51–54].
Mammals express a number of DNA (cytosine 5) methyl-
transferase (DNMTs) isoforms, which are responsible for the
establishment and maintenance of DNA methylation patterns
[55]. These are expressed in cell type- and stage-specific manners
due to sex-specific germline promoters [56,57]. In vertebrates,
DNA methylation sites are (with minor exceptions) almost exclu-
sively CpG dinucleotides [44], whereas in plants, cytosine methyl-
ation also occurs outside of CpGs [58]. The methylation status of
the promoters of key transcription factors for pluripotency, Oct-4
and Nanog, correlates well with their expression pattern [59] and
tissue-specific demethylation of the Il-2 and Sry promoters leads
to transcriptional activation [60,61]. Large-scale analyses (bisulfite
sequencing) demonstrated that the DNA methylome differs
between embryonic stem cells and differentiated cells, and also
between normal and tumor tissue [45].
DNA methylation plays a key role in genomic imprinting of
a selected panel of genes where only one of the two parental
alleles in mammals and plants is modified. In mammals,
imprinted genes are organized in large chromosomal clusters
with DNA methylation and gene expression patterns depend-
ing on whether they are inherited from the mother or from the
father [62]. Genomic imprinting involves both DNA and his-
tone methylation and is controlled by crucial DNA sequence
elements called imprinting control regions (ICRs), which are
rich in CpG dinucleotides. During female gametogenesis, most
ICRs are methylated, whereas during spermatogenesis, methyl-
ation occurs only at some ICRs. Following fertilization, meth-
ylation of ICRs is maintained resulting in different methylation
patterns on paternal and maternal chromosomes in somatic tis-
sues. DNA methylation is only removed by passage through the
newly formed germline in the developing embryo. 
DNA methylation has been connected to other epigenetic
modules in several recent studies within diverse organisms. In
many organisms, particularly plants, DNA methylation has
been linked to histone PTMs and ncRNAs (see ‘Non-coding
RNAs’). There is emerging evidence that methyl-CpG binding
proteins, such as MeCP2 or methyl-CpG-binding domain
protein 2 (MBD2), are found in large protein complexes con-
taining HDACs and chromatin remodeling factors (see ‘ATP-
dependent chromatin remodeling’) [63]. All known DNA meth-
ylation in Neurospora crassa and some known DNA methyla-
tion in Arabidopsis depends on methylation of H3K9 [64–66]. In
mouse embryonic stem cells, major satellite DNA in pericentric
regions, but not minor satellite repeats and endogenous retro-
viral sequences, show reduced DNA methylation in Suv39h
(the enzyme responsible for H3K9me3) mutants [67]. 
Recently, a negative influence of histone PTMs on DNA
methylation has been established. It was shown that a DNMT3
complex, containing the enzymatically active subunits
DNMT3A2 and DNMT3B as well as the adapter protein
DNMT3L, interacts with the N-terminal tail of H3 and in turn
methylates the underlying DNA sequence. Interestingly, methy-
lation of H3K4 strongly inhibits binding of this complex,
thereby preventing DNA methylation and gene silencing [68].
These data suggest that PTMs and other chromatin modifying
activities have strong influences on DNA methylation.
ATP-dependent chromatin remodeling 
In addition to histone PTMs, histone variants and DNA
methylation, which are modifications of the constituents of
chromatin, the modulation of nucleosomes themselves is
another important principle affecting the accessibility of
genomic information. This includes ATP-dependent chroma-
tin or nucleosome remodeling, which is achieved by remodel-
ing ‘machines’, which are most often large multisubunit com-
plexes, using ATP hydrolysis to mobilize histones by weakening
histone–DNA contacts. This can result in different alterations
of the chromatin substrate, such as relocalization of nucleo-
somes on the DNA (sliding), changes in the accessibility of the
DNA to interacting proteins (e.g., transcription factors) or
eviction of histones (reviewed in [69–71]).
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In general, remodeling complexes are classified by their
ATPase subunit, which belongs to one of the four subfamilies
of the Swi2/Snf2 family of DNA helicases/ATPases: ISWI,
SWI/SNF, CHD and INO80 [70]. Despite the multitude of
complexes and their biological functions, remodelers appear to
share the same mechanistic principle: detaching a piece of
DNA and subsequent migration of this bulge around the
nucleosomal superhelix (bulge propagation) [70,71]. The remod-
eling reaction can result in both increase or decrease of DNA
accessibility, depending on the respective complex [71].
Recruitment of remodelers to their substrate involves genetic
as well as epigenetic determinants. Besides recruitment of
remodelers by interaction with sequence-specific DNA-binding
proteins, histone modifications can target remodelers that con-
tain several modules that are able to interact with either methy-
lated (chromodomain, PHD-finger) or acetylated (bromo-
domain) lysines (reviewed in [71,72]). Pray-Grant et al. provided
the first example of the direct binding of a chromodomain-con-
taining remodeler (Chd1) to a methylated lysine residue
(H3K4me2) [73]. Recently, Wysocka et al. coupled the recruit-
ment of the NURF chromatin remodeling complex via inter-
action of a particular PHD finger in its subunit BPTF to
H3K4me3, which leads to gene activation [74]. However, remod-
eler binding can also be inhibited by specific histone modifica-
tions. As Clapier et al. showed, ISWI binding to chromatin is
inhibited by PTMs (H4K12ac or H4K16ac, respectively),
thereby masking its recognition epitope [75].
Additionally, it has been demonstrated that chromatin
remodeling is not only an effect, but also a cause of histone
modifications. One example is the cell cycle-regulated expres-
sion of the HO gene in budding yeast, which encodes an endo-
nuclease participating in mating type switching. The remodel-
ing complex SWI/SNF is required for the recruitment of the
HAT complex SAGA to the HO gene promoter and the acetyl-
ation of nucleosomes residing there, which leads to HO gene
activation [76,77]. Adding another layer of complexity, remodel-
ers can also be substrates of histone-modifying enzymes, as
recently reported for ISWI, which can be acetylated by the
HAT Gcn5 [78].
The biological significance of the interaction of remodelers
and histone core PTMs can be explained by the regulated
nucleosome mobility model (see also ‘Histone variants’) [4,12].
The model proposes that remodelers (possibly recruited by
PTM(s) of the N-terminal tail) increase the histone acces-
sibility for modifying enzymes, which consequently modify
residues of the globular histone core domain. This would lead
to an altered histone–DNA affinity and thus changes in
nucleosome mobility. 
Additionally, histone variants and chromatin remodeling
influence each other. While it has been shown that
MacroH2A can inhibit remodeling by both SWI/SNF and
ACF (see ‘Histone variants’) [39,42], different complexes have
been found to only act in concert with certain variants. For
example, exchange of H2A/H2B dimers towards Htz1/H2B
(the yeast homolog of H2A.Z) requires the SWR1 remodeling
complex in Saccharomyces cerevisiae [79–81], while incorporation
of H3.3 into chromatin in the decondensing male pronucleus
of Drosophila embryos requires the remodeler Chd1 [82]. The
latter study also highlights the importance of ATP-dependent
chromatin remodeling for de novo nucleosome assembly in vivo.
Furthermore, ATP-dependent chromatin remodeling has
also been linked to both histone PTMs and histone variants.
One example of this circuit can be found in the DSB repair
process. The histone variant H2A.X is recruited to sites of
DSBs and phosphorylated on serine 139 (γ-H2A.X)
(FIGURE 3A). Kusch et al. demonstrated that the Drosophila
homolog of the Tip60 complex, which contains the HAT
Tip60 and the chromatin remodeler Domino, acetylates
lysine 5 of the phosphorylated Drosophila homolog of H2A.X
(γ-H2A.X) shortly after the occurrence of DSBs (FIGURE 3B).
This acetylated form of γ-H2A.X is then exchanged with an
unmodified H2A.X through the ATPase Domino (FIGURE 3C)
[83]. During repair, this potentially creates a new sensor site
for DNA damage occurring in the future. Different remodel-
ing complexes, such as RSC, SWI/SNF, INO80 and SWR,
have also been implicated in the cellular response to DNA
damage, indicating that remodeling activity in connection with
other chromatin-related processes, is important for further
mechanisms extending gene regulation [84]. 
Not only histone PTMs can recruit ATP-dependent remod-
eling complexes, but methylated DNA can also target remodel-
ing activity [69]. One example connecting histone modifica-
tions, DNA methylation and chromatin remodeling is the
human MeCP1 complex. It consists of the NuRD remodeling
complex, which, in addition to the remodeling activity, also
contains several histone deacetylases and MBD2 (a methyl-
DNA binding protein). Functional analyses of the MeCP1
complex revealed that it preferentially binds to methylated
DNA and remodels and deacetylates nucleosomes. These
events lead to subsequent gene silencing [85,86]. 
Noncoding RNAs
Noncoding RNAs (ncRNAs) are a heterogeneous group of
RNAs that are not translated into proteins. They can be catego-
rized based on their regulatory potential. ncRNAs such as
rRNAs, tRNAs, snRNAs and snoRNAs, are more or less
directly involved in the mechanism of gene expression, but
steadily growing evidence illustrates the importance of ncRNAs
in the regulation of gene expression. In this section, we want to
introduce the main classes of regulatory ncRNAs and discuss
their connections with other epigenetic mechanisms. ncRNAs
can act on the locus they are derived from (cis) or they act on
another locus (trans).
Since the discovery of RNAi in Caenorhabditis elegans in
1998 [87], multiple subgroups of small ncRNAs,
19–31 nucleotides in length, have been identified. These small
ncRNAs function in different gene silencing pathways and
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include, among others, siRNAs and miRNAs. Both are derived
from a long double-stranded precursor RNA processed by
Dicer, and incorporated into the RNA-induced silencing com-
plex (RISC), which is responsible for targeting the respective
mRNA transcript. The subunits directly interacting with these
small ncRNAs belong to the family of Argonaute (Ago) pro-
teins. In general, siRNAs mediate cleavage of target mRNAs,
whereas miRNAs repress their translation (reviewed in [88]).
In addition to the post-transcriptional gene silencing
described above, small ncRNAs can promote transcriptional
silencing by different mechanisms. One such mechanism is
the induction of histone modifications, for which the assem-
bly of heterochromatin in Schizosaccharomyces pombe is an
example. The siRNA component of the RNA-induced initia-
tion of transcriptional gene silencing complex (RITS) is
responsible for targeting the complex to homologous
sequences, subsequently leading to a distribution of RITS over
heterochromatic regions [89–91]. Additionally, the chromo-
domain of one of its subunits (Chp1) binds to histone H3
methylated on lysine 9, thus localizing RITS to chromatin [89].
In a later step, H3K9 methylation is spread by the recruitment
of the HMT Clr4, leading to the assembly and maintenance
of heterochromatin [92].
Interestingly, small ncRNAs have also been connected to
DNA methylation by a process called RNA-directed DNA
methylation, which is found in plants (reviewed in [93]). These
small ncRNAs, many of which originate from transposons and
repeats, are targeted to their homologous DNA sequences, to
which they recruit DNMTs that, in turn, methylate the
underlying DNA. This process is thought to play a role in the
regulation of plant development and perhaps stress response. 
Only recently, two independent groups demonstrated that
small ncRNAs are not only able to repress gene expression, but
can also activate it (dsRNA-induced gene activation [RNAa]); a
process that combines histone PTMs with ncRNAs [94,95]. Li
et al. designed double-stranded RNAs against promoter regions
of different human genes. Surprisingly, instead of silencing
genes, these RNAs led to a long-lasting, sequence-specific tran-
scriptional activation of the respective target gene in vivo. The
observed effect was Ago2-dependent and occurred with a loss of
repressive H3K9 methylation at target sites. By targeting other
regions in the respective promoters with the same method, it
was still possible to repress transcription of these genes [95].
Although these results clearly show the possibility of activating
gene expression by small ncRNAs, to date no evidence has been
found that this is an endogenous mechanism.
Figure 3. Connection of post-translational modifications, histone variants and remodeling. (A) The histone variant H2A.X is 
recruited to sites of DNA DSBs and phosphorylated on serine 139 (γ-H2A.X). (B) The histone acetyltransferase Tip60 acetylates lysine 5 
(K5) on γ-H2A.X, leading to (C) the exchange of γ-H2A.X-H2B dimers with unmodified H2A.X–H2B dimers through the ATP-dependent 
remodeler Domino within the same complex.
DSB: Double strand break.
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In addition to the small ncRNAs described thus far, there
are a number of long(er) ncRNAs that are also implicated in
the regulation of gene expression. In the following we will
provide examples of epigenetic circuits that involve long
ncRNAs, histone PTMs, histone variants, DNA methylation
and ATP-dependent chromatin remodeling.
One example is the regulation of HOX genes during devel-
opment. HOX genes encode transcription factors, which are
crucial for establishing morphologies along the head–tail
axis in the embryos of various organisms. They are clustered
along chromosomes in a co-linear arrangement, with their
expression along the body axis [96]. A recent analysis of tran-
scriptional activity at human HOX clusters demonstrated a
positive correlation between antisense transcription from
intergenic regions at the HOXA locus and the activity of
neighboring HOXA genes. HOXA gene activation is accom-
panied by the loss of the polycomb repressive complex
PRC2, which methylates H3K27, and the simultaneous
increase in histone marks associated with active chromatin.
The ncRNAs derived from the HOXA cluster therefore act
in cis to induce and maintain the active state of this
cluster [97]. An example for trans repression is the long
ncRNA HOTAIR (2.2 kb), which is encoded in the HOXC
cluster. HOTAIR has been identified to act in trans to
repress the transcription of the HOXD locus. HOTAIR was
shown to directly recruit PRC2 to the HOXD cluster, thus
mediating H3K27me3 at this locus [98]. These findings
implicate the manifold roles of ncRNAs in the regulation of
HOX gene transcription. 
Another remarkable example for the concerted action of epi-
genetic mechanisms is the transcriptional silencing of rRNA
genes (rDNA) in mammals (FIGURE 4). In this scenario, the nucle-
olar remodeling complex (NoRC) is targeted to the rDNA
locus by specific interactions with the transcription termination
factor TTF-1 [99], with H4K16ac (via a bromodomain) [100]
and with a long ncRNA derived from the intergenic spacer that
separates rRNA genes (FIGURE 4A) [101]. NoRC remodels chroma-
tin and mediates histone deacetylation by recruitment of
HDAC1 (FIGURE 4B). Subsequently, NoRC recruits a DNA
methyltransferase (DNMT) leading to CpG methylation and
gene silencing (FIGURE 4C). Interestingly, this epigenetic state can
be inherited by the next generation [102].
One of the best-studied examples for the role of long
ncRNAs in gene regulation is found during dosage compensa-
tion in flies and mammals. In both cases, females have two
X chromosomes while males have only one. In Drosophila, dos-
age compensation is achieved by approximately twofold
upregulation of X-linked gene transcription in male flies. Here,
X-encoded ncRNAs, together with different proteins, build the
dosage compensation complex that has been shown to acetylate
H4K16 [103].
By contrast, random X inactivation occurs in the mam-
malian female embryo (FIGURE 5). The initiation of X inactiva-
tion depends on the expression of the 19-kb ncRNA Xi-spe-
cific transcript (Xist), which is transcribed from specific
X-linked DNA sequences termed the ‘X-inactivation center’
(Xic). Xist coats the X chromosome and induces silencing in
cis (FIGURE 5A). At later stages, the repressed state of the Xi is no
Figure 4. Connection between post-translational modifications, ATP-dependent remodeling, DNA methylation and 
noncoding RNAs. (A) Interactions of the remodeler complex NoRC with TTF-1, H4K16ac (via a bromodomain) and an intergenic ncRNA 
from the locus lead to its recruitment to the rDNA locus. (B) NoRC remodels chromatin (not shown) and recruits HDAC1, which 
deacetylates histones. (C) Binding of a DNA methyltransferase to NoRC leads to CpG methylation and subsequent silencing of the locus.
ncRNA: Noncoding RNA; NoRC: Nucleolar remodeling complex; rRNA: Ribosomal RNA.
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longer Xist dependent, but becomes locked by several changes
in its chromatin structure (reviewed in [104]). The establish-
ment of X-inactivation starts with the transient localization of
PRC2 to the Xi to set the H3K27me3 mark, and subsequent
recruitment of PRC1 leading to ubiquitination of H2AK119
(FIGURE 5B). To further lock the inactive state, the histone vari-
ant MacroH2A is incorporated into nucleosomes of the Xi
and the promoter DNA of X-linked genes is methylated by
DNMT (FIGURE 5C). The recruitment of MacroH2A appears to
be Xist dependent, however, no direct association between the
histone variant and the long ncRNA has been observed to
date. Consistent with its heterochromatic state, the Xi is spa-
tially segregated from its active counterpart and associates
with the nuclear scaffold protein SAF-A. This interaction
helps the formation of a repressive nuclear compartment
(reviewed in [105]).
The examples presented above clearly provide evidence for
epigenetic regulatory circuits connecting ncRNAs and other
components of the chromatin-modifying machinery.
Nuclear architecture 
In the nucleus, chromatin is organized in a nonrandom, highly
structured yet dynamic fashion that possibly determines the
expression status of genes. In this section, we will first intro-
duce certain features that constitute nuclear architecture and
then present some examples that functionally connect nuclear
architecture with the other epigenetic circuits. 
Chromosomes occupy certain positions, so-called ‘chromo-
some territories’ (CTs). Although recent findings revealed that a
large proportion of the genome is actually transcribed [106], active
and gene-rich (euchromatic) chromosome sections are,  generally,
located in the interior, silent and gene-poor (heterochromatic)
sections are located at the periphery of the nucleus (reviewed in
[107,108]). An exception to this rule can be found in yeast. In this
organism, some actively transcribed loci are located closely to the
nuclear pores, suggesting that facilitating RNA export (gene gat-
ing) has an exceptionally positive effect on transcription in the
small yeast nucleus (reviewed in [107,109]).
Figure 5. Connection between post-translational modifications, histone variants, DNA methylation, long noncoding RNAs 
and nuclear architecture on the Xi. (A) Initiation of mammalian X chromosome inactivation. The female X chromosome loses its active 
marks (not shown) and the long ncRNA Xist starts to coat the Xi. (B) Establishment of X inactivation. PRC1 and PRC2 are recruited to the 
Xi and ubiquitinate H2AK119 and methylate H3K27, respectively. (C) Maintenance of X inactivation. The promoter sequence of X-linked 
genes is methylated by a DNMT and the histone variant MacroH2A is incorporated. Eventually, the Xi associates with the nuclear scaffold 
protein SAF-A, establishing a repressive nuclear compartment (not shown, see also ‘Noncoding RNAs’).
ncRNA: Noncoding RNA; Ub: Ubiquitination.
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In addition to CTs, the nucleus contains several types of
structural and functional entities not surrounded by mem-
branes, such as the nuclear lamina (scaffolding function),
nucleoli (production and assembly of ribosome components),
promyelocytic leukemia (PML) bodies (associated with many
biological functions; e.g., transcription, apoptosis and pro-
teolysis), Cajal bodies (assembly and modification of the
transcription machinery) and nuclear speckles (enriched in
splicing factors); (for review see [109,110]).
Transcription and RNA processing occur in the inter-
chromatin (IC) compartment, which constitutes approximately
half of the nucleus without detectable amounts of DNA
(reviewed in [108,111]). It is expected that this compartment con-
sists of channels and cavities very different in size, pervading
the CTs and thereby leading to an enormous increase of accessi-
ble chromatin surface [111]. At the periphery of compact chro-
matin domains resides the perichromatin region. This region
consists of decondensed chromatin looping out of its chromo-
some territory. Interestingly, these chromatin loops can interact
with each other in an event termed ‘gene kissing’, even if they
are located far away on the same chromosome (cis) or on differ-
ent chromosomes (trans) [111]. The resulting relocalization of
chromosomal loci also contributes to the nuclear architecture,
albeit at a smaller scale.
It has been proposed that actively transcribed loci and regula-
tory elements come together in distinct foci of active transcrip-
tion, so-called ‘transcription factories’, where RNA Pol II and
associated factors are enriched. Although there is some experi-
mental evidence for their existence [112] (for reviews see [107,113]),
location within such foci does not appear to be a requirement
for transcription of the respective gene [114]. Consequently, the
biological relevance and generality of transcription factories is
still of some controversy [114].
An intriguing example for gene activation by interaction of
certain loci in concert with DNA methylation is the receptor
choice in olfactory sensory neurons in mouse. In these cells,
only one out of 1300 odorant receptor (OR) genes of the
genome is expressed. Lomvardas et al. found that this is caused
by the stochastic interaction of a monoallelic functional
enhancer sequence with an OR gene leading to this gene’s
expression [115]. Remarkably, only in sensory neurons, one of
these enhancer alleles carries a nonclassical CpA methylation,
which could be involved in defining the functionality of the
enhancer sequence.
In addition, DNA methylation influences the structure of
imprinted loci causing their differential expression (for details
about imprinting, see ‘DNA methylation’). A prominent exam-
ple is the Igf2–H19 locus in mammals where only the paternal
allele of Igf2 is expressed. Transcription of the Igf2 gene
requires its interaction with downstream enhancers; both are
separated by the ICR H19. This ICR, as well as sequences
flanking the Igf2 gene, contain several binding sites for the
insulator protein CCCTC-binding factor (CTCF). Insulator
proteins act by blocking interactions of genes with enhancers
by binding to insulator elements, which are often located in
between these sequences. CTCF binding to its recognition site
is abolished by CpG methylation, which is present on the pater-
nal, but not on the maternal, allele. Hence, CTCF exclusively
interacts with its binding sites within the maternal ICR and Igf2
flanking sequences leading to the looping of the Igf2 gene. This
event prevents the association with the downstream enhancers
and results in transcriptional silencing of the maternal allele. In
addition, it was shown by different chromosome conformation
capture methods, which allow the detection of loci interactions
at a molecular level, that other genomic loci in cis and trans are
regulated by the H19 ICR via long-range contacts mediated by
CTCF (reviewed in [107,116]). 
Colocalization of loci can also involve writers of histone
PTMs. One example is the gene silencing by Polycomb
Group (PcG) proteins in Drosophila. PcG proteins specifically
recognize DNA sequences, termed ‘PcG response elements’
(PREs), and lead to heterochromatin formation with subse-
quent gene silencing (reviewed in [19,117]). This mechanism
also involves the colocalization of genomic loci, either of
homologous PRE sequences [118] or of independent chromo-
somal loci [119]. Besides the involvement of chromatin modifi-
ers, this colocalization also requires components of the RNAi
machinery, which also co-localizes with PcG bodies [120].
Interestingly, the mechanism of gene silencing at the nuclear
envelope functionally connects the position of a gene with epi-
genetic processes. This mechanism involves interactions of
lamin-associated polypeptides (LAPs) with proteins that pro-
mote heterochromatin formation (“writers” and “readers” of
histone PTMs; for review see [121]). The nuclear envelope pro-
tein lamin B receptor has been shown to interact with hetero-
chromatin protein 1 (HP1), and LAP2β was found to bind to
HDAC3 (reviewed in [109]). These results demonstrated that
specific nuclear compartments are able to recruit different pro-
teins involved in epigenetic processes, which in turn change the
structure of chromatin.
Different compaction levels of chromatin (i.e., establishment
of either decondensed euchromatin or condensed hetero-
chromatin) influence nuclear architecture and subnuclear local-
ization. Hence, all mechanisms involved in assembly and main-
tenance of these specific chromatin structures, such as histone
PTMs and variants, chromatin remodeling, DNA methylation
and ncRNAs, might also contribute to nuclear architecture and
vice versa.
Expert commentary & five-year view
In the coming years, it will be crucial to combine the knowledge
researchers have gathered about the different components that
constitute and regulate chromatin and its structure into a multi-
dimensional picture that connects all of these aspects. Of course,
much work is still needed to obtain a complete picture of all his-
tone PTMs and their functional relationship, to identify all his-
tone variants and their functions, and to understand why so
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many ATP-dependent remodelers are so abundant and how their
specificity is determined. We also need to enhance our under-
standing of the functions of different ncRNAs, especially after
the finding that almost the complete human genome is tran-
scribed, an observation that changes our view of what constitutes
a gene [106]. There are many basic questions to be answered in the
next years, for example, how ncRNAs regulate chromatin struc-
ture and how the specificity in their regulation is achieved. Fur-
thermore, we still know very little about the relationship between
nuclear architecture and epigenetic processes. Does the position
of a chromatin domain in the nucleus influence its gene expres-
sion or is the specific nuclear location just a consequence of its
regulation? What is cause and what is consequence? 
Many chromatin-related processes have been shown to play a
significant role in the development of various diseases when
deregulated. These include histone PTMs, readers and writers
of PTMs, DNA methylation and ATP-dependent chromatin
remodelers (reviewed in [122,123]). Based on these and numer-
ous other reports, efforts are underway to develop therapeutics
that target epigenetic mechanisms. One example is suberoyl-
anilide hydroxamic acid (SAHA), which belongs to the class of
HDAC inhibitors, and was recently approved for the treat-
ment of cutaneous T-cell lymphoma [124]. In addition, soon
after discovering RNAi as a mechanism to silence genes in
mammalian cells, Phase I clinical studies started to evaluate the
therapeutic efficacy of this system. The first results obtained
from numerous studies in different organisms are promising.
However, problems remain, including the delivery of the RNA
to the affected tissue, its half-life and potential off-target
effects. Although these problems remain to be overcome, the
enormous potential of siRNA drugs can already be anticipated
from these studies (reviewed in [125]). But not only siRNAs
open huge opportunities for therapeutic use, also the recently
discovered RNAas have been proposed for this purpose.
Regardless of whether RNAa is a biological phenomenon or
not, one can imagine RNAas as another useful tool for treating
various diseases [94,95].
In addition to diseases such as cancer, epigenetic alterations,
such as DNA methylation, have been found to contribute to
the process of aging, which in turn might increase the risk of
developing cancer. Global hypomethylation and CpG island
hypermethylation accumulate with increasing age and might
lead to gene deregulation (reviewed in [126]). These and many
other observations clearly demonstrate that many different epi-
genetic mechanisms contribute to the variation in the chroma-
tin polymer and have far-reaching implications for biology and
human health. 
The next 5 years will hopefully shed light on many open
questions regarding the interplay between many chromatin-
related processes which we tried to overview here, and the
mechanisms by which chromatin-based information is car-
ried from one generation to the next. Only when we learn
more about the functional connections of all epigenetic
“players” involved, which constitute the epigenetic regulatory
circuit, will we gain the crucial insights into how genetic
information is regulated and how we can integrate these
findings in clinical applications. 
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Key issues
• Post-translational histone modifications change chromatin structure directly through charge differences and/or indirectly by 
serving as a binding platform for ‘effector’ proteins that translate this coding information into biological readouts.
• Histone variants differ in their amino acid sequence from canonical histones and are found in specific chromatin regions, thereby 
suggesting that they might have different biological functions. 
• DNA methylation predominantly occurs at promoter regions on CpG islands in mammals and is associated with gene silencing. It is 
inherited without any DNA sequence changes and is therefore considered a true epigenetic mark. 
• ATP-dependent chromatin remodeling is performed by multisubunit protein complexes, which slide or evict nucleosomes on 
specific chromatin sites and modulate chromatin dynamics. 
• Noncoding RNAs are involved in the regulation of gene expression either by repressing transcription through influencing 
chromatin structure, or by guiding RNA cleavage and translation repression.
• Nuclear architecture describes nuclear components as well as the localization of genomic loci in the highly structured nucleus. 
Correct positioning of chromatin domains to specific nuclear components can lock chromatin in a close and transcriptionally 
inactive conformation. 
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1.2 THE NUCLEOSOME 
The “monomeric building block” of chromatin, the nucleosome, contains about 150 bp of DNA 
wrapped around a histone octamer consisting of two of each of the core histones H2A, H2B, H3 and 
H4 in 1.65 left-handed superhelical turns (16). The existence of a chromatin subunit, the nucleosome, 
was first proposed in 1973/74 based on regular patterns upon nuclease digestion and electron 
microscopic analyses of chromatin ((13-15), for review see (19,20)). About 25 years later, the 
nucleosome structure at 2.8 Å resolution revealed its fascinating details (16). The (H3-H4)2 tetramer is 
built by connecting two H3-H4 dimers at the dyad symmetry axis via a strong 4 helix bundle (4 HB) 
between the two H3 molecules. Interaction of H2A-H2B dimers with this tetramer is accomplished by 
a weaker 4 HB between H2B and H4 with additional interactions provided by the C-terminal H2A 
docking domain with H3 and H4, directing the H3 N-terminal helix to interact with DNA (Figure 1). 
Furthermore, contacts between the H2A loop 1 (L1) regions of the two H2A-H2B-dimers stabilize 
their association within the nucleosome (Figure 1). However, the nucleosome is not a static entity but 
rather flexible and dynamic (see (19-21) and references therein). As reviewed in van Holde et al., 
evidence for nucleosomes organizing DNA lengths between 100 and 170 bp is abundant, stressing that 
the crystal structure with 147 bp must rather be viewed as a “snapshot”. In addition, recent single 
molecule analyses using Förster resonance energy transfer (FRET) contributed to the characterization 
of nucleosome dynamics providing evidence for an alternative, more open nucleosome state (0.2% to 
3% under physiological salt conditions in vitro) where all histones are bound to DNA but the 
dimer/tetramer interactions are broken (19,22). 
Histone variants are non-allelic isoforms of canonical histones that differ in both, their primary 
sequence as well as their expression timing (23). Expression of canonical histones is almost 
completely limited to S-phase, whereas most histone variants are expressed throughout the cell cycle. 
The S-phase dependent expression of canonical histones is mainly due to their unique mRNA structure 
(24). In general, canonical histone genes lack introns and their corresponding mRNAs are not 
polyadenylated but have a unique 3´ stem loop crucial to modulate mRNA stability, transport and 
translation. In contrast, histone variant mRNAs are polyadenylated and their pre-mRNAs can contain 
introns (24). To date, only two histone transcripts have been shown to be alternatively spliced, 
macroH2A1 (25) and H2A.Z.2 (26,27), giving rise to histones with distinct functional and structural 
properties, respectively. 
In the following section I summarize literature on H2A variants biology. Here I do neither discuss 
their influences on nucleosome structure and stability nor on higher-order chromatin structure, since 
these are the topics of the discussion section. 
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Figure 1: The crystal structure of the nucleosome. (A) Amino acid sequence of histone H2A type 1 
from Xenopus leavis (NCBI Reference Sequence: NP_001089684.1). -helices are indicated by boxes 
below and important structural features are highlighted with colored boxes (L1 loop: magenta, acidic 
patch: cyan and docking domain: orange). The color code for the amino acids is red: small, 
hydrophobic (A, V, F, P, M, I, L, W); blue: acidic (D, E); magenta: basic (R, K); green: hydroxyl, 
sulfhydryl, amine, glycine (S, T, Y, H, C, N, G, Q) (B) Nucleosome crystal structure based on ((16), 
PDB ID: 1AOI). H2A is shown in yellow, H2B in red, H3 in blue, H4 in green and DNA in light gray. L1 
loop, acidic patch and docking domain are highlighted and shown in magenta, cyan and orange, 
respectively. Zoomed images of docking domain and L1-L1 interface are depicted on the right. All 
pictures were generated using PyMOL (28). 
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1.3 THE HISTONE H2A FAMILY 
Due to the specific nucleosomal protein-protein and protein-DNA interactions of each of the core 
histones, they are subject to different degrees of structural constraint probably resulting in different 
potentials to evolve variants (7,29). For example, H4 is one of the most slowly evolving eukaryotic 
proteins (29) with variants only described in tetrahymena (30), trypanosomes (31) and the 
urochordate, Oikopleura dioica (32). The H2A family, on the other hand, contains a plethora of 
variants with some “universal variants” found in almost all organisms, namely H2A.Z and H2A.X (7). 
These different degrees of variation might be attributed to the extensive intranucleosomal interactions, 
in the case of H4, and the location of H2A on the “edges” of the nucleosome. In general, the highest 
degree of diversification among histone H2A variants is to be found in their C-termini, regarding both 
length and amino acid sequence ((33) and Figure 2). 
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Figure 2: Amino acid sequences of human H2A variants. Alignments of human H2A type 1 (NCBI 
Reference Sequence: NP_003501.1) with (A) H2A.X (NP_002096.1), (B) H2A.Z.1 (NP_002097.1), (C)
H2A.Bbd (NP_001017990.1) and (D) macroH2A1.2 (NP_004884.1). Important structural features are 
highlighted with colored boxes. For details on color coding see legend of Figure 1. The consensus 
symbols below the alignment are: an asterisk (*) to indicate fully conserved residues, a colon (:) to 
indicate conservation between groups of strongly similar properties and a period (.) to indicate 
conservation between groups of weakly similar properties. (D) MacroH2A1.2´s linker region (aa 122-
160) and macro domain (aa 161-370) are highlighted with dark gray and light gray boxes, respectively. 
All alignments were carried out using the ClustalW alignment tool on the EBI homepage (34,35). 
H2A´s position within the nucleosome might explain this finding. Its C-terminus is located at the DNA 
entry/exit site (Figure 1), making variations at this domain a powerful tool to functionally diversify 
nucleosomes by altering nucleosome stability and dynamics, binding to DNA and/or the linker histone 
H1 or other interacting factors. Furthermore, the L1 region in the histone fold, where interaction 
between the two H2A variants takes place, shows a high degree of variation among H2A variants 
(Figure 2). 
In addition to the bona fide H2A variants (discussed below), canonical H2A proteins are not 
completely identical but rather show some sequence variability. In 1977, based on electrophoretic 
separation and subsequent analysis of amino acid composition, two different H2A isoforms (H2A.1 
and H2A.2) that differ in amino acid position 51 (leucine or methionine respectively) were identified 
in mammals (36). After the human and mouse genomes were sequenced, it became apparent that 
canonical H2A proteins can differ in many more positions, especially in the C-terminal six amino 
acids (23). However, thus far no functional specialization of these canonical H2A isoforms has been 
demonstrated. 
Interestingly, in addition to canonical H2A, H2A.X- and H2A.Z-like proteins, plants exhibit a special 
class of H2A isoforms which have an extended C-terminus comprising SPKK motifs (37,38). This 
kind of motif (more general T/SPXK) is also present in many subtypes of the linker histone H1 as well 
as in sea urchin sperm specific H2B, and it is a known target site for phosphorylation (39). This class 
of H2A proteins has been shown to protect about 16 bp more linker DNA from Micrococcal Nuclease 
(MNase) digestion than chicken erythrocyte H2A (40). Their property to bind more DNA might help 
to compact the inactive genome during seed dormancy. Upon germination, the H2A C-terminus is 
rapidly phosphorylated probably to weaken DNA binding by neutralizing the positive charge of the 
SPKK motifs (41). A similar situation is found in the sea urchin egg-specific histone variant CS H2A. 
Here, C-terminal phosphorylation occurs upon fertilization possibly leading to chromatin 
decondensation, which in turn could facilitate chromatin assembly during replication (39). Recently, 
the histones of bdelloid rotifers, freshwater invertebrates that are highly resistant to ionizing radiation 
and desiccation (42), were analyzed (43). Interestingly, the H2A proteins in this organism are very 
different from all other species with no canonical H2A, H2A.X or H2A.Z present. Instead, bdelloid 
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H2As have a longer C-terminus that was speculated to play a role in adaption to their environment, 
especially dealing with DNA damage upon desiccation (7,43). 
In the next part, I briefly introduce the major H2A variants known thus far. For more detailed 
information about histone H2A variants and histone variants in general, see (7,44-46). The influence 
of H2A variants on nucleosome stability as well as on chromatin folding will not be addressed in this 
part but in separate sections below. 
1.3.1 H2A.X 
Histone H2A.X was, together with H2A.Z, first described in 1980 (47). H2A.X is defined by its 
SQ[E/D] motif (where  is a hydrophobic amino acid) in the C-terminus. Upon DNA damage, the 
serine becomes phosphorylated (H2A.X) and renders H2A.X an important player in preserving 
genome integrity (see below). Apart from the C-terminus, human H2A and H2A.X differ by just four 
amino acids in primary sequence; two substitutions in the N-terminal tail, (Q6T and T16S), one in the 
L1 loop (N38H) and one in the docking domain (K99G) (Figure 2). However, since residue 38 is 
located in the region where the two H2A-H2B dimers interact with each other (Figure 1), it has been 
suggested that this substitution might influence the ratio of homotypic (containing two H2A.X) versus 
heterotypic nucleosomes (containing one H2A and one H2A.X) (48). To my knowledge, it is not 
known whether H2A.X forms homo- or heterotypic nucleosomes in vivo. For a recent review on 
H2A.X structure and function, see (48). In some organisms, the SQ[E/D] motif is present in other 
H2A family members hence, no distinct H2A.X exists in these organisms. For example, in yeast and 
the flagellated protozoan Giardia lamblia, the SQ[E/D] motif is present in canonical H2A, whereas 
in the fly, it is present in the H2A.Z protein called H2AvD. 
During S phase, the human and mouse H2A.X transcripts are processed in an identical manner to the 
canonical histone mRNAs, resulting in a stem loop structure and no polyA tail (49,50). Outside S 
phase, a longer transcript is produced by using a downstream polyadenylation site. Therefore, H2A.X 
exhibits both characteristics of replication-dependent and replication-independent histone genes. 
H2A.X has been shown to be involved in the DNA damage response (DDR). Upon DNA double 
strand breaks (DSBs), the serine in the SQ[E/D] motif (position 139 in human) is phosphorylated 
resulting in “H2A.X” foci which can extend for up to 30 Mb surrounding the damaged site (51). 
H2A.X phosphorylation is a very early event in DDR leading to structural alterations, at the damaged 
site, to foster DNA repair. Although there are studies pointing towards a direct destabilization of the 
nucleosome by H2A.X (52,53), two studies in yeast, employing serine to glutamate mutants to mimic 
a phosporylated serine, come to different results. While one study (54) found increased nuclease 
accessibility, suggesting a more open chromatin structure, another one (55) did not find any evidence 
for a direct structural influence on chromatin. In contrast to these controversial reports, the importance 
of ATP-dependent chromatin remodeling during DDR is undisputed. Several studies established the 
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crucial role of ATP-dependent chromatin remodeling complexes to increase DNA accessibility at the 
DSB site (reviewed in (56)). Since chromatin decondensation is not severely impaired in H2A.X 
knock out cells (57,58), it has been suggested that the critical role of H2A.X is not the primary 
recruitment of remodeling factors but in retaining them at the repair site to define a “damage 
neighborhood” and to keep the two DNA strands together for efficient repair (reviewed in (48)). 
Recently, two additional phosphorylation sites, in the vicinity of the extensively studied serine 139, 
have been reported. Firstly, the very C-terminal tyrosine 142 in the SQEY motif can be 
phosphorylated in vertebrates (59-62). The modification status of this residue, which is absent in yeast 
(L instead of Y), has been suggested to play a critical role in cell fate decision after DNA damage. If 
tyrosine 142 is phosphorylated, interaction of H2A.X with the pro-apoptotic JNK1 is increased at the 
expense of DDR factor recruitment. Hence, its dephosphorylated form facilitates DNA repair whereas 
its phosphorylated one promotes apoptosis. Secondly, phosphorylation of threonine 136 has been 
reported (53,63). Although the biological function of this modification is not yet known, it was 
speculated that together with serine 139 phosphorylation it might alter chromatin structure upon DNA 
damage (53). 
Interestingly, a recent analysis of H2A variant dynamics in pre-implantation embryos suggested a 
novel role for H2A.X in chromatin remodeling during mouse development (64). The authors found a 
striking increase in H2A.X chromatin incorporation at the expense of canonical H2A, H2A.Z and 
macroH2A after fertilization, leading to chromatin containing mostly H2A.X and H2A during the one 
to four cell stages. Notably, this effect seems to depend primarily on H2A.X’s C-terminus but not on 
serine 139, suggesting an intriguing and not well-understood effect of H2A.X on chromatin structure 
outside the DDR. 
1.3.2 H2A.Z 
Histone H2A.Z is an almost universal variant which evolved early and only once in evolution (65). 
H2A.Z is only ~60% identical to canonical H2A within the same species (66), but strikingly more 
conserved between different species (~80% identity between most organisms) with the most divergent 
member in trypanosomes (~50-60%) (67). This suggests that it fulfills specific and unique functions 
that cannot be carried out by other H2A variants. Indeed, H2A.Z has been shown to be essential in 
many organisms like mouse (68), fly (69), frogs (70) and tetrahymena (71); but not in bakers (72) and 
fission yeast (73), where knock-out leads to severe growth phenotypes. A very elegant study in 
drosophila demonstrated that the essential regions for H2A.Z function are located in its C-terminus 
(M6 and M7, Figure 3) (74). In line with this finding, the M6 region is required for interaction of 
H2A.Z with the evolutionary conserved SWR1 chromatin remodeling complex important for H2A.Z 
targeting (discussed below), providing a reasonable explanation for its essential nature (75). 
Furthermore, this region comprises residues of the acidic patch, important for H2A.Z deposition and 
function in yeast (76) and chromatin higher-order structure (see respective section below). 
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Figure 3: Amino acid sequences of human H2A.Z variants. Alignment of human H2A.Z.1 with 
H2A.Z.2.1 and H2A.Z.2.2. -helices are indicated by open boxes below and structural features that 
are discussed in the text are highlighted with colored boxes. For details on color coding and 
consensus symbols see legends of Figures 1 and 2, respectively. Sequence elements required for 
H2A.Z function (74) are indicated by gray boxes below and sites of PTMs as described in the legend. 
Alignment was carried out using the ClustalW alignment tool on the homepage of the EMBL-EBI 
(34,35).
Surprisingly, despite significant sequence divergence, the H2A.Z nucleosome structure (77) revealed, 
overall, high similarity to the canonical one (16). Striking differences between both structures are 
found in L1, important for interaction of the two H2A-H2B dimers within the nucleosome. This led to 
the hypothesis that it is unlikely that H2A and H2A.Z are present within the same nucleosome, 
proposing the exclusive existence of homotypic nucleosomes for H2A.Z (77). This prediction 
however, was proven wrong in vitro (78) as well as in vivo, using tagged H2A variants in HeLa cells, 
where the main proportion of H2A.Z containing nucleosomes is heterotypic (79). Further differences 
between the two structures were found in the C-terminal docking domain suggesting a subtle 
destabilization of the H2A.Z nucleosome and, due to the presence of a metal ion at the nucleosomal 
surface, a possibly altered interaction site for the linker histone or other factors. Additionally, an 
increased acidic patch on the nucleosome surface is observed for H2A.Z (Figure 2), suggesting an 
influence on internucleosomal interactions ((77) and see below). 
Like other histones, H2A.Z can be post-translationally modified by acetylation, sumoylation and 
ubiquitination with different functional outcomes (reviewed in (80)). H2A.Z sumoylation has been 
implicated in DNA repair in yeast (81), ubiquitination correlates with localization to the inactive X 
chromosome (Xi) in mammals (82), whereas N-terminal acetylation leads to nucleosome 
destabilization (83). It was suggested that H2A.Z acetylation works as a switch-like mechanism to 
modulate H2A.Z nucleosome stability, ascribing repressive functions to the unmodified and activating 
functions to the acetylated form (83). Furthermore, acetylated H2A.Z was found associated with active 
genes but its role at these sites is not yet completely understood (reviewed in (80)). 
The biological function of H2A.Z has been extensively studied revealing roles in transcription 
regulation, DNA repair, heterochromatin formation, chromosome segregation and mitosis. Due to 
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space constraints, I cannot discuss all aspects of H2A.Z biology. Excellent reviews covering the vast 
amount of literature are available (66,84-89).  
Many studies focused on the influence of H2A.Z on transcription (reviewed in (84-86)) revealing that 
in yeast (90-93) and mammals (94) H2A.Z is enriched at gene promoters. Interestingly, it has been 
found that H2A.Z can have both, activating as well as repressive influences on transcription (84). 
Evidence accumulated that H2A.Z affects nucleosome mobility and positioning (84,91,95-99) which 
could explain the sometimes rather contrasting impact on transcription. As a consequence of such 
changes, incorporation of H2A.Z could differentially increase or decrease binding of both activating 
and repressive regulatory factors to their target sequences. Hence, the naïve view of H2A.Z as a 
transcriptional activator (or repressor), acting merely by structural alterations should be extended by 
one interpreting H2A.Z as a modulator of nucleosome positioning which consequently influences 
different biological processes including gene activity by transcription regulation. In addition to gene 
promoters, H2A.Z is associated with other regulatory regions like enhancers and insulators as well as 
heterochromatin (reviewed in (66)), consistent with the wide variety of biological processes this 
variant is implicated in. 
The intriguing finding that H2A.Z is non-uniformly localized within the genome leads to the question 
by which means H2A.Z is enriched at its target sites. Two non-mutually exclusive mechanisms can be 
envisioned. Firstly, H2A.Z can be actively incorporated at specific sites by targeting factors and 
secondly, H2A.Z can be randomly incorporated and afterwards (actively) removed from non-target 
sites (100). Evidence is found for both mechanisms (for recent reviews on H2A.Z deposition see 
(87,89,100)). The ATP-dependent chromatin remodeling complex SWR-1 is important for H2A.Z 
deposition, in yeast, by exchanging nucleosomal H2A-H2B dimers (H2A-H2B) for free H2A.Z-H2B 
dimers (H2A.Z-H2B) (101-103). Here, target sites for H2A.Z incorporation can be defined by at least 
two different manners. On the one hand, it was suggested that the SWR-1 complex can be recruited by 
acetylated histones (90,92); on the other hand, the insertion of a certain DNA sequence that harbors 
elements, common in yeast promoters, into an inactive gene, was shown to be sufficient to induce a 
typical feature of yeast promoters: a nucleosome-free region (NFR) flanked by two H2A.Z containing 
nucleosomes (92). Therefore, both genetic as well as epigenetic factors contribute to establish the 
specific H2A.Z pattern in yeast. In mammals, two SWR-1 related complexes, the p400/NuA4/TIP60 
and the SRCAP complex, exist ((89) and references therein). Both can catalyze the exchange of 
nucleosomal H2A-H2B for free H2A.Z-H2B, but their different compositions implicate functional 
specialization. More recently, the importance of the ATP-dependent chromatin remodeling complex 
INO80 (Inositol-requiring protein 80) for H2A.Z localization patterns, in yeast, was established (104). 
Papamichos-Chronakis et al. could show that INO80 catalyzes the opposite reaction as SWR-1, 
namely the active exchange of nucleosomal H2A.Z-H2B for free H2A-H2B. Addressing the in vivo 
relevance of this reaction, they found that loss of INO80 leads to mislocalization of unacetylated 
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H2A.Z, which results in genome instability. Speculating about the underlying mechanism, they 
hypothesized that impairment of removal of unacetylated H2A.Z might interfere with processes 
preventing genome stability by altering chromatin structure. 
In vertebrates, two H2A.Z genes are present, H2A.Z.1 (H2AFZ) and H2A.Z.2 (H2AFV), which are 
expressed in a wide variety of tissues (26,105). Both genes contain introns, give rise to polyadenylated 
mRNAs and to protein products that differ in only three amino acids (106). Both H2A.Z proteins can 
be acetylated at the same N-terminal lysine residues (105) and show very similar nuclear localization 
patterns (26,105) and fluorescence recovery after photobleaching (FRAP) mobilities (26). Their 
promoter structures, however, are different between both genes (105) and knock out of H2A.Z.2 but 
not of H2A.Z.1 leads to BCL6 down regulation and increased apoptosis in chicken DT40 cells, 
suggesting functional (sub)specialization of the two H2A.Z variants (107). 
Recently, we (26) and others (27) showed that the human H2A.Z.2 transcript can be alternatively 
spliced giving rise to two isoforms, the already known H2A.Z.2.1 (Z.2.1, formerly H2A.Z.2) and the 
novel H2A.Z.2.2 (Z.2.2). In contrast to the highly conserved major isoform Z.2.1, Z.2.2 is putatively 
primate-specific and present at much lower levels in most tissues. In brain tissues however, Z.2.2 is 
significantly enriched with abundances similar to Z.2.1. The two alternatively spliced transcripts differ 
only in their last exons, resulting in differences only in the C-termini of the encoded proteins. Z.2.2 is 
the shorter protein, lacking the utmost C-terminal tail and having a unique C-terminus/docking domain 
but retaining the extended H2A.Z acidic patch completely (Figure 3). Furthermore, we could show 
that Z.2.2 nucleosomes exhibit striking differences with regards to nucleosome stability both in vivo 
and in vitro (discussed in the respective section below). Notably, it has been suggested that alternative 
splicing can be a significant evolutionary driving force since alternative splicing events are very often, 
as in the case of H2A.Z.2, associated with exon gain or loss when compared between human, mouse 
and rat (108,109). Modrek & Lee proposed that alternatively spliced isoforms can serve as “internal 
paralogs” (108). Initially underrepresented due to weak splice signals, they can be tolerated since they 
do not interfere with gene function and are not detrimental for the cell. Over time however, they are 
able to accumulate mutations and become functionally important in a tissue-specific manner where 
they can represent 30-70% of all transcript isoforms from the respective locus (108). Indeed, more 
than 90% of human multi-exon genes are alternatively spliced with splicing patterns varying between 
different tissues (110). These findings are in perfect agreement with data from us (26) and others (27), 
showing that Z.2.2 mRNA is normally low abundant but constitutes up to 50% of the H2A.Z.2 
isoforms in brain tissues. It is tempting to speculate that Z.2.2 is the major H2A.Z.2 isoform in some 
specialized cell types in the primate brain. There, it might be able to substitute for Z.2.1 and to confer 
unique structural and functional properties to H2A.Z containing nucleosomes, possibly acting in 
concert with chaperone complexes containing brain specific subunits (111,112). 
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1.3.3 H2A.Bbd 
Histone H2A.Bbd (Barr body deficient) was first described just over one decade ago (113), but 
identification of the endogenous protein was published only recently (114). As found most often for 
replacement variants (23), H2A.Bbd is encoded by a polyadenylated mRNA. On the protein level, 
H2A.Bbd is only about 50% identical to canonical H2A (113) and is the most quickly evolving histone 
variant known, even exceeding the rate of evolution of the linker histone H1 (114,115). In agreement 
with its fast evolution, several H2A.Bbd-like proteins (also known as H2AL1-3 (116) or H2A.Lap2-4 
(117)) are found in mouse, which are not all present in the human genome (116). Thus far, H2A.Bbd 
has only been found in mammals (115). 
Comparison of histone H2A.Bbd and H2A protein sequences reveals several striking differences 
(Figure 2). H2A.Bbd is considerably shorter, lacking the C-terminal tail and part of the docking 
domain. Additionally, it does not contain an acidic patch implicated in internucleosomal contacts and 
chromatin fiber condensation (see below). Therefore, H2A.Bbd is also called H2A.Lap1 (Lack of 
acidic patch) in mouse (117). Interestingly, H2A.Bbd contains relatively few lysine residues indicating 
poor conservation of possible modifications, for example acetylation in the N-terminus. I decided to 
stick to the more widely used term H2A.Bbd in the following text. 
H2A.Bbd is not present in all tissues but strongly expressed in testis (113,114,117) and to a much 
lesser extent in brain (117), suggesting a tissue-specific function. Indeed, H2A.Bbd plays a role in 
mouse spermatogenesis (114,117). Soboleva et al. could show that H2A.Bbd is involved in creating a 
specific chromatin landscape at the promoters of active genes, during spermatogenesis, in a temporally 
specific manner, where H2A.Z occupies the -2 nucleosome and H2A.Bbd the -1 nucleosome with 
respect to the transcription start site (TSS) of active genes. Since incorporation of H2A.Bbd hinders 
chromatin fiber folding to a similar extent like acetylated H3 and H4, the authors suggested that 
employing H2A.Bbd instead of histone acetylation could be advantageous in the process of rapid 
chromatin remodeling during spermatogenesis in mouse. H2A.Bbd’s association with actively 
transcribed chromatin is further supported by co-localization of ectopically expressed H2A.Bbd with 
acetylated H4 (113). To address the mechanism by which H2A.Bbd influences transcription, 
experiments in vitro have been employed. Surprisingly, they found only mild effects on transcription 
of chromatin reconstituted with H2A.Bbd compared to canonical H2A chromatin (118,119). Angelov 
et al. found a maximal two-fold increased interaction of a transcription factor (NF-B) with its binding 
site for H2A.Bbd versus canonical H2A nucleosomes in vitro. Furthermore, they reported a slightly 
more efficient transcriptional activity when using an H2A.Bbd chromatin template. This effect was 
dependent on the acetyltransferase p300 and coincident with elevated histone acetylation. Bao et al. 
also reported slightly more transcription from H2A.Bbd containing chromatin; however, p300 seemed 
to level out expression from both kinds of templates. Interestingly, and counter-intuitively, H2A.Bbd 
is much less efficiently remodeled by a variety of ATP-dependent chromatin remodeling complexes 
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like SWI/SNF (SWItch/Sucrose NonFermentable), ACF (ATP-utilizing Chromatin Assembly and 
Remodeling Factor) (118) and RSC (Remodels the Structure of Chromatin) (120). However, since 
H2A.Bbd is expressed more or less testis-specifically, it is possible that it is remodeled by, as yet, 
unidentified, tissue-specific, molecular machines. 
In general, testis-specific variants of other histone families, such as H3t (121) and TSH2B (122), are 
also known,. Together they contribute to the unique chromatin structure in testis and are speculated to 
be involved in the process of histone to protamine replacement. However, due to tissue-specific 
expression of H2A.Bbd and other testis-specific histone variants, findings from studies focusing on 
them are limited in the generality of their implications on chromatin structure in other tissues. For 
most tissues and cells types, chromatin structure cannot be influenced by variants like H2A.Bbd 
simply due to their absence or low expression levels (Z.2.2). Hence, structural alterations must be 
accomplished by other, more general means. On the other hand, tissue and cell type-specific histone 
variants (and other chromatin factors) could contribute to specialized chromatin functions only 
required in certain cell types and tissues like testis (H2A.Bbd) and brain (Z.2.2). 
1.3.4 MacroH2A 
Histone macroH2A is the most diverged H2A variant known to date. It was first described two 
decades ago (123) and has since fascinated researchers because of its particular domain architecture. 
MacroH2A has a tripartite structure consisting of an N-terminal histone domain connected via a lysine 
rich H1-like linker region to a non-histone macro domain (Figure 2) resulting in a protein about three 
times larger than canonical H2A. MacroH2A is conserved among vertebrates, whereas macro domain-
containing non-histone proteins are found in all organisms (124). The highly conserved macro domain 
is known to be a binding module for NAD metabolites and implicated in diverse biological functions 
like transcriptional regulation, chromatin remodeling and DNA repair (for a recent review on macro 
domain proteins see (125)). Two macroH2A genes are present in mammals (macroH2A1/H2AFY and 
macroH2A2/H2AFY2), with one of them (macroH2A1), known to be alternatively spliced (25), giving 
rise to two isoforms, macroH2A1.1 and macroH2A1.2. The two splice variants differ only in their 
macro domains which results in differences in their abilities to interact with NAD metabolites 
(126,127). MacroH2A1.1 can bind NAD metabolites, including poly(ADP-ribose), whereas 
macroH2A1.2 cannot. This suggests a unique role for macroH2A1.1 in chromatin remodeling that 
depends on poly-ADP-ribose polymerase (PARP) activity, which is induced by different biological 
stimuli such as DNA damage and metabolic stress. 
The first insights into macroH2A´s biological function(s) came from immunofluorescence microscopy 
studies showing an enrichment on the Xi in female mammals (128). Mammalian dosage compensation 
is accomplished by transcriptional silencing of one of the two X chromosomes in females resulting in 
the same gene dose as in males (recently reviewed in (129)). The Xi is a bona fide model for an 
epigenetically regulated chromatin state since, once established, it is stable and passed on during 
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mitosis. These initial findings constituted the basis for the general view of macroH2A as an epigenetic 
repressor of gene transcription involved in X inactivation. Recently, nuclear transfer experiments in 
frogs showed that macroH2A inhibits reprogramming and hence contributes to stability and 
maintenance of differentiated epigenomes (130). Although macroH2A´s role in X inactivation is well 
established, two findings suggested early on a function(s) outside X inactivation. MacroH2A is present 
in vertebrates other than mammals that do not undergo X inactivation and it is expressed equally in 
both male and female mammals (25,124). 
Many studies analyzed the influence of macroH2A on gene expression both on the X chromosome and 
on autosomes. The general view is that macroH2A represses transcription by setting up a repressive 
chromatin environment ((128,131-133) reviewed in (124,134)). However, some recent studies 
challenge this view by reporting a positive influence on some macroH2A target genes, thereby also 
influencing cell differentiation (135-137). How macroH2A mechanistically works on these target 
genes is not well understood. 
In 2005, the structure of the macroH2A containing nucleosome was published showing overall 
similarity when compared to the canonical one (138). The structure of the macroH2A docking domain, 
although harboring several substitutions, is not altered and the residues constituting the acidic patch 
are completely conserved. However, the two structures differ substantially in a four amino acid region 
in the L1 loop, which constitutes the interaction site of the two H2A-H2B dimers within the 
nucleosome. Interestingly, macroH2A preferentially forms heterotypic nucleosomes over homotypic 
ones in vitro with an overall similar structure but changes in the L1-L1 interface due to the amino acid 
sequence differences in the two H2A variants (139). This is in contrast to H2A.Z and H2A.Bbd, which 
form stochastic mixtures of homo- and heterotypic nucleosomes in vitro (78). In addition to affecting 
nucleosome structure, the L1 region of macroH2A might play a role in targeting to the Xi, since, when 
inserted into canonical H2A, it is sufficient for Xi enrichment (140). Together with two other regions 
sufficient for Xi targeting (one in the 1 helix and one in the docking domain), the L1 region is 
located on the outside of the macroH2A-H2B dimer, constituting a possible chaperone-binding site 
(140). 
In contrast to H2A.Z, factors involved in macroH2A targeting are not well characterized; only our 
recent study provides first insights (141). We showed that macroH2A associates with ATRX (-
thalassemia/MR, X-linked), although it is not known whether this interaction is direct or not. 
Importantly, macroH2A-ATRX binding is independent of DAXX (Death-Domain Associated Protein), 
which acts together with ATRX in H3.3 deposition at telomeres (142-144). These findings 
demonstrate that two distinct ATRX-containing complexes act together on H3.3 and macroH2A. 
Interestingly, in contrast to its role in active H3.3 deposition (142,143), ATRX is a negative regulator 
of macroH2A chromatin association by an, as yet, unknown mechanism. ATRX knock-down leads to 
increased macroH2A incorporation at telomeres and the -globin gene cluster, concomitant with its 
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reduced expression. Together with the study by Papamichos-Chronakis et al. (see above), this one 
contributes to the emerging, thus far underappreciated, regulation of histone variant localization by 
factors negatively influencing their chromatin association. 
Several studies employed in vitro experiments to gain insight into the mechanisms by which 
macroH2A functions to repress transcription. Angelov et al. suggested that macroH2A acts on at least 
two distinct levels to repress transcription (145). Firstly, by interfering with transcription factor 
binding if the binding site is close to the nucleosome dyad axis, the part which shows strongest 
alteration in DNaseI digestion pattern and secondly, by inhibiting ATP-dependent nucleosome 
remodeling. The authors found that the influence on transcription factor binding is dependent on 
macroH2A´s non-histone region (NHR; linker and macro domain, amino acids 121-372), whereas the 
histone domain alone is sufficient to inhibit remodeling. Another study, however, reinvestigated 
nucleosome remodeling of macroH2A with different results (146). Here, ATP-dependent nucleosome 
remodeling of macroH2A nucleosomes by SWI/SNF and ACF was not found to be impaired. Using 
competition experiments, they could show that the activating SWI/SNF complex binds preferentially 
canonical over macroH2A nucleosomes whereas the ACF complex, mostly involved in gene 
repression, does not show any preference. Interestingly, all effects were dependent on the NHR in 
contrast to the study by Angelov et al. 
In addition to the mechanisms discussed above, macroH2A also represses transcription more indirectly 
by reducing histone acetylation via different mechanisms dependent on the NHR. On the one hand, 
macroH2A inhibits p300-dependent histone acetylation in vitro (147); on the other hand it interacts 
with histone deacetylases resulting in co-precipitation with hypoacetylated chromatin (138). 
Taken together, the H2A family has a multitude of different members that differ strikingly with 
regards to their evolutionary conservation, amino acid sequences and domain architectures, and the 
biological processes they play roles in. The mechanisms of their functions are often not well 
understood; open questions remain including how they are targeted to their respective chromatin sites 
and how specific interaction partners contribute to their biological roles. One very plausible 
mechanism of function is the alteration of nucleosome and higher-order chromatin structure brought 
about by H2A variant incorporation. In the next section, H2A variants and the properties they confer 
to chromatin on different levels, ranging from the nucleosome to higher-order chromatin structure, are 
discussed. 
  
  Discussion 
- 34 - 
2. DISCUSSION 
2.1 THE INFLUENCE OF H2A VARIANTS ON NUCLEOSOME STABILITY 
2.1.1 The H2A C-terminus influences nucleosome properties such as stability, dynamics, 
positioning and linker histone binding 
Core histones have a common structural architecture as they consist of a histone fold domain (three  
helices connected by short loops) and an unstructured N-terminal tail (16). In addition, and in contrast, 
to the other core histones, H2A also exhibits a flexible tail at the C-terminus. From the crystal 
structure, it can be seen that the C-terminal part of H2A (amino acids 80-119), including the 3 and 
C helices, forms a ladle shaped docking domain that constitutes an important interface for interaction 
with the (H3-H4)2-tetramer (16). The very C-terminal amino acids protrude from the globular 
nucleosome structure and interact with DNA, which is illustrated by molecular dynamics (MD) 
simulations, revealing stable hydrogen bonds between DNA and the lysines 118 and 119 in H2A 
(148). This is consistent with the recent finding that H2A monoubiquitination destabilizes 
nucleosomes during repair of UV induced DNA damage (149), possibly by neutralization of the 
negative charge of the -amino group. Interactions of the H2A C-terminus with nucleosomal DNA are 
modulated by the presence of linker DNA as well as the linker histone H1 (150,151). Moreover, H2A 
can directly interact with H1, as has been shown by crosslinking experiments (152,153) and, recently, 
the interaction site was mapped to the last 17 amino acids of H2A further stressing the importance of 
its C-terminal tail (154). 
The question of whether linker histone binding to nucleosomes is affected by H2A variant 
incorporation has been addressed for all major H2A variants in vitro. In general, canonical H2A 
nucleosomes seem to bind the linker histone most efficiently, in accordance with the direct interaction 
between the two proteins (152-154). Incorporation of H2A.X into nucleosomes exhibits only mild 
effects on interaction with H1, but phosphorylation of the H2A.X C-terminus leads to significant 
impairment of this binding (53). More pronounced reductions of interaction with H1 were reported for 
H2A.Z (99) and H2A.Bbd nucleosomes (120). In the case of H2A.Bbd, this has been further dissected, 
showing that reduced interaction with H1 can be attributed to the H2A.Bbd docking domain. In 
contrast to the other variants, the influence of macroH2A on H1 binding has not been analyzed using 
in vitro assembled nucleosomes. However, fractionation experiments of native chicken chromatin 
revealed an almost mutually exclusive distribution; chromatin is either associated with linker histone 
or it contains macroH2A (155). This finding suggests that macroH2A interferes with linker histone 
binding, probably by its large C-terminal NHR, but it does not address the question whether 
macroH2A incorporation influences H1 binding as directly as the band shift assay carried out for other 
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H2A variants (see above). Notably, it has been shown that the H1-like linker domain of macroH2A 
fosters chromatin folding and compaction in the absence of the macro domain, leading to the 
speculation that it might fulfill linker histone function after removal of the macro domain by 
proteolytic cleavage (156). However, no evidence pointing towards relevance of this mechanism in
vivo is available thus far. 
The importance of the H2A C-terminus for protein-protein interactions within the histone octamer was 
established almost 25 years ago (157). Eickbush et al. found that removal of H2A´s 15 C-terminal 
amino acids resulted in a significant destabilization of the isolated histone octamer under high salt 
conditions. (The histone octamer is unstable under physiological salt conditions but can be stabilized 
by high salt concentrations (158).) Cleaving the peptide bond between valine 114 and leucine 115 
destroys a short  helix (Q112-L116) that is present in both the isolated octamer (159) as well as the 
nucleosome (160) and contributes to complex stability by hydrophobic interactions between H2A and 
H3 (159). Recently, Vogler et al. analyzed C-terminal truncations of canonical H2A in vitro and in 
vivo (154). They reported moderately decreased nucleosome stability due to removal of the C-terminal 
15 amino acids. More interestingly, they also found altered nucleosome positioning as well as less H1 
binding and decreased susceptibility to ATP-dependent chromatin remodeling consistent with data 
from others (120). The biological significance of these findings is illustrated by reduced stress 
resistance of cells expressing H2A truncations at levels of about 10% of endogenous H2A, probably 
brought about by altered chromatin structure due to insufficient H1 recruitment and erroneous 
nucleosome positioning. Furthermore, C-terminal truncations of H2A enhance thermal nucleosome 
mobility, pointing towards the influence of the H2A C-terminus in defining specific and stable 
nucleosome positions (154,161). The possible role of H2A.Z in creating nucleosomes harboring 
special properties with regards to nucleosome positioning and mobility (see above) further highlights 
the importance of H2A variants in defining unique nucleosomal properties. 
The evidence for an alternative nucleosome state in which all histones are bound to DNA but where 
the interface between the (H3-H4)2-tetramer and the H2A-H2B dimer is opened, suggests an intriguing 
model for the influence of H2A variants on nucleosome stability and dynamics (19,22). H2A variant 
incorporation can lead to alterations of this particular interface thereby shifting the equilibrium 
between the closed and the open nucleosome state and consequently confers distinct dynamic 
properties to variant-containing nucleosomes. Since H2A variants differ significantly in their C-
termini that are implicated in these interactions, this could be one mechanism by which they 
accomplish their distinct biological functions. Consistent with the idea that the H2A-H3 interface is 
sensitive to changes on both sides and critical for nucleosome properties, mutations of residues within 
the H3 N helix (I51A or Q55A), involved in interactions with the H2A C-terminus, greatly increase 
nucleosome thermal mobility, H2A-H2B dimer exchange and abolish octamer formation under high 
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salt conditions in vitro (161). The influence of the different H2A variants on nucleosome stability is 
discussed below.  
2.1.2 H2A.X 
In general, the biochemical and biophysical properties of H2A.X have not been studied as extensively 
as for the other major H2A variants. This might be due to its high similarity to canonical H2A. 
However, a recent study analyzed the stability of H2A.X as well as H2A.X containing nucleosomes 
by analytical ultracentrifugation (53). Surprisingly, they found striking nucleosome destabilization by 
H2A.X, further enhanced by C-terminal phosphorylation. Indeed, H2A.X harbors two substitutions in 
comparison to H2A (N38H and K99G) which were suggested to influence nucleosome stability as 
they are located in regions important for protein-protein interactions, within the nucleosome (48). Li et 
al. state that the observed destabilization of H2A.X nucleosomes is similar to observations on yeast 
nucleosomes which also exhibit decreased salt stability (162). However, this comparison is difficult to 
draw even though yeast H2A can be seen as an ortholog of H2A.X. Slight alterations in amino acid 
sequences are present in all yeast histones and distributed throughout the whole nucleosome structure 
(163), thereby making it hard to evaluate the influence of yeast H2A on nucleosome stability in an 
isolated manner. It is tempting to speculate that the extended C-terminal tail present in H2A.X might 
be involved in the changes discussed above, since nucleosome stability is further reduced upon C-
terminal phosphorylation. Future studies will hopefully reveal which changes in H2A.X´s primary 
structure are relevant for the observed destabilization. 
2.1.3 H2A.Z 
The stability of the H2A.Z containing nucleosome has been intensively studied with contrasting results 
(reviewed in (66)). Some studies found stabilization (83,164,165), whereas others found 
destabilization of the nucleosome upon H2A.Z incorporation (77,90,166). Some FRET measurements 
detected only subtle effects on stability in vitro (26,167), consistent with two studies measuring 
H2A.Z mobility in vivo using FRAP (26,168). The reported differences can have a multitude of 
reasons, for example the use of H2A.Z from different organisms (note: 80% identity means 20% 
divergence), different experimental setups and different sources of chromatin (recombinant vs. native 
chromatin). Comparison of the available studies is further complicated by the fact that recombinant 
chromatin consists of homotypic, whereas native chromatin consists mostly of heterotypic 
nucleosomes (79) that can also be post-translationally modified (80). Moreover, comparing studies 
with in vitro assembled chromatin is complicated by the different DNA sequences used (167). Two 
examples nicely illustrate these problems; Zhang et al. (90) found destabilization by analyzing native 
chromatin fibers prepared from yeast, whereas Park et al. (165) found stabilization by performing 
FRET analyses of in vitro reconstituted nucleosomes from Xenopus histones, produced in E. coli, on 
5S rDNA. What one could hypothesize from these studies is that H2A.Z is probably not the sole 
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determinant of nucleosome stability but might modulate it, integrating influences like DNA sequence, 
post-translational modifications and nucleosome composition. 
In line with this, the Felsenfeld lab reported that H2A.Z severely destabilizes nucleosomes if present 
with H3.3 in the same particle (169). Nucleosomes prepared from native chromatin containing both 
H2A.Z and H3.3, are highly salt sensitive and are disrupted in the presence of minimal (80 mM) NaCl. 
In a second paper (170), they analyzed the genome wide distribution of H3.3/H2A.Z-containing, 
double variant, nucleosomes and found that they mark the NFRs of active promoters, enhancers and 
insulator regions. These nucleosomes are highly unstable and can therefore be more easily replaced by 
other DNA binding proteins, such as transcription factors. Unfortunately, all experiments employed 
ectopically expressed H3 variants with the tag located at the C-terminus, close to the H3-H3-
dimerization interface. Taking into account the dynamic nature of the nucleosome (19,20), this could, 
potentially, have differential influence on H3.3/H2A.Z-containing double variant nucleosomes 
compared to those containing H3/H2A.Z ones in vivo. Surprisingly, another study (99), employing 
nucleosomes reconstituted, in vitro, from human histones purified from E. coli, did not find any drastic 
changes for H3.3/H2A.Z-containing double variant nucleosomes. As stated above, technical 
differences in these studies can explain the different outcomes and hamper the drawing of final 
conclusions. 
In the last two years, the importance of the H2A.Z C-terminus for nucleosome stability and chromatin 
association has been explored in yeast as well as in human (26,27,171). Two studies in yeast revealed 
that C-terminal deletions, depending on the extent of truncation, decrease or completely abolish 
chromatin association (27,171). As expected, loss of chromatin association leads to phenotypes similar 
to the complete knock-out of the H2A.Z gene in yeast, such as reduced resistance to genotoxic stress 
and spreading of heterochromatin into euchromatic regions, indicating that chromatin association is 
essential for H2A.Z function. Interestingly, by analyzing chimeric proteins, both groups found that the 
C-terminus of canonical H2A can completely restore chromatin association and rescue the H2A.Z 
knock-out phenotype, consistent with the idea that the primary function of the H2A.Z C-terminus in 
yeast is anchoring the protein to chromatin. 
The recent discovery of Z.2.2, an alternatively spliced H2A.Z isoform, provided fascinating new 
insights into the role of H2A.Z´s C-terminus (26,27). Alternative splicing of the H2A.Z.2 gene gives 
rise to two isoforms, Z.2.1 and Z.2.2 (Figure 3). The novel isoform 2 is different from isoform 1 in 
two respects: it is 14 amino acids shorter and has a stretch of six unique amino acids in its very C-
terminus. We and others have found identical properties with respect to chromatin association and 
nucleosome stability of Z.2.2 (26,27). In contrast to isoform 1, the cellular pool of the shorter isoform 
2 is not completely associated with chromatin but exhibits a major soluble pool. Moreover, the 
chromatin-bound fraction is less tightly incorporated into nucleosomes, both in vitro and in vivo, 
further establishing the importance of H2A.Z´s C-terminus in providing stable chromatin 
  Discussion 
- 38 - 
incorporation. To further break down which of the two distinguishing properties of Z.2.2´s C-
terminus, its shortened length or unique amino acid sequence, are critical for its decreased extent and 
stability of chromatin incorporation, we analyzed deletion mutants and chimeric proteins. Surprisingly, 
mere shortening of Z.2.1 to the same length as Z.2.2 does not dramatically alter chromatin 
incorporation in vivo. In contrast, transferring Z.2.2´s unique docking domain to the respective site of 
H2A results in a protein with chromatin incorporation virtually identical to Z.2.2. These results 
demonstrate that the specific sequence within Z.2.2´s docking domain and not just its shortened length 
is the critical determinant for the unique properties of Z.2.2 with respect to its incorporation into 
chromatin. To gain insight into the underlying structural alterations in Z.2.2 nucleosomes, we 
performed MD simulations that point towards a more flexible C-terminus of Z.2.2 which is also more 
distant to the H3 N helix, thereby reducing interactions with the (H3-H4)2-tetramer in a sequence-
specific manner. These MD simulations are further supported by Z.2.2´s inability to form stable 
histone octamers under high salt conditions, which is in contrast to Z.2.1 or canonical H2A. From the 
results obtained in silico and in vitro, one can hypothesize that the changed interaction interface with a 
striking increase in C-terminal flexibility leads to less stable DNA organization but increased DNA 
breathing instead, which is confirmed by decreased resistance to MNase digest. Taken together, Z.2.2 
is an intriguing protein that, by specific changes in its C-terminus, drastically alters basic H2A.Z 
properties possibly leading to a shift in H2A.Z function in certain tissues of high Z.2.2 abundance, 
e. g. brain tissues (26,27). 
2.1.4 H2A.Bbd 
Because of its shorter length and highly divergent amino acid sequence (about 50% identical to H2A 
(113)), H2A.Bbd was expected to alter nucleosome structure and organization of DNA significantly. 
Indeed, several studies investigated H2A.Bbd nucleosome properties mostly using in vitro assays; all 
of which consistently revealed an open structure of H2A.Bbd containing chromatin. H2A.Bbd 
organizes DNA less tightly, leading to a more relaxed and elongated structure with almost 180° 
between the DNA entry/exit sites in contrast to the V-shaped canonical nucleosomes (119,172). These 
differences in nucleosomal DNA constraint are concomitant with less resistance to digestion by 
MNase (119,172). Notably, no H2A.Bbd crystal structure is available thus far, compatible with global 
structural alterations leading to a more dynamic particle that prevents formation of well diffracting 
crystals (19). This is in line with findings that DNaseI footprinting experiments showed significant 
changes of DNA organization in the H2A.Bbd containing nucleosome (118,120,172). Analysis of 
H2A.Bbd nucleosome stability showed that it does not refold into histone octamers under high salt 
conditions (26,119), indicating weaker interaction of H2A.Bbd-H2B dimers with the (H3-H4)2-
tetramer ultimately resulting in reduced nucleosome stability (26,115,172,173). In accordance with in
vitro studies discussed above, determination of H2A.Bbd mobility in vivo using FRAP showed a much 
faster exchange than canonical H2A (26,174). 
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Several studies investigated the role of H2A.Bbd´s C-terminus for the observed changes in structure 
and stability. As apparent for Z.2.2, the C-terminus of H2A.Bbd differs from canonical H2A in both 
length and amino acid composition. Hence, the question was whether the shortened length or amino 
acid sequence is the main determinant for H2A.Bbd´s unique properties. Bao et al. analyzed canonical 
H2A truncations in vitro. They found that mere shortening of the C-terminal tail neither impairs 
histone octamer assembly under high salt conditions nor significantly alters DNA organization, 
indicating that H2A.Bbd´s shortened length cannot be the sole determinant for its characteristic 
properties (119). In contrast, chimeric proteins consisting of H2A.Bbd´s C-terminus/docking domain 
fused to the N-terminal part of canonical H2A exhibit properties characteristic for H2A.Bbd. They do 
not refold into histone octamers under high salt conditions and bind DNA less tightly with a 
H2A.Bbd-like geometry, pointing towards an essential role of H2A.Bbd´s docking domain in defining 
interactions with the (H3-H4)2-tetramer as well as DNA (119,120,172). This role is further underlined 
by the finding that the C-terminus of canonical H2A fused to the H2A.Bbd histone fold is sufficient to 
organize DNA comparably to canonical H2A nucleosomes and partly restores the normal V-shaped 
geometry (172). The analysis of H2AL2, an H2A.Bbd-like protein present in mouse (116,117), 
revealed striking similarities to H2A.Bbd, as H2AL2 nucleosomes arrange nucleosomal DNA in a 
more open structure as canonical ones (175). In conclusion, H2A.Bbd incorporation results in 
reduction of nucleosome stability and structural constraint of nucleosomal DNA in a manner highly 
dependent on its docking domain, consistent with its presence at active genes during spermatogenesis 
(117).  
2.1.5 MacroH2A 
The crystal structure of the macroH2A nucleosome provided important clues about alterations upon 
incorporation of this variant (138). Despite the overall high structural similarity to the canonical 
particle, a four amino acid sequence in L1, which is implicated in interactions between the two H2A-
H2B dimers within the nucleosome (Figure 1 and 2), showed noticeable differences. This finding led 
to the suggestion of increased stability for macroH2A-containing nucleosomes due to stronger 
interactions between the two macroH2A-H2B dimers. Whether this is indeed the case was addressed 
by analysis of the macroH2A-containing histone octamer in the absence of DNA. Interestingly, 
Chakravarthy et al. found that the macroH2A-containing octamer is less reliant on high salt 
stabilization than the canonical one (139). Canonical octamers dissociate if salt concentration is 
lowered to 1.1 M NaCl whereas macroH2A octamers are still completely stable under these 
conditions. Importantly, by mutational studies, the authors could show that the four amino acid 
substitutions in the L1 region are solely responsible for the changes observed in octamer stability, 
pointing towards the importance of the L1 region in defining interactions within the nucleosome. 
Consistent with these findings, from studies on in vitro reconstituted nucleosomes, analysis of native 
chromatin from chicken cells showed an increased stability of macroH2A chromatin incorporation as 
well (155). Taken together macroH2A increases nucleosome stability by alterations within a four 
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amino acid stretch in L1, which is in strong contrast to Z.2.2 or H2A.Bbd that lead to a significant 
decrease in nucleosome stability mediated by their characteristic docking domains. 
Further evidence supporting macroH2A´s role in constituting nucleosomes that are more stable and 
static is provided by the finding that chaperone-assisted H2A(variant)-H2B dimer exchange is 
inhibited by macroH2A containing nucleosomes (139). Interestingly, the L1 region and the docking 
domain are not sufficient to transfer this property to canonical H2A, thereby indicating the importance 
of other regions for macroH2A´s static nature. The authors state that the best explanation for these 
findings is reduction of macroH2A´s relative affinity to the chaperone used (yNAP1) compared to 
canonical H2A. This points towards a question neglected in most in vitro studies, namely the influence 
of the relative affinity of histone variants to factors other than the nucleosome such as chaperones and 
remodeling complexes. In principle, the affinity of a histone variant to soluble protein complexes 
promoting its absence from chromatin must also be considered, since these factors are abundant and 
contribute significantly to the equilibrium between soluble and chromatin-bound histone variant in the 
cell. However, it is complicated to exhaustively analyze these protein complexes in vitro due to their 
immense diversity in the living cell. On the other hand, in vivo assays such as FRAP can provide 
valuable insights; unfortunately, these data are hard to dissect due to the complexity of the 
experimental system, i.e. the cell. Thorough analyses should therefore follow a complementary 
approach employing both in vitro and in vivo analyses to compensate for the limitations of each of 
them. 
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2.2 THE INFLUENCE OF H2A VARIANTS ON CHROMATIN STRUCTURE 
The work discussed in the last section focused primarily on the influence of H2A variants on the 
nucleosome and its basic properties. To understand how H2A variants can alter the “monomeric 
building block” of chromatin provided us with plenty of insight into the mechanisms of their 
biological functions. In the cell however, chromatin is not present in a linear “beads-on-a-string” 
conformation but adopts higher-order structures impacted by the complex interplay of DNA, core and 
linker histones and other chromatin architectural proteins (reviewed in (176-179)). Short-range 
(intramolecular) interactions within a linear chromatin strand lead to a more compact secondary 
structure, the 30 nm fiber. In addition (or instead), long-range (intermolecular) interactions between 
distinct chromatin fibers lead to large oligomeric tertiary complexes. 
To understand the intricate relationship of structure and function in chromatin, the influence of 
chromatin components on secondary and tertiary chromatin structures must be taken into account. In 
this section, I discuss the influence of histone variants on chromatin structure with a special focus on 
the crucial role of the H2A acidic patch. 
2.2.1 The H2A acidic patch is a key regulator of higher-order chromatin structure 
H2A and H2B form an obligate dimer under physiological conditions (180), hence it is the structure of 
the H2A-H2B dimer that must be considered to be involved in biologically relevant protein-protein 
interactions (181). Despite the overall basic nature of histones, the nucleosome crystal structure 
revealed the presence of an acidic patch on the surface of the H2A-H2B dimer which is mainly 
comprised by H2A (six out of seven amino acids) (16). Interestingly, in this structure, the H4 N-
terminal tail (K16-N25) contacts the acidic patch on the adjacent nucleosome and this contact is 
required for crystallization (16). In addition to the H4 tail, interactions with at least five more non-
histone proteins make the acidic patch an important binding site in chromatin with the potential to 
differentially contribute to diverse biological processes by its alteration due to H2A variant 
incorporation (181). In support of this notion, Interleukin-33 interacts with the acidic patch of H2A or 
H2A.Z but binding to H2A.Bbd, which lacks an acidic patch, is strongly decreased (182). 
The importance of the H4 tail for the establishment of proper secondary and tertiary chromatin 
structure has been established and depends on its charge and PTMs (reviewed in (176)). Richmond 
and coworkers could show that the H4 tail has a critical role beyond the other histone tails for both 
intra- and intermolecular interactions (183). Furthermore, by using mutant proteins, they could 
crosslink the H4 tail (H4-V21C) to the acidic patch of H2A (H2A-E64C) upon array folding, thereby 
providing evidence for the direct interaction in solution when a more compact secondary structure, the 
30 nm fiber, is formed (184). More recently, intermolecular crosslinks between H4-V21C and H2A-
E64C have been reported as well (185). However, additional intermolecular contacts between 
chromatin fibers must be very important since arrays containing only (H3-H4)2 tetramers can 
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oligomerize just as nucleosomal arrays (186) and binding of the H4 tail to DNA is another important 
mechanism for the establishment of intermolecular interactions (187). 
The modulation of chromatin folding by PTMs is of particular importance as histone PTMs are 
abundant and implicated in a multitude of biological processes (4). Two H4 tail modifications have 
been studied with regards to their influence on chromatin folding, acetylation of lysine 16 and 
trimethylation of lysine 20. These two modifications appear to have opposing biological functions as 
H4K16ac is associated with euchromatin and active transcription, whereas H4K20me3 plays a role in 
heterochromatin formation (reviewed in (188)). In accordance with the opposing biological functions, 
H4K16ac inhibits both intra- and intermolecular interactions of the H4 tail and consequently promotes 
an open chromatin structure (189). Contrariwise, H4K20me3 leads to more efficient intramolecular 
folding which results in a more compact secondary chromatin structure without influencing 
intermolecular folding ((190), reviewed in (178)). Taken together, the interaction of the H4 tail with 
the acidic patch of H2A is important for both short-range (intramolecular) and long-range 
(intermolecular) chromatin interactions and can be modulated by PTMs of the H4 tail as well as 
incorporation of H2A variants (see below). 
2.2.2 Alterations of the acidic patch due to H2A variant incorporation influence higher-order 
chromatin structure 
Two H2A variants, H2A.Z and H2A.Bbd, have been studied with regards to the influence of their 
acidic patch on secondary and tertiary chromatin structure. These studies contributed significantly to 
our understanding of the importance of the acidic patch on higher-order chromatin structure. 
Compared to canonical H2A, H2A.Z has an extended acidic patch whereas H2A.Bbd virtually lacks it 
(Figure 2). In H2A.X and macroH2A, the residues constituting the acidic patch are completely 
conserved. 
Ten years ago, Tremethick and coworkers investigated the influence of H2A.Z on chromatin folding in
vitro (95). They reported that arrays assembled with H2A.Z exhibit increased intramolecular folding 
and therefore a more compact secondary structure than canonical arrays. Interestingly, H2A.Z arrays 
impair intermolecular contacts and therefore array oligomerization. Two years later, the authors 
extended their studies by employing acidic patch mutants and H4 tail deletions to mechanistically 
understand H2A.Z´s influence on chromatin folding (191). They found that the extended acidic patch 
of H2A.Z leads to increased intramolecular folding and decreased intermolecular oligomerization. 
Furthermore, intramolecular folding also requires the H4 tail suggesting that the same mechanism of 
folding seen for canonical arrays also applies to H2A.Z variant-containing chromatin fibers (183), but 
with a higher affinity due to the larger acidic patch of H2A.Z which allows stronger electrostatic 
interactions. In addition, they analyzed HP1 (heterochromatin binding protein 1 ) binding to arrays 
containing either canonical H2A or H2A.Z. The authors found that HP1 binds highly folded 
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chromatin (hence H2A.Z containing chromatin) to further enhance intramolecular folding but it does 
not bridge chromatin fibers. These findings could be relevant for structure and function of H2A.Z 
containing chromatin at centromeres in vivo (192). Greaves et al. reported the association of H2A.Z 
with both major satellite repeats in pericentric heterochromatin and minor satellite repeats in CENP-A-
containing centric chromatin. Moreover, they suggest that H2A.Z could be important for the assembly 
of H3K4me2 euchromatin into compact chromatin structures within the CENP-A-containing centric 
chromatin regions, required for centromere function on chromosomes relatively deficient in pericentric 
heterochromatin. 
To explain opposing influences of H2A.Z´s extended acidic patch on chromatin compaction and 
oligomerization, they propose a model based on competition between intra- and intermolecular 
interaction partners for the H4 tail (Figure 4). The H4 tail can either interact with the acidic patch 
within one fiber and lead to a more compact secondary structure or it can participate in other contacts 
that promote array oligomerization, for example with DNA of another chromatin fiber (187). Hence, 
the interaction of the H4 tail with the acidic patch in an intramolecular manner inhibits any other 
(intermolecular) interactions and therefore inhibits oligomerization. Therefore, the stronger the 
interaction of the acidic patch with the H4 tail, the more favored the compact secondary structure and 
the less favored array oligomerization and vice versa. 
To test whether the competition model applies more generally, the Tremethick lab analyzed arrays 
assembled in vitro with H2A.Bbd, canonical H2A and acidic patch mutants of both (193). In line with 
the proposed model, H2A.Bbd inhibits intramolecular folding but fosters internucleosomal 
oligomerization. Moreover, H2A.Bbd mutants with a restored acidic patch increase the tendency to 
form compact secondary structures depending on the H4 tail and the extent of the acidic patch 
restoration, whereas mutants of canonical H2A that lack the acidic patch form compact secondary 
structures less efficiently than wild type but oligomerize chromatin fibers more efficiently. Taken 
together, these analyses support the competition model and further strengthen the view of the acidic 
patch as a key regulator of chromatin structure. On the one hand, the extended acidic patch of H2A.Z 
results in more efficient formation of compact secondary structures while inhibiting oligomerization of 
chromatin fibers; on the other hand the smaller acidic patch of H2A.Bbd has contrasting effects by 
fostering oligomerization at expense of secondary structure formation (Figure 4). 
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The lack of acidic patch in H2A.Bbd could also explain why no crystal structure is available thus far. 
Luger et al. reported that the contact of the H4 tail with the acidic patch, which cannot be formed with 
H2A.Bbd nucleosomes, is required for crystallization (16). Whether this is the only reason for the 
inability of H2A.Bbd nucleosomes to be crystallized could be easily tested by using the reported 
H2A.Bbd mutant with a restored acidic patch (193).  
Further evidence of how sensitive chromatin folding responds to alterations of the acidic patch was 
provided by the experimental comparison of human H2A.Bbd with its mouse homologue (117). A 
single amino acid substitution from human to mouse (T100D) increases the acidic patch of mouse 
H2A.Bbd that in turn is able to partially fold chromatin into more compact secondary structures. 
Mutation of this residue back to threonine, as found in the human protein, disables higher-order 
chromatin folding indicating its functional importance. 
Interestingly, Z.2.2 combines features of H2A.Bbd as well as H2A.Z. One the one hand, it 
significantly destabilizes nucleosomes, similarly to H2A.Bbd; on the other hand it completely retains 
the extended acidic patch of H2A.Z (Figure 2). Thus far, no analysis of chromatin folding and 
oligomerization of Z.2.2 containing arrays are available but from the literature on the acidic patch, one 
would expect that Z.2.2, although severely destabilizing nucleosomes, behaves like H2A.Z and allows 
the formation of compact secondary chromatin structures due to the key role of the acidic patch. This 
Figure 4: The acidic patch 
regulates chromatin structure by 
interaction with the H4 tail. The 
H4 tail can engage in 
intramolecular interactions with the 
acidic patch of neighboring 
nucleosomes within the same 
chromatin fiber to form more 
compact secondary structures (left). 
Alternatively, it can form different 
intermolecular interactions with 
DNA and histones of other 
chromatin fibers to form large 
tertiary oligomeric complexes 
(right). Which interactions are 
preferred is influenced by acidic 
patch alterations in H2A variants. 
The extended acidic patch of H2A.Z 
fosters compact secondary 
structure formation (right) whereas 
the reduced acidic patch of 
H2A.Bbd leads to preferred 
oligomerization (left). DNA is shown 
in black, H2A in yellow, H2B in red, 
H3 in blue and H4 in green. Flexible 
histone tails for histones other than 
H4 are omitted for clarity. 
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would give Z.2.2 an intriguing role by promoting a compact chromatin structure of unstable 
nucleosomes. Future studies will ascertain whether this is indeed the case or not. 
In addition to their structural analyses, Zhou et al. also functionally investigated the influence of the 
acidic patch and its impact on secondary and tertiary chromatin structure on transcription (193). 
Surprisingly, efficient transcription can occur within large oligomeric chromatin structures but is only 
impaired by the formation of compact secondary chromatin structures by H2A.Bbd mutants that 
restore the acidic patch. This is consistent with H2A.Bbd´s euchromatic localization and role in gene 
activation by inhibiting the formation of highly compact chromatin structures (117). For H2A.Z, these 
findings would suggest a repressive role in gene transcription if present in large domain. However, the 
localization of H2A.Z on gene promoters does not appear to build large domains but to rather position 
individual nucleosomes (see above) and is therefore hard to compare with in vitro experiments 
employing nucleosomal arrays. 
Another important player involved in establishment of higher-order chromatin structure is the linker 
histone H1 (176,178,194) that facilitates formation of chromatin higher-order structures by 
neutralization of the negatively charged DNA. As discussed above, both H2A.Bbd and H2A.Z 
mononucleosomes bind H1 less efficiently than canonical H2A (99,120). To our knowledge, linker 
histone binding has not been analyzed on H2A variant-containing chromatin fibers, which might 
influence this interaction by adoption of secondary and tertiary structures. However, if H2A.Z 
chromatin indeed binds H1 less efficiently than canonical H2A in vivo, this might compensate for the 
higher tendency of H2A.Z to form compact secondary structures and even out structural differences 
between H2A- and H2A.Z-containing chromatin. More interestingly, it is tempting to speculate that 
H2A.Z and H2A form structurally and functionally different chromatin due to their different inherent 
properties to engage in secondary and tertiary chromatin folding as well as in recruitment of H1 and 
other chromatin factors. 
It is important to mention that another group found contrasting influences of H2A.Z incorporation on 
chromatin folding (166). However, the experiments are hard to compare since here, monovalent 
cations have been used to enhance chromatin folding whereas the Tremethick lab used divalent cations 
and the sources of histones were different in the studies by the two labs. 
In conclusion, incorporation of H2A variants into chromatin can alter its secondary and tertiary 
structure. The key regulators for these alterations are the H2A acidic patch and the H4 tail, which 
together define different kinds of interactions with distinct structural and functional outcomes. 
Moreover, the different affinities of H2A variant-containing nucleosomes to the linker histone H1 
could also play an important role in specifying distinct chromosomal domains. Although a lot of 
progress has been made in the last decade, the complex composition of chromatin in vivo makes it 
hard to set up suitable models in vitro. 
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2.3 CONCLUDING REMARKS 
The importance of H2A variants in a multitude of biological processes is well established; however 
the mechanisms by which they function are not yet completely understood. From the literature 
available today, one can envision that histone variants, in general, and H2A variants, in particular, 
function by conferring characteristic properties to chromatin both on the nucleosomal and higher-order 
structural level. Our mechanistic understanding of chromatin structure alterations and histone domains 
involved revealed the functional significance of different regions in H2A, like the L1 loop, the 
docking domain and C-terminal tail as well as the acidic patch. The recent discovery of the H2A.Z 
splice isoform Z.2.2 questions the completeness of our knowledge on existing histone variants. 
Although a lot of progress was made in the last decade, we are far from understanding the 
structure/function interplay of H2A variants. Notably, the importance of H2A variants in a tissue 
specific manner was shown for H2A.Bbd (117) and was suggested for Z.2.2 (26,27). In future studies 
it will be of particular interest to analyze histone variants with respect to their tissue specific 
influences on chromatin structure and function. 
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ABSTRACT
The histone variant H2A.Z has been implicated in
many biological processes, such as gene regulation
and genome stability. Here, we present the identifi-
cation of H2A.Z.2.2 (Z.2.2), a novel alternatively
spliced variant of histone H2A.Z and provide a com-
prehensive characterization of its expression and
chromatin incorporation properties. Z.2.2 mRNA is
found in all human cell lines and tissues with highest
levels in brain. We show the proper splicing and
in vivo existence of this variant protein in humans.
Furthermore, we demonstrate the binding of Z.2.2 to
H2A.Z-specific TIP60 and SRCAP chaperone
complexes and its active replication-independent
deposition into chromatin. Strikingly, various inde-
pendent in vivo and in vitro analyses, such as bio-
chemical fractionation, comparative FRAP studies
of GFP-tagged H2A variants, size exclusion chroma-
tography and single molecule FRET, in combination
with in silico molecular dynamics simulations,
consistently demonstrate that Z.2.2 causes major
structural changes and significantly destabilizes
nucleosomes. Analyses of deletion mutants and
chimeric proteins pinpoint this property to its
unique C-terminus. Our findings enrich the list of
known human variants by an unusual protein
belonging to the H2A.Z family that leads to the
least stable nucleosome known to date.
INTRODUCTION
In the eukaryotic nucleus, DNA is packaged into chroma-
tin. The fundamental unit of this structure is the nucleo-
some consisting of a histone octamer (two of each H2A,
H2B, H3 and H4) that organizes 147 bp of DNA (1). In
order to allow or prevent nuclear regulatory proteins
access to the DNA, the chromatin structure has to be
ﬂexible and dynamic. Several mechanisms ensure
controlled chromatin changes, one being the incorpor-
ation of specialized histone variants (2,3).
Variants of the histone H2A family are the most diverse
in sequence and exhibit distinct functions (4,5), com-
prising DNA damage repair, transcriptional regulation,
cell cycle control and chromatin condensation, though
the exact mechanisms of action are not fully understood
yet. Interestingly, the highest sequence variation among
H2A variants is found in the C-terminus, suggesting that
differences in structure and biological function might be
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primarily attributed to this domain (6–9). One of the best
investigated and highly conserved but also functionally
enigmatic histone variant is H2A.Z. This variant is essen-
tial in most eukaryotes and possesses unique functions
(10,11). H2A.Z is involved in transcriptional regulation,
chromosome segregation and mitosis, acting in an
organism- and differentiation-dependent manner (12,13).
Furthermore, H2A.Z has been implicated in regulating
epigenetic memory (14) and in inhibiting read-through
antisense transcription (15). In higher eukaryotes,
H2A.Z might play a role in heterochromatin organization
(16), genome stability and chromosome segregation (17).
Despite many efforts to elucidate the exact biological
functions of H2A.Z, its roles have been and remain con-
troversial (18). Furthermore, deregulation of H2A.Z ex-
pression or localization seems to be connected to the
development of several neoplasias (19–23). Interestingly,
in vertebrates two non-allelic genes coding for two highly
similar H2A.Z proteins, H2A.Z.1 and H2A.Z.2, exist (24)
(previously named H2A.Z-1 and H2A.Z-2, preﬁxes were
changed due to a new histone variant nomenclature;
Talbert P.B., manuscript in preparation). They have a
common origin in early chordate evolution, are both
acetylated on the same N-terminal lysines (25–27) and
might be ubiquitinated on either one of the two
C-terminal lysines (28).
Here, we report the identiﬁcation and structural char-
acterization of H2A.Z.2.2 (Z.2.2), an unusual alternative
splice form of H2A.Z. We show that Z.2.2 mRNA is
expressed to different degrees in all human cell lines and
tissues examined, with highest levels found in brain. Cell
biological and biochemical analyses consistently reveal the
presence of two distinct Z.2.2 populations within the cell.
The majority of Z.2.2 is freely dispersed in the nucleus,
whereas only a minority is stably incorporated into chro-
matin, most likely through the H2A.Z-speciﬁc p400/
NuA4/TIP60 (TIP60) and SRCAP chaperone complexes.
In vivo and in vitro analyses, in agreement with molecular
dynamic (MD) simulations, demonstrate that due to its
unique docking domain Z.2.2 chromatin incorporation
leads to severely unstable nucleosomes. Our data
provide compelling evidence that a novel H2A.Z variant
exists in humans that plays a distinct and novel role in
chromatin structure regulation.
MATERIALS AND METHODS
See Supplementary Materials and Methods section for
detailed protocols.
Cell culture, transfection, FACS and cloning
Cell lines were grown in DMEM medium (PAA) supple-
mented with 10% FCS (Sigma) and 1% penicillin/strepto-
mycin at 37C and 5% CO2. Cells were transfected using
FuGene HD (Roche Applied Science) according to the
manufacturer’s instructions. For details on cell selection,
FACS and cloning of expression plasmids see Sup-
plementary Materials and Methods section.
RNA expression analysis
RNA isolation and cDNA generation were performed as
previously described (29). Data were analyzed with the
advanced relative quantiﬁcation tool of the Lightcycler
480 (Roche) software including normalization to HPRT1
and HMBS levels. Statistical evaluation was done using
t-test (two-tailed distribution, heteroscedastic). Total
RNA from different human tissues was commercially
acquired from: Applied Biosystems: normal lung, breast
and tumor breast, lung and ovary; Biochain: tumor lung,
breast, thyroid and bone, normal testis, cerebellum,
cerebral cortex, hippocampus, thalamus and total fetal
brain; amsbio: frontal lobe.
Histone extraction, RP–HPLC puriﬁcation, sucrose
gradient, cellular fractionation and salt stability
experiments
Acid extraction of histones was done as previously
described (30). Histones were separated by RP–HPLC as
previously described (29). Fractions were dried under
vacuum and stored at 20C.
Details on MNase digest and sucrose gradient fraction-
ation can be found in Supplementary Materials and
Methods section.
Fractionation and salt stability experiments were
carried out as described previously (31–33) with minor
changes. For details on these methods see Supplementary
Materials and Methods section.
Antibodies
For the generation of a Z.2.2-speciﬁc antibody (aZ.2.2), a
peptide spanning the last C-terminal amino acids
GGEKRRCS of Z.2.2 was synthesized (Peptide Specialty
Laboratories GmbH) and coupled to BSA and OVA,
respectively. Development of Z.2.2-speciﬁc monoclonal
antibodies in rats was done as previously described (29).
The aZ.2.2 clone 1H11-11 of rat IgG1 subclass was
applied in this study. Rabbit aZ.2.2 antibody (rabbit 2,
bleed 3) was generated by the Pineda-Antiko¨rper-Service
company using the identical peptide epitope followed by
afﬁnity puriﬁcation. Following other primary antibodies
were used: aGAPDH (sc-25778, Santa Cruz), aGFP
(Roche Applied Science), aH2A (ab 13923, abcam), aH3
(ab1791, abcam) and aH2A.Z (C-terminus: ab4174,
abcam; N-terminus: ab18263, abcam). Following second-
ary antibodies and detection kits were used in imm-
unoblots: GFP-Z.2.2 and GFP-Bbd histones (aGFP)
and endogenous Z.2.2 (aZ.2.2) were detected using
HRP-conjugated secondary antibodies (Amersham) with
ECL advance (Amersham), all other proteins were
detected using ECL (Amersham). Detection of recombin-
ant proteins to evaluate histone stoichiometry of in vitro
assembled nucleosomes was carried out using
IRDye-labeled secondary antibodies (LI-COR).
Fluorescence microscopy of cells and chromosomes
Preparation of cells and chromosome spreads for ﬂuores-
cence microscopy was done as previously reported (34).
Wide-ﬁeld ﬂuorescence imaging was performed on
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a PersonalDV microscope system (Applied Precision)
equipped with a 60/1.42 PlanApo oil objective
(Olympus), CoolSNAP ES2 interline CCD camera (Pho-
tometrics), Xenon illumination and appropriate ﬁltersets.
Iterative 3D deconvolution of image z-stacks was per-
formed with the SoftWoRx 3.7 imaging software
package (Applied Precision).
FRAP and exponential ﬁtting
For details see Supplementary Materials and Methods
section.
Stable isotope labeling with amino acids in cell culture
(SILAC) and mass spectrometric identiﬁcation of
H2A.Z-speciﬁc chaperone complexes
HeLa cells expressing GFP-Z.2.1 or GFP-Z.2.2 were
SILAC labeled and nuclear extracts were prepared as
described before (35,36). High-resolution LC MS/MS
analysis was performed on an Orbitrap platform: details
on the experimental procedure are found in Supple-
mentary Materials and Methods section. Mass spectro-
metric (MS) operation and raw data analysis (37) are
described in Supplementary Materials and Methods
section. A complete list of all proteins identiﬁed is found
in Supplementary Table S1.
Immunoﬂurescence microscopy of cell cycle-dependent
GFP-Z.2.1 and GFP-Z.2.2 chromatin incorporation
Details on the experimental labeling (38) and microscopy
procedures are found in Supplementary Materials and
Methods section.
Expression of recombinant human histone proteins in
Escherichia coli, in vitro octamer and nucleosome
reconstitution
Histones were expressed, puriﬁed and assembled into
octamers as described (39) and mononucleosomes were
assembled on DNA containing the 601-positioning
sequence (40) according to (39,41). For details on
in vitro octamer and nucleosome reconstitution, see Sup-
plementary Materials and Methods section.
Single molecule Fo¨rster resonance energy transfer
Single molecule Fo¨rster resonance energy transfer
(smFRET) single molecule burst analysis followed by the
removal of multi-molecular events (42–45) are described in
detail in the SupplementaryMaterials andMethods section.
Molecular modeling and MD simulations
The molecular modeling suite YASARA-structure version
9.10.29 was employed, utilizing the AMBER03 force ﬁeld
(46) for the protein and the general amber force ﬁeld
(GAFF) (47) throughout this study. The partial charges
were computed using the AM1/BCC procedure (48) as
implemented in YASARA structure (49). The starting
point for molecular modeling was the crystal structure of
a nucleosome core particle containing the histone variant
H2A.Z (PDB 1F66) (50). Missing side chain atoms were
added (Glu E 634). The missing N-terminal and C-terminal
residues were not modeled, although they might interact
with the neighboring DNA, e.g. in the case of missing
C-terminal residues in H2A.Z (119–128;
GKKGQQKTV). All structures were solvated in a water
box with 0.9% NaCl and neutralized (51). The structures
were initially minimized using steepest descent and
simulating annealing procedures. All deletions and muta-
tions were introduced sequentially using YASARA struc-
ture. MD simulations were carried out at 300K over 2.5 ns
in an NPT ensemble using PME. All simulations were per-
formed four times using various starting geometries. The
2.5 ns MD trajectories were sampled every 25 ps, resulting
in 100 simulation frames per run, which were evaluated
after an equilibration phase of 500 ps to derive statistical
averages and properties of the corresponding variant.
Finally, the interaction energy of H2A and H3 was
calculated from a simulation of the solvated octamer and
the isolated (H3–H4)2 tetramer or the isolated respective
H2A.Z–H2B dimer. The interaction energy is calculated as
energy difference of the solvated octamer minus the
solvated (H3–H4)2 tetramer and H2A.Z–H2B dimer.
RESULTS
Alternative splicing of H2A.Z.2 occurs in vivo
Two non-allelic intron-containing genes with divergent
promoter sequences that code for H2A.Z variants exist in
vertebrates (24,27). In humans, the H2A.Z.2 (H2AFV)
primary transcript is predicted to be alternatively spliced
thereby generating ﬁve different gene products
(Supplementary Figure S1A). Using PCR and conﬁrmed
by sequencing we detected not only H2A.Z.2.1 (Z.2.1) but
also H2A.Z.2.2 (Z.2.2) mRNA, though none of the other
splice variants in human cells (Supplementary Figure S1B)
showing that the H2A.Z.2 primary transcript is indeed al-
ternatively spliced in vivo. Interestingly, database searches
found Z.2.2 mRNA to be predicted in chimpanzee (Pan
troglodytes) and Northern white-cheeked gibbon
(Nomascus leucogenys) as well. In addition, the coding
sequence of the unique exon 6 was present downstream
of the H2AFV locus of several other primate genomes,
such as gorilla (Gorilla gorilla gorilla), macaque (Macaca
mulatta), orangutan (Pongo abelii) and white-tufted-ear
marmoset (Callithrix jacchus) (data not shown). In all of
these primates, with the exception of marmoset, the result-
ing protein sequence, if translated, is 100% identical to the
unique human Z.2.2 peptide. Further searches revealed
that the genomes of horse, and to a certain extent also
rabbit and panda bear, contain sequences downstream of
their H2AFV loci that could, if translated, lead to proteins
with some similarities to human Z.2.2, although they are
much more divergent and even longer (rabbit, panda bear).
Due to these differences, it is highly likely that those species
do not express a Z.2.2 protein homolog. Surprisingly, we
could not detect Z.2.2-speciﬁc sequences in mouse, rat or
other eukaryotic genomes, suggesting that Z.2.2 might be
primate speciﬁc.
Next, we wanted to determine to what degree all three
H2A.Z mRNAs are expressed in different human cell lines
and tissues and performed quantitative PCR (qPCR).
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Z.2.2 mRNA was present to different degrees in all human
cell lines and tissues tested, though less abundant than Z.1
and Z.2.1 mRNAs that are expressed in similar amounts
(Supplementary Figure S1C and D). Z.2.2 constituted
between 5% and 15% of total Z.2 transcripts in all cell
lines and tissues, with the exception of brain, where it was
statistically signiﬁcant upregulated (p=1.7 104; Figure
1A). In some regions of this particular organ Z.2.2 ac-
counted for up to 50% of all Z.2 transcripts pointing
toward an exciting brain-speciﬁc function of this novel
variant.
Encouraged by our ﬁndings we next investigated
whether the endogenous protein is present in vivo. The
distinctive feature of Z.2.2 is its C-terminus that is 14
amino acids shorter and contains six amino acids differ-
ences compared to Z.2.1 (Figure 1B). Due to this
shortened C-terminal sequence, ubiquitination sites at
positions K120 and K121 (28) and part of the H3/H4
docking domain (50) are lost in Z.2.2. We generated
antibodies against Z.2.2’s unique C-terminal amino acids
(aZ.2.2) in rats and rabbits and conﬁrmed their speciﬁcity
in immunoblots (IB) with recombinant Z.2.1 and Z.2.2
proteins (Supplementary Figure S1E and data not
shown). We extracted histones from several human and
mouse cell lines, puriﬁed them by reversed phase–high
performance liquid chromatography (RP–HPLC) and
analyzed obtained fractions by IB (Figure 1C). Using
aZ.2.2 (polyclonal rabbit), we observed a signal of the
calculated weight of Z.2.2 that elutes shortly before Z.1-
and Z.2.1-containing fractions in all human samples.
Similar results were obtained with a monoclonal aZ.2.2
rat antibody (data not shown). In agreement with the
ﬁnding that Z.2.2-speciﬁc exon 6 sequences are mainly
restricted to primate genomes, we could detect Z.2.2
protein in human but not in mouse cells (Figure 1C). In
summary, our data show that Z.2.2 protein indeed exists
in vivo, albeit at a low expression level.
GFP-Z.2.2 is partially incorporated into chromatin
Having demonstrated the existence of this novel variant
in vivo, we next sought to clarify whether Z.2.2 constitutes
a bona ﬁde histone by being part of the chromatin struc-
ture. Due to high background of all our aZ.2.2 antibodies
in IB with cell extracts (data not shown), we generated
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Figure 1. Identiﬁcation of Z.2.2. (A) qPCR with cDNA from different human cell lines and tissues using primers speciﬁc for Z.2.1 and Z.2.2. Data
were normalized to HPRT1 and HMBS expression levels. Controls generated without reverse transcriptase (no RT) were used to assess ampliﬁcation
threshold. Shown are the levels of Z.2.2 mRNA as percentages of total Z.2 transcripts (Z.2.1+Z.2.2). For an evaluation of absolute expression levels
see Supplementary Figure S1C and D. (B) Amino acid alignment of human Z.1, Z.2.1 and Z.2.2 proteins using ClustalW Alignment (MacVector
10.0.2). Identical amino acids are highlighted in dark gray, similar amino acids in light gray and changes are set apart on white background. Known
acetylation sites are depicted with stars and ubiquitination sites with circles. A schematic representation of the secondary structure of Z.1 and Z.2.1 is
shown below the alignment, including depiction of the H3/H4 docking domain (50). M6 and M7 boxes indicate regions important for H2A.Z-speciﬁc
biological functions in D. melanogaster (60). (C) IB analyses of RP–HPLC puriﬁed fractions from different human (HEK293, HeLa, HeLa Kyoto
and U2OS) and mouse (NIH3T3) cell lines using a polyclonal rabbit aZ.2.2 and aH2A.Z (aZ, C-terminal) antibodies. Recombinant Z.2.2 protein
(rZ.2.2) was loaded in the ﬁrst lane as positive control for aZ.2.2 antibody. Similar results were obtained when using a monoclonal rat aZ.2.2
antibody (data not shown).
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HeLa Kyoto cell lines stably expressing GFP-tagged H2A
variants (HK-GFP cells) for subsequent analyses.
Expression levels of GFP-tagged histone variants were
determined by FACS (Supplementary Figure S2A) and
by comparing expression levels of GFP-tagged variants
with endogenous H2A.Z proteins in IB (Supplementary
Figure S2B). GFP-Z.1 and -Z.2.1 were expressed in
similar amounts as the endogenous H2A.Z protein, and
GFP-Z.2.2 expression levels were considerably lower than
those of other GFP-tagged H2A variants, with the excep-
tion of GFP-H2A.Bbd (Barr body deﬁcient; Bbd). These
data show that all GFP-H2A variants were not expressed
in abnormal amounts in cell clones used for further
analyses.
In ﬂuorescence microscopy, GFP-Z.2.2 exhibited a sole
but rather diffuse nuclear distribution similar to GFP-
Bbd, suggesting that both variants might have similar
properties (Figure 2A). Additionally, GFP-Z.2.2 was
detected in condensed mitotic chromosomes, with a faint
residual staining in the surrounding area (Figure 2B), sug-
gesting that it is incorporated into chromatin, although to
a lesser extent than other GFP-H2A variants. To discrim-
inate between a potential non-speciﬁc DNA binding and
nucleosomal incorporation of Z.2.2 we puriﬁed mono-
nucleosomes by sucrose gradient centrifugation.
GFP-Z.2.2 was detected by IB in fractions containing
mononucleosomes (Figure 2C), suggesting that Z.2.2 is
indeed a nucleosomal constituent.
To analyze the extent of Z.2.2 chromatin incorporation
in more detail, we isolated soluble (sol) and chromatin
(chr) fractions from HK-GFP cells. IB analyses revealed,
as expected, that similar to GFP-Bbd, GFP-Z.2.2 is pre-
dominantly nuclear soluble, with only minor amounts
present in chromatin (Figure 3A). Based on fractionation
and ﬂuorescence imaging results, we hypothesized that
this novel variant behaves in a different manner as
compared to other H2A variants with regard to chromatin
exchange mobility in vivo. To test this prediction, we per-
formed ﬂuorescence recovery after photobleaching
(FRAP) experiments with HK-GFP cells. Using spinning
disk confocal microscopy we monitored the kinetic
behavior of H2A variants with variable intervals over
2min (short-term) up to several hours (long-term) after
bleaching a 5mm 5 mm square nuclear region (Figure
3B and Supplementary Figure S3). As expected, GFP
alone showed the highest mobility. In contrast,
GFP-H2A, -Z.1 and -Z.2.1 showed a slow recovery,
which is in agreement with a previous report (52).
GFP-Bbd has been described to exhibit low nucleosomal
stability and a fast FRAP kinetic (53), which we also
observed in our experiment. Interestingly, GFP-Z.2.2
showed an even faster recovery than GFP-Bbd, with
80% of initial ﬂuorescence reached after 1min. Careful
assessment and bi-exponential ﬁtting of FRAP data
allowed us to also calculate ratios of fractions with fast,
intermediate and slow recovery and their respective
half-time of recovery (t1/2) as an indication of exchange
rate thereby revealing quantitative differences between
Z.2.2 and other H2A variants (Figure 3D, Supplementary
Figure S3C and E). For Z.2.2 as well as for Bbd, we
identiﬁed a fast fraction of unbound or very transiently
interacting molecules (78%, t1/2 1.1 s and 52%, t1/2
 2.5 s, respectively; for comparison GFP t1/2  0.4 s)
and a substantially slower fraction with a t1/2 in
the range of 7–9min. In contrast, GFP-H2A, -Z.1
and -Z.2.1 showed no fast mobile fraction but intermedi-
ate slow fractions with t1/2 in the range of 8–17min and a
second even slower class exchanging with a t1/2 of a few
hours. For comparison, we measured the linker histone
H1.0 (54–57) and the histone binding protein HP1a
(58,59), both DNA-associated proteins, and found that
HP1a shows an overall much faster recovery than all
H2A variants. In contrast to Z.2.2 and Bbd, no
unbound fraction of H1.0 was detected. More import-
antly, with regards to the bound Z.2.2 and Bbd fractions
overall H1.0 showed a faster recovery, arguing against
an unspeciﬁc DNA-association of Z.2.2 and Bbd. In
agreement with cell biological and biochemical analyses,
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Figure 2. Z.2.2 localizes to the nucleus and is partially incorporated
into chromatin. (A) Fluorescence imaging of stably transfected HeLa
Kyoto cells shows nuclear localization of all GFP-H2A variants
(middle). DNA was counterstained with DAPI (top). Overlay of both
channels in color is shown at the bottom (Merge; GFP: green, DAPI:
blue). Scale bar=5 mm. (B) Deconvolved images of metaphase spreads
of HeLa Kyoto cells stably expressing GFP-H2A variants (middle).
Merged images in color are shown below (GFP: green; DAPI: blue).
Scale bar=10 mm. (C) Chromatin from HeLa Kyoto cells stably ex-
pressing GFP-Z.2.2 was digested with MNase followed by a puriﬁca-
tion of mononucleosomes using sucrose gradient centrifugation.
Isolated DNA from subsequent sucrose gradient fractions was
analyzed by agarose gel electrophoresis (left). Fractions containing
pure mononucleosomes (marked with asterisk) were combined and
analyzed by IB (right) using aGFP antibody for the presence of
GFP-Z.2.2 (top), and aH3 (bottom).
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these data clearly demonstrate that a large fraction of the
splice variant Z.2.2 is very rapidly exchanged or chromatin
unbound, and a minor population is incorporated into
chromatin.
Z.2.2’s unique docking domain, but not its shortened
length, weakens chromatin association
The functional importance of speciﬁc C-terminal domains
of H2A.Z has previously been demonstrated by nucleo-
somal structure analyses (7,50) and in rescue experiments
in ﬂies (60). Since the C-terminus of Z.2.2 is shorter and
has a distinct sequence when compared to Z.1 and Z.2.1, it
is not clear which of these features determines Z.2.2’s
unusual chromatin-association.
Therefore, we generated deletion and domain-swap
constructs (Supplementary Figure S3D) for FRAP experi-
ments (short-term: Figure 3C and long-term:
Supplementary Figure S3B). Surprisingly, C-terminal
deletions of GFP-H2A (H2A111) and GFP-Z.2.1
(Z.2.1113) to mimic the shortened length of Z.2.2 did not
affect their original mobility in short-term and only
modestly in long-term FRAP. Hence, the mere shortening
of the C-terminus is not sufﬁcient to weaken stable
chromatin association.
To investigate whether the unique six C-terminal amino
acids of Z.2.2 are sufﬁcient to generate highly mobile
proteins, we created a further C-terminally truncated
GFP-H2A construct (H2A105) and added the Z.2.2
speciﬁc C-terminal six amino acids (H2A105+CZ.2.2).
Although both mutant constructs are slightly more
mobile than H2A111, their indistinguishable recovery
kinetics demonstrate that the unique six C-terminal
amino acids of Z.2.2 alone are not sufﬁcient to cause its
extreme mobility in vivo.
To explore whether the complete Z.2.2 docking domain
is able to induce high-protein mobility, we transferred the
respective domain of either Z.2.1 (amino acids 91–127) or
Z.2.2 (amino acids 91–113) onto a C-terminally truncated
H2A (H2A88+CZ.2.1 and H2A88+CZ.2.2, respectively).
Interestingly, only the docking domain of Z.2.2, but not
the one of Z.2.1, confers high mobility. In conclusion,
the six unique C-terminal amino acids of Z.2.2 prevent
chromatin-association of a large proportion of this
protein, but only when present in the context of
the preceding H2A.Z-speciﬁc docking domain sequence.
Z.2.2 interacts with H2A.Z-speciﬁc TIP60 and SRCAP
chaperone complexes and is deposited into chromatin
outside of S-phase
Our so far obtained data strongly imply that at least a
minor amount of the cellular Z.2.2 protein is incorporated
into nucleosomes. Since previous studies have shown that
evolutionary conserved Swr1-related ATP-dependent
chromatin remodelers speciﬁcally exchange canonical
H2A–H2B with H2A.Z–H2B dimers within nucleosomes
(10,61), we wondered if such complexes are also able to
actively deposit Z.2.2 into chromatin. HK cells and HK
cells stably expressing GFP-Z.2.1 or -Z.2.2 were SILAC
labeled, soluble nuclear proteins isolated, GFP-tagged
Z.2.1 and Z.2.2-associated proteins precipitated using
GFP nanotrap beads and identiﬁed by quantitative mass
spectrometry (Figure 4 and Supplementary Table S1 for a
complete list of all identiﬁed proteins). Whereas the
majority of proteins are background binders clustering
Figure 3. The majority of Z.2.2 protein is nuclear soluble and highly
mobile in a sequence-dependent manner. (A) HK-GFP cells were sub-
jected to biochemical fractionation. Fractions sol and chr of identical
cell equivalents were probed in IB with aGFP (top), aH2A (middle)
and aGAPDH (bottom). (B) FRAP quantiﬁcation curves of average
GFP signal relative to ﬂuorescence intensity prior to bleaching are
depicted for GFP, GFP-tagged wild-type H2A variants, linker histone
H1.0 and heterochromatin protein 1a (HP1a). Mean curves of 10–29
cells are shown for each construct. Error bars are omitted for clarity.
(C) FRAP quantiﬁcation curves similar to (B) are depicted for GFP,
GFP-tagged wild-type H2A, Z.2.1, Z.2.2 and mutant constructs.
(D) Quantitative evaluation of FRAP curves. Plot shows calculated
mobility fraction sizes of different wild-type and mutant H2A variant
constructs, as well as H1.0 and HP1a, based on bi-exponential ﬁtting of
FRAP data. Error bars indicate SD (see Supplementary Figure S3 for
long-term FRAP and for numerical values).
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around 0, speciﬁc interactors can be found on the right
side having a high ratio H/L or ratio L/H for Z.2.1 and
Z.2.2, respectively. In accordance with previous studies
(62–65), we found GFP-Z.2.1 to be part of two major
complexes, the SRCAP and the p400/NuA4/TIP60
(TIP60) complexes (Figure 4A), as we were able to
detect all of their thus far identiﬁed members, with the
exception of actin, as signiﬁcant outliers. Interestingly,
GFP-Z.2.2 also associated with both SRCAP and TIP60
complexes (Figure 4B), showing an almost identical
binding composition as GFP-Z.2.1 (Figure 4C). These
results strongly imply that Z.2.2 is, similar to other
H2A.Z variants, actively deposited into chromatin
through speciﬁc chaperone complexes.
Based on these results, we predicted that Z.2.1 and Z.2.2
should be incorporated into chromatin in a highly similar
spatial manner. Since both SRCAP and TIP60 chaperone
complexes are evolutionary conserved between different
species, we tested mouse C127 cells that do not express
endogenous Z.2.2 for their ability to deposit GFP-Z.2.2.
Hereby we should be able to distinguish whether SRCAP
and TIP60 complexes are sufﬁcient for deposition, or if
other potential primate-speciﬁc factors are needed.
GFP-Z.2.1 and -Z.2.2 were transiently expressed in C127
cells, S-phase stages highlighted by EdU-incorporation
and co-localization patterns visualized by ﬂuorescence
microscopy (Figure 5). GFP-Z.2.1 and -Z.2.2 showed an
almost identical chromatin localization and deposition
pattern, suggesting that Z.2.2 is, like Z.2.1, deposited
through SRCAP and TIP60 complexes. In accordance
with a recent study, we observed an enrichment of both
H2A.Z variants in facultative heterochromatin regions in
interphase nuclei (66). Surprisingly, although H2A.Z is
expressed in all cell cycle phases (67), and GFP-Z.2.1
and -Z.2.2 expression is driven by a constitutive active
promoter, chromatin deposition of both proteins is
underrepresented at replication foci. This result underlines
our ﬁndings that Z.2.2 interacts with all members of both
TIP60 and SRCAP complexes and is actively and not pas-
sively deposited, as would have been the case during
S-phase when nucleosomes are highly exchanged.
Structural changes in Z.2.2’s C-terminus prevent histone
octamer folding and enhance DNA breathing on
structurally destabilized nucleosomes
Our ﬁndings thus far imply that Z.2.2 is incorporated
into nucleosomes and most likely targeted by TIP60 and
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Figure 4. Z.2.2 associates with H2A.Z-speciﬁc SRCAP and TIP60
chaperone complexes. GFP-pull-downs for H2A.Z-speciﬁc chaperone
complexes are shown. HK cells stably expressing GFP-Z.2.1 (A) and
GFP-Z.2.2 (B) were SILAC-labeled and subjected to single-step afﬁnity
puriﬁcations of soluble nuclear proteins in a ‘forward’ (GFP-Z.2.1)
or ‘reverse’ (GFP-Z.2.2) pull-down using GFP nanotrap beads. In
Figure 4. Continued
each panel the ratio of the identiﬁed proteins after MS is plotted.
Proteins known to interact with H2A.Z are indicated in the following
way: members of the SRCAP complex in red, members of the TIP60
complex in blue and shared subunits in purple. Potential novel
H2A.Z-interacting proteins are shown as green dots (‘other outliers’)
and are distinguished from background binders (gray dots) and con-
taminants (yellow dots). See also Supplementary Table S1 for a list of
all identiﬁed proteins. (C) List of the SRCAP and TIP60 complex
members and their normalized binding intensity to Z.2.1 or Z.2.2.
Note that for comparison reasons the obtained H/L ratios of
GFP-Z.2.2 binders (numbers in brackets) were calculated in the corres-
ponding L/H ratios. See also Supplementary Table S1 for a list of all
identiﬁed proteins and their normalized H/L ratios.
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SRCAP complexes. Then why does a large fraction of the
cellular Z.2.2 protein pool shows a high mobility and is
freely dispersed in the nucleus? One plausible possibility is
that Z.2.2 severely destabilizes nucleosomes due to its di-
vergent C-terminal docking domain and is hence rapidly
exchanged. To test this hypothesis, we used an in vitro
reconstitution system. Recombinant human H2A
variants together with H3, H2B and H4 (Supplementary
Figure S4A) were refolded by dialysis, and formed
complexes puriﬁed by size exclusion chromatography. As
expected, both H2A and Z.2.1 containing samples readily
formed histone octamers (Figure 6A, solid lines). Bbd
served as a negative control, because it has been
demonstrated to not form octamers under these condi-
tions (41), a result we also observed (Figure 6A left,
dotted line). Interestingly, in accordance with our FRAP
data, Z.2.2 behaved like Bbd in that it only formed Z.2.2–
H2B dimers, but did not complex together with (H3–H4)2
tetramers to generate octamers (Figure 6A right, dotted
line), which was further conﬁrmed by SDS–PAGE
analyses of the separate fractions (Figure 6B). Thus, like
for Bbd the incorporation of Z.2.2 destabilizes the inter-
face between Z.2.2–H2B dimers and (H3–H4)2 tetramers
in a C-terminal sequence dependent manner (Sup-
plementary Figure S4B and C). In conclusion, the Z.2.2
docking domain is sufﬁcient to prevent octamer
formation.
Although no Z.2.2 containing histone octamers could
be generated in vitro, our results using GFP-Z.2.2 strongly
suggest that Z.2.2 can be part of nucleosomes. To test this
in vitro and to evaluate the effect of Z.2.2 on nucleosome
stability, we reconstituted mononucleosomes by mixing
Z.2.2–H2B dimers, (H3–H4)2 tetramers and DNA con-
taining a ‘Widom 601’ DNA positioning sequence in a
2:1:1 ratio. As controls, we reconstituted H2A or Z.2.1
containing nucleosomes by mixing octamers and DNA
in a 1:1 ratio. As expected, analysis of all nucleosomes
by native PAGE showed a single band before and after
heat shift (Figure 7A), indicating a unique position on the
‘Widom 601’ DNA template. Puriﬁcation of nucleosomes
from a native gel and analysis of the protein content by
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Figure 5. Z.2.1 and Z.2.2 are actively deposited into chromatin and are under-represented at replication foci. C127 cells transiently expressing
GFP-Z.2.1 (left) and -Z.2.2 (right) were pulse labeled with EdU to visualize replication foci and to identify S-phase stages. DNA was counterstained
with DAPI and analyzed by wide-ﬁeld deconvolution microscopy. To remove the unbound fraction in GFP-Z.2.2 expressing cells, an in situ
extraction was performed prior to ﬁxation. Cells in early, middle and late S-phases were distinguished due to their characteristic differential EdU
replication labeling patterns of eu- and heterochromatic regions. Merged images in color are shown alongside (GFP: green; EdU: red; DAPI: blue).
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Figure 6. Z.2.2 does not constitute stable histone octamers with H2B,
H3 and H4 in vitro. (A) Size exclusion chromatography of refolding
reactions using recombinant human H3, H4 and H2B proteins to-
gether with either H2A (solid line) or Bbd (dashed line) (left overlay)
or with either Z.2.1 (solid line) or Z.2.2 (dashed line) (right overlay).
Peaks corresponding to aggregates, histone octamers, tetramers or
dimers are labeled respectively. (B) Fractions corresponding to H2A-
containing octamers, Bbd-containing tetramers and dimers (left) or
Z.2.1-containing octamers and Z.2.2-containing tetramers and dimers
(right) were analyzed by 18% SDS–PAGE and stained with Coomassie
brilliant blue.
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SDS–PAGE (Coomassie staining and immunoblot)
showed that Z.2.2 was indeed incorporated into nucleo-
somes (Figure 7B). All nucleosomes were further
evaluated for their resistance to MNase cleavage as an
indicator of stably organized nucleosomes and to deter-
mine nucleosomal DNA length (Figure 7C and
Supplementary Figure S5). We observed fragments corres-
ponding to protected nucleosomal DNA with the length of
146 bp for all variant nucleosomes tested. The appearance
of smaller, subnucleosomal fragments indicates that DNA
breathing occurred (68). Interestingly, DNA of Z.2.2
nucleosomes is less protected, since subnucleosomal frag-
ments were obtained at lower MNase concentrations than
with H2A or Z.2.1 nucleosomes. Additionally, at higher
MNase concentrations a stable DNA fragment of about
120 bp was most abundant for Z.2.2 nucleosomes
(Supplementary Figure S5), indicating that this might be
the preferred DNA length wrapped around this octamer.
These data suggest that increased DNA breathing occurs
in Z.2.2 nucleosomes, which as a result might be less
stable. To quantify nucleosome stability in vitro we
measured salt-dependent changes in nucleosome structure
using smFRET (69). In line with the results presented
above, Z.2.2 containing recombinant nucleosomes lost
their compact structure at lower salt concentrations than
Z.2.1 or H2A-containing ones (Figure 7D). To investigate
whether the observed Z.2.2-dependent nucleosome desta-
bilization is true in the context of chromatin, we isolated
chromatin from HK cells expressing GFP-H2A variants
and incubated it with buffer containing increasing
amounts of salt. Histones that remained stable chroma-
tin components were precipitated and detected by IB
(Figure 7E). As observed with FRET techniques,
Z.2.2-containing nucleosomes disintegrated between 200
and 400mM NaCl, and were therefore even less stable
than Bbd-containing ones. In summary, incorporation
of Z.2.2 leads to a severely reduced nucleosome stability
due to C-terminal sequence dependent changes in its
docking domain and subsequent loss of its interaction
with histone H3.
Our FRAP data suggest that the Z.2.2 C-terminal
amino acids might have a direct inﬂuence on the nucleo-
somal structure by affecting interactions with DNA and/
or adjacent histones. Based on the existing structural data
(50), we performed MD simulations of nucleosomes con-
taining Z.1 (Supplementary Figure S7) or Z.2.2.
In addition, we also included the deletion mutant
Z.2.1113, which did not show any change in short-term
FRAP (Figure 3C), but some increase in mobility in
long-term FRAP (Supplementary Figure S3B) in our
assay. These in silico models revealed that changes in the
C-terminus of H2A.Z strongly affect its protein structure
(Figure 8A). Strikingly, different statistical descriptors
over the MD-trajectory like distance and mobility
(B-factor) show in contrast to Z.1 and Z.2.1113 unique
properties for the Z.2.2 tail. Only Z.2.2 leads to a substan-
tial structural change in the C-terminus resulting in an
increased distance to histone H3, which in turn makes a
hydrogen bond interaction between peptide backbone NH
of Cys112 in Z.2.2 and the oxygen in the Gln55 side chain
in H3 impossible (Figure 8B). Additionally, an increase in
the B-factor for Z.2.2 indicates a substantially enhanced
mobility of Z.2.2’s C-terminus (Figure 8C). We also
calculated the Z.2.2–H3 interaction energy and observed
a switch from negative to positive values in the case of
Z.2.2 suggesting that this histone variant destabilizes the
nucleosome (Figure 8D). In summary, these data suggest
that the C-terminal sequence of Z.2.2 leads to a more
dynamic structure that in turn loses binding to histone
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Figure 7. Z.2.2-containing nucleosomes are less resistant to MNase
digestion and increased ionic strength. (A) H2A, Z.2.1 or Z.2.2 con-
taining nucleosomes were assembled on DNA by salt gradient depos-
ition, incubated at 4C or 37C to evaluate DNA positioning and
separated by a native 5% PAGE gel. (B) Agarose-gel-electro-eluted
material from (A) was analyzed by 18% SDS–PAGE and Coomassie
stained to evaluate stoichiometry of histones after nucleosome assembly
(top). Stars indicate H2A variants that were used for assembly. Further
evaluation of histone stoichiometry after nucleosome assembly was
done by IB using a LI-COR instrument (bottom). Assembled nucleo-
somes containing Z.2.1 or Z.2.2 were immunoblotted and the amount
of histones was visualized using an aH3 antibody (top) and an
N-terminal aZ antibody (recognizes all H2A.Z variants, bottom).
(C) Mononucleosomes containing either H2A, Z.2.1 or Z.2.2 were
digested with increasing concentrations of MNase and extracted
DNA was separated using Bioanalyzer. Stars indicate DNA length of
146 bp. For detailed electropherogram analyses of fragment lengths in
each sample see Supplementary Figure S5. (D) Mononucleosomes
containing either H2A, Z.2.1 or Z.2.2 histones together with double
dye labeled DNA were incubated with increasing amounts of salt.
smFRET measurement values of each salt concentration were
normalized to 0mM NaCl. Error bars represent SEM of six measure-
ments. (E) Chromatin from HK-GFP cells was isolated and incubated
with increasing amounts of salt. Chromatin-bound histones were
precipitated and detected by IB using aGFP antibody. Staining with
aH2A was used as loading control.
Nucleic Acids Research, 2012 9
 at U
niversitaetsbibliothek M
uenchen on M
ay 9, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
H3 and destabilizes the nucleosomal structure, providing a
reasonable explanation for the observed in vivo and
in vitro data.
DISCUSSION
In this work, we have identiﬁed a previously unknown
histone H2A.Z variant and provide a comprehensive
characterization of its nucleosomal properties. This alter-
natively spliced variant, Z.2.2, is present to different
degrees in all human cell lines and tissues investigated,
with a signiﬁcant enrichment in brain. Z.2.2 contains a
shortened and in six amino acids divergent C-terminus
compared to Z.1 and Z.2.1 that is necessary, but not
sufﬁcient, to weaken chromatin association. Only in
the context of the unique Z.2.2 docking domain does
the C-terminal sequence negatively affect nucleosome
stability in vitro and in vivo. To our knowledge,
Z.2.2 has the strongest destabilizing effect on nucleosomal
structure compared to other histone H2A variants
reported to date.
Only one other histone variant, macroH2A, has been
shown thus far to be alternatively spliced (70). Here, like
our observation with H2A.Z, two independent genes
mH2A1 and mH2A2 exist in mammals, with only
mH2A1 being alternatively spliced resulting in functional
different proteins (71). In our study, we demonstrate that
the human H2A.Z.2 (H2AFV) primary transcript is alter-
natively spliced generating Z.2.1 and Z.2.2 mRNAs and
proteins. These observations suggest that Z.2.2 is tightly
regulated in a tissue-speciﬁc manner through alternative
splicing and/or RNA stability. Our ﬁndings now raise the
intriguing possibility that alternative splicing of histone
variants might not be rare but more common than previ-
ously thought. If true, it will be of interest to reevaluate
other intron-containing histone variant genes with regard
to their possible alternative transcripts and protein
products.
Bioinformatic genome analyses revealed the existence of
Z.2.2-speciﬁc sequences only in humans, old and new
world primates and to some extend in other mammals,
with the exclusion of mouse, rat and even lower eukary-
otes. It remains to be seen, whether Z.2.2’s evolution is
indeed limited to primates only. Primate-speciﬁc gene
products have been often identiﬁed in human brain
and reproductive tissues (72), supporting the notion that
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their RNAs and proteins might be essential to adaptive
changes leading to human development and further specu-
lates that primate-speciﬁc genes might be important in re-
productive function and disease. Since we have found
Z.2.2 transcripts to be strongly enriched in brain samples
of higher brain function in comparison to other tissues and
cell types, it will be of great interest to determine in future
studies, if this novel variant might play an important
functional role in this particular organ. These observations
also raise the interesting question of how alternative
splicing and/or differential stability of H2AFV transcripts
are tissue speciﬁcally regulated.
Another intriguing feature of Z.2.2 is its inﬂuence on
nucleosome stability. Although Z.2.2 localizes exclusively
to the nucleus, only a minor proportion is stably
incorporated into chromatin. The only other exception
in humans known thus far is Bbd, which has previously
been demonstrated to destabilize the nucleosome structure
(41,53,73). Bbd, similar to Z.2.2, is a shorter H2A variant
with an unusual C-terminus and a considerable different
primary histone fold sequence that might explain its
ability to destabilize nucleosomes. In agreement, a recent
study demonstrated that the incomplete C-terminal
docking domain of Bbd results in structural alterations
in nucleosomes and that those are in turn associated
with an inability of the chromatin remodeler RSC to
both remodel and mobilize nucleosomes (8). Z.2.2, on
the other hand, is identical to Z.2.1, except that its
C-terminus is 14 amino acids shorter and in six amino
acids altered. How can this small change in Z.2.2’s
primary sequence lead to such drastic effects on chromatin
association?
We show that Z.2.2 can be part of a bona ﬁde nucleo-
some and that it interacts with the H2A.Z-speciﬁc TIP60
and SRCAP chaperone complexes. These complexes have
been shown to catalyze the exchange of H2A–H2B dimers
with H2A.Z–H2B dimers in nucleosomes and our ﬁnding
therefore suggests that both complexes are also involved in
an active chromatin incorporation of Z.2.2. Supporting
this idea is the observation that both Z.2.1 and Z.2.2 are
incorporated into chromatin in a replication-independent
manner, even in mouse cells that do not express endogen-
ous Z.2.2. Both H2A.Z variants are not primarily de-
posited at replication foci, not even in middle S-phase
when facultative heterochromatin is replicated, where the
majority of the H2A.Z protein pool is found in interphase
cells (66). Our ﬁndings are in agreement with a model
proposed by Hardy and Robert, in which H2A.Z
variants are randomly deposited into chromatin by
speciﬁc chaperone complexes in a replication-independent
manner coupled to a subsequent targeted H2A.Z deple-
tion (74). As a consequence, an enrichment of H2A.Z at
non-transcribed genes and heterochromatin regions over
several cell generations can be observed (74). It might be
possible that INO80 facilitates this eviction function, as it
has been shown to exchange nucleosomal H2A.Z–H2B
dimers with free H2A–H2B dimers (75). It will be of
interest in future studies to determine whether Z.2.2
exchange is subjected to a similar mechanism. Taken
together, our ﬁndings strongly imply that Z.2.2 is
actively deposited into chromatin through the interaction
with evolutionary conserved chaperone complexes.
Nevertheless, a large fraction of Z.2.2 protein is not chro-
matin bound and we have mapped the region crucial for
high FRAP mobility to its docking domain. In addition to
Z.2.2’s unique C-terminal amino acids this region spans
the highly conserved acidic patch responsible for depos-
ition (76), the M6 region that is functionally essential in
ﬂy H2A.Z (60) and required for the interaction with
the SWR1 complex in yeast (77). Strikingly, in silico simu-
lation of Z.2.2 predicted dynamic structural changes
that in turn weaken interaction with histone H3 and
destabilize the nucleosome structure. Such a gross struc-
tural alteration explains why Z.2.2 is not able to form
stable octamers in vitro and leads to enhanced DNA
breathing in a nucleosomal context. Hence, Z.2.2 incorp-
oration into chromatin disrupts nucleosomes more easily
and supports a model in which Z.2.2 is more rapidly
exchanged than Z.2.1.
What functional outcome might Z.2.2 cause when
incorporated into chromatin? And how is the variant
composition of Z.2.2 containing nucleosomes? It has
been shown that a special class of nucleosomes contain-
ing both H2A.Z and H3.3 variants exists in humans (78).
These nucleosomes are enriched at promoters, enhancers
and insulator region and promote the accessibility of
transcription factors to these DNA regions (78), most
likely due to their extreme sensitivity to disruption (79).
Since these studies nicely demonstrate that differential
nucleosome stabilities due to the incorporation of
different histone variants inﬂuence transcriptional regula-
tion, it is tempting to speculate that Z.2.2 might also
affect chromatin-related processes. Future experiments
will shed light on Z.2.2 function(s), especially with
regard to its increased expression in human brain areas,
and explain why and where nucleosomal destabilization is
needed. This is of particular interest, since Bbd that also
leads to nucleosomal destabilization is almost exclusively
present in testis (80–82) in contrast to the apparently ubi-
quitously expressed Z.2.2, possibly pointing toward
distinct roles of both destabilizing H2A variants in dif-
ferent tissues. Our data suggest that additional interest-
ing, yet unidentiﬁed, histone variants may exist and await
their discovery.
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Supplementary Figure S1: Identification of Z.2.2. 
(A) Schematic representation of exon/intron structure of the predicted five alternative 
human Z.2 (H2AFV) splice forms (http://www.ncbi.nlm.nih.gov/gene/94239). Untrans-
lated sequences (UTR) are depicted in dark gray, coding regions in light gray and introns 
as kinked lines. Sizes of exons/introns are not drawn to scale. Primers used to amplify 
specific splice forms by PCR (see Supplementary Figure S1B) are shown as F 
(hybridizes to 5’UTR of all spliced mRNAs), R1 (specific for exon V of splice forms 1, 3, 4 
and 5) and R2 (specific for exon VI of H2A.Z.2.2). Expected PCR amplicon sizes of each 
splice form are indicated on the right. (B) Agarose gel to visualize amplified DNA after 
PCR with cDNA generated from HeLa and HEK293 total RNA, respectively, using F+R1 
(A, lanes 1 and 3) or F+R2 (B, lane 2 and 4) primer pairs. Expression levels of Z.1 and 
Z.2 (Z.2.1 + Z.2.2), and (C) of Z.1, Z.2.1 and Z.2.2 (D) mRNAs measured by qPCR and 
normalized to HPRT1 and HMBS. Controls generated without reverse transcriptase (no 
RT) were used to assess amplification threshold. (E) Immunoblot with recombinant Z.2.1, 
recombinant Z.2.2 and acid extracted HeLa histones to validate specificity of both, rat 
monoclonal and rabbit polyclonal antibodies (top). Equal loading was ensured by 
Ponceau staining of the membrane before antibody incubation (bottom).
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Supplementary Figure S2: Characterization of HeLa Kyoto cell lines stably expressing GFP-H2A variants. 
(A) FACS profiles of representative HeLa Kyoto cell lines (single cell clones, dark gray) used in this study. WT and GFP controls 
(light gray) are shown for comparison. Table of mean fluorescence intensity (MFI) is shown on the right. (B) Immunoblot of 
whole cell extracts prepared from HeLa Kyoto cell lines stably expressing GFP-H2A variants. Immunoblot with αGFP antibody 
(top) to compare expression levels of different GFP-H2A variants. Expression of GFP-Z.2.2 and GFP-Bbd is much lower than 
for the other variants and GFP-Bbd is only detectable using ECL Advance. Equal loading was ensured by αGAPDH antibody. 
Immunoblot with antibody against H2A.Z C-terminus (bottom) shows similar expression of GFP tagged Z.1 and Z.2.1 compared 
with endogenous protein.
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Supplementary Figure S3: FRAP analysis of GFP-H2A variants.
(A) FRAP experiment to evaluate nucleosomal stability of wild type and mutant H2A variants using spinning disk confocal 
microscopy. A small nuclear area (box) of HeLa Kyoto cells expressing GFP-tagged H2A variants, H1.0, HP1α or GFP alone 
was photobleached and the recovery of the fluorescent signal was monitored for up to 5 hours. For each construct, selected 
time points of one exemplary time series are shown. Scale bar = 5 μm. (B) Long-term (60 min) FRAP quantification curves 
of average GFP signal recovery after photobleaching relative to flourescence intensity prior to bleaching are depicted for 
wild type (solid lines) and mutant (dashed lines) GFP-tagged H2A variant constructs, H1.0, HP1α and GFP. Mean curves of 
10 to 29 individual cells are shown for each construct. For clarity error bars are omitted. (See also Figure 3B and 3C for 
short-term FRAP curves and Supplementary Figure S2E for numerical values and standard deviations). (C) Quantitative 
evaluation of FRAP curves. Plot shows calculated half-time of recovery (t1/2) values of different control constructs, wild type 
and mutant H2A variant constructs based on bi-exponential fitting of FRAP data (± standard deviation (SD), see Fig. S2E 
for numerical values) (D) Schematic representation of GFP-tagged (green box) H2A variants deletion and domain swap 
constructs used in FRAP studies. H2A is depicted in yellow, Bbd in purple, Z.1/.2.1/.2.2 in orange with Z.2.2’s unique 
C-terminal amino acids highlighted in red. (E) Table of mean half-time of recoveries (t1/2) and respective mobility fraction 
sizes (± SD) as determined from exponential fitting. While a single exponential function was sufficient to fit GFP alone, all 
other GFP fusion proteins were fitted with a bi-exponential function identifying either a fast (t1/2 < 62 s) and an intermediate 
fraction (t1/2 0.3-20 min), or an intermediate and a slow fraction (t1/2 > 1.5 h). 
E
N 
t1/2 fraction [%] 
fast (s) slow (h) fast intermediate slow 
 
GFP 17 0.4 ± 0.2 - -  100 - - 
HP1α  14 1.6 ± 0.3 0.3 ± 0.1 -  82 ± 6 18 ± 6 - 
H1.0 15 61.8 ± 23.5 9.9 ± 4.7 -  61 ± 13 39 ± 13 - 
Bbd  14 2.5 ± 0.8 9.0 ± 2.5 -  52 ± 7 48 ± 7 - 
- Z.2.2   29 1.1 ± 0.3 7.3 ± 4.1 -  78 ± 8 22 ± 8 
H2A105 10 1.4 ± 0.3 14.5 ± 2.7 -  32 ± 4 68 ± 4 - 
H2A105+CZ.2.2 14 2.1 ± 1.0 10.6 ± 5.2 -  30 ± 10 70 ± 10 - 
H2A88+CZ.2.2 15 1.1 ± 0.2 2.7 ± 0.6 -  83 ± 8 17 ± 8 - 
   
H2A 24 - 17.3 ± 6.8 4.0 ± 1.4  - 25 ± 9 75 ± 9 
Z.1  13 - 8.4 ± 7.7 1.6 ± 0.7  - 18 ± 11 82 ± 11 
Z.2.1  15 - 16.8 ± 9.5 4.9 ± 2.5  - 28 ± 8 72 ± 8 
H2A111  
Z.2.1113 
14 - 10.7 ± 8.0 1.5 ± 1.2  - 42 ± 19 58 ± 19 
H2A88+CZ.2.1 25 - 16.7 ± 10.9 4.2 ± 2.7  - 28 ± 13 72 ± 13 
 13 - 13.5 ± 9.1 1.9 ± 1.1  - 44 ± 18 56 ± 18 
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Supplementary Figure S4: Z.2.2 destabilizes histones octamers in a sequence-dependent manner.
(A) Evaluation of purity of recombinant human histone proteins. Human core histones (H3, H4, H2B, H2A) and H2A variants Bbd, 
Z.2.1 and Z.2.2 were expressed in E. coli. After purification, recombinant proteins were separated on 18% SDS-PAGE and stained 
with Coomassie brilliant blue. (B) Size exclusion chromatography of refolding reactions using recombinant histones, as described 
in Figure 6, but with the use of H2A88+CZ.2.1 (solid line) and H2A88+CZ.2.2 (dashed line) proteins instead of H2A. (C) Fractions 
corresponding to octamers, tetramers and dimers depicted in Supplementary Figure S4B were analyzed by 18% SDS-PAGE and 
stained with Coomassie brilliant blue.
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Supplementary Figure S5: MNase digest of mononucleosomes containing different H2A variants. 
Electropherograms of deproteinized DNA fragments separated on a Bioanalyzer after digestion of mononucleosomes containing either 
H2A, Z.2.1 or Z.2.2 with increasing amounts of MNase (see also Figure 6C). Numbers indicate respective DNA fragment length in bp.
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Supplementary Figure S6: smFRET analysis of mononucleosomes containing different H2A variants.
(A) Exemplary two-dimensional FRET efficiency versus stoichiometry histogram showing H2A Nucleosomes at 0 mM NaCl. Data 
is filtered using TDS < 1 and TDSred-PIE < 0.6 and a stoichiometry threshold (S = 0.15 – 0.55).  The separation between low and 
high FRET at E = 0.4 (40% FRET efficiency) used to analyze the data presented here is marked by a dark grey line. (B) Composite 
of raw data, TDS and additional dynamic filter. The two dimensional plot of stoichiometry versus FRET efficiency recorded with a 
mononucleosome sample containing Z.2.1 (TE pH 7.6), together with the one-dimensional projections. Besides dual labeled 
nucleosomes, the sample contained also impurities of donor and acceptor only complexes. Only bursts within a stoichiometry 
range of S = 0 – 0.7 are shown. The high concentration of molecules in the sample combined with the significant amount of single 
labeled impurities cause strong multi-molecular trailing (left). A significant improvement of the data quality is reached by removing 
the multi-molecule events using TDS < 0.6 and TDSred-PIE < 0.6 (right). 
Supplementary Figure S7: Simulation of Z.1-containing nucleosome.
In silico model of nucleosome based on H2A.Z published crystal structure data (50) containing Z.1 (yellow), H2B (red), H3 (blue), 
H4 (green) and DNA (gray). Box highlights region depicted in Figure 8A.
 
“H2A.Z.2.2 is an alternatively spliced histone H2A.Z variant that causes severe 
nucleosome destabilization” by Bönisch et al. 
 
 
SUPPLEMENTARY MATERIALS AND METHODS 
 
Cell culture, transfection, FACS analysis and cloning  
Cell lines were grown in DMEM medium (PAA) supplemented with 10% FCS 
(Sigma) and 1% penicillin/streptomycin or 50 µg/ml gentamicin (C127 cells) at 37°C 
and 5% CO2. The following human cell lines were used in this study: HEK293 
(embryonic kidney), HeLa (cervix carcinoma), HeLa Kyoto (cervix carcinoma), 
U2OS (osteosarcoma), hFB (fibroblasts), SK-N-SH (neuroblastoma), and the 
following mouse cell lines were used: NIH3T3 and C127. Human cell lines were 
transfected using FuGene HD (Roche Applied Science) and mouse C127 cells were 
transiently transfected using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions. Z.2.1 and Z.2.2 were cloned from HeLa cDNA into 
pT7blue3 (Novagen). For expression in human cells, Z.2.1, Z.2.2, Bbd and deletion or 
domain swap mutants were cloned into the pEGFP-C1 vector (Clontech) to generate 
N-terminally tagged proteins. For simplicity eGFP-tagged constructs are referred to as 
GFP-tagged throughout the text. Plasmids coding for GFP-H2A (H2A type 1, 
NP_003501.1) and GFP-Bbd (H2A.Bbd type 2/3, NP_542451.1) were kindly 
provided by Emily Bernstein. The plasmid coding for GFP-Z.1 was a gift from 
Sachihiro Matsunaga, the H1.0-GFP construct was kindly given by M.J. Hendzel (1) 
and the GFP-HP1α construct was provided by T. Misteli (2). Stable cell lines were 
selected with 600 µg/ml G418 (PAA) and individual cell clones sorted by using a 
FACSAria machine (Becton Dickinson). Expression levels of GFP-proteins were 
quantified by using a FACSCanto machine (Becton Dickinson).  For expression in E. 
coli, Z.2.1, Z.2.2, Bbd and domain swap mutants were cloned into the pET-21a(+) 
vector (Novagen). Plasmids for expression of recombinant human H2A, H2B, H3 and 
H4 were kindly provided by Robert Schneider. Cloning and PCR amplification 
accuracy was verified by sequencing (MWG). 
 
Histone extraction, RP-HPLC purification, cellular fractionation, MNase 
digestion, sucrose gradient fractionation and salt stability experiments  
Acid extraction of histones was done as previously described (3). Histones from 
HEK293 cells were separated by RP-HPLC as previously described (4). Fractions 
were dried under vacuum and stored at -20°C.   
Fractionation experiments were carried out as described previously (5) with minor 
changes. Briefly, 2 x 107 cells were resuspended in 1 ml buffer A supplemented with 
0.1% NP40, incubated for 10 min and collected by centrifugation. The pellet was 
washed once with buffer A and incubated in buffer B for 30 min. The resulting 
chromatin pellet was washed once with buffer B and resuspended in SDS loading 
buffer (chromatin fraction). After sonification (Diagenode Bioruptor) and 
denaturation, nucleic acids were degraded by benzonase (VWR) treatment. All 
centrifugations were performed at 6.500 g for 5 min at 4°C except the final one 
(20.000 g for 20 min at 4°C). The soluble fraction was obtained by combining the 
supernatants of all centrifugations (incl. washing steps). Proteins were pelleted as 
described (6) and resuspended in SDS loading buffer. Identical cell equivalents of 
soluble and chromatin fractions were analyzed by immunoblotting. 
For MNase digestion, chromatin was prepared from 5 x 107 HK cells stably 
expressing GFP-Z.2.2 as described above, resuspended in 500 µl EX100 (10 mM 
HEPES pH 7.6, 100 mM NaCl, 1.5 mM MgCl2, 0.5 mM EGTA, 10 % (v/v) glycerol, 
1 mM DTT, 1 x Roche protease inhibitors) and digested with 1.5 U MNase (Sigma) 
for 20 min at 26°C. The reaction was stopped by addition of EGTA to a final 
concentration of 10 mM and centrifuged (3.200 g for 20 min at 4°C). A gradient of 
5%-35% sucrose in EX100 was prepared using a Gradient Master (Biocomp), 400 µl 
of the supernatant after MNase digest were loaded on top and ultracentrifuged (30.000 
rpm for 18 h at 4°C using a Beckmann SW41 rotor). Afterwards, 500 µl fractions 
were manually taken from top and analyzed for DNA content after RNase A and 
Proteinase K digest by agarose gel electrophoresis. Purity of mononucleosome 
containing fractions was verified using DNA 1000 reagents (Agilent Technologies) 
with the 2100 Bioanalyzer (Agilent Technologies). Pure mononucleosome fractions 
were combined, concentrated by TCA precipitation and analyzed by immunoblot.  
For salt stability assays (7), chromatin was prepared in the same manner as in 
fractionation experiments. After washing with buffer B, chromatin was incubated 
with incubation buffer (10 mM TrisHCl pH 7.5, 1 mM DTT, 1 mM EDTA, 1x 
protease inhibitors (Roche Applied Science), 0.1% Triton X-100) containing different 
salt concentrations ranging from 50 mM to 600 mM NaCl for 1 h at room 
temperature. Chromatin was pelleted, solubilized in the same manner as in 
fractionation experiments and analyzed by immunoblotting.  
 
FRAP and exponential fitting 
FRAP experiments were performed using an UltraVIEW VoX spinning disk 
microscope system (PerkinElmer) equipped with a heated environmental chamber and 
CO2 perfusion as previously described (4) with the following changes. To determine 
short-term recovery kinetics, 2D time series were recorded for 2 min to 1 h with time 
intervals between 0.1 s and 1 min depending on the recovery kinetics of the construct. 
For long-term recovery kinetics, image z-stacks were recorded with intervals between 
1 min and 5 min. The central 3-5 image planes were average projected for quantitative 
evaluation. To correct for cell-to-cell differences in bleaching depth, the normalized 
mean intensity values of the first postbleach values were linearly interpolated to 
determine an estimated value for the time point t = 0. This value was subtracted from 
all mean fluorescence values after previous double normalization to correct for 
potential gain or loss of total fluorescence, e.g. by import and bleaching-by-
acquisition. 
The normalized FRAP curves were further evaluated and quantified by a commonly 
used fitting procedure (8): A sum of exponential time dependencies can be used to 
describe the intensity I(t) of the fluorescence recovery. 
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To discriminate at least two different species within our sample, we restricted our self 
to the bi-exponential case, where 121 =+ AA . Therefore the parameters α1, α2 and A 
had to be determined from the individual recovery curves by a least-square 
optimization algorithm. This was carried out automatically by a self-made python 
(www.python.org) script, which applied the leastsq function from the scipy.optimize 
package (www.scipy.org).  Only curves with a reasonable set of resulting parameters 
were taken into account for the final summary, wherein the exponents α are 
transformed into their corresponding, more intuitive half-times of recovery.  
1
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Most of the recovery data were described adequately by this bi-exponential 
characteristic, manifested in a close approximation by the fitted curve. An evaluation 
of the goodness of the fits was therefore not necessary. However, in some 
experiments where GFP alone was expressed, a single exponential curve already 
allowed a sufficiently close approximation. Applying the bi-exponential model to 
these data sets leads to two almost identical exponentials, showing the invalidity of 
the more complex model. This categorization allowed us therefore to distinguish 
between two types of complexity: One type with only a single mobile species and on 
the other hand the case, where at least two mobile species are apparent. Extension to 
three mobile species did typically not result in significant improvement of the fits. 
 
Stable isotope labeling with amino acids in cell culture (SILAC) and mass 
spectrometry (MS) identification of H2A.Z-specific chaperone complexes 
HeLa cells expressing GFP-Z.2.1 or GFP-Z.2.2 were SILAC labeled and nuclear 
extracts were prepared as described before (9). Nuclear extracts were diluted in 
incubation buffer (150 mM NaCl, 50 mM Tris-HCl pH 8.0, 0.25% NP40) 
supplemented with complete protease inhibitors w/o EDTA (Roche) and 0.5 mM 
DTT to a concentration of 1.5 µg/µl. 400 µl solution were incubated with GFP trap 
(Chromotek) for 3 h at 4°C. Beads were washed 3 times with 1 ml incubation buffer, 
combined and eluted by boiling in loading buffer. Samples were loaded on 1D 
NuPAGE gels (Invitrogen), lanes cut into 8 slices, in gel digested with trypsin and 
desalted by stage tipping. Mass spectrometry (MS) was performed on an LTQ 
Orbitrap mass spectrometer as described before (10). Peptides were separated online 
to the mass spectrometer by using an easy nano-LC system (Proxeon Biosystems) 
with a 15-cm fused silica emitter with an inner diameter of 75 µm packed in house 
with RP ReproSil-Pur C18-AQ 3 µm resin (Dr. Maisch). Peptides were eluted with a 
segmented gradient from 5% to 60% B with a constant flow of 0.25 ml/min (solvent 
B: 80% acetonitrile, 0.5% acetic acid) over 110 min.  
The MS was operated in data dependent mode. A full scan MS (m/z 300 - 1650) was 
acquired in the Orbitrap cell with a resolution of 60,000 at a theoretical m/z ratio of 
400 after accumulation of 1,000,000 ions in the C-trap (maximum filling time of 1000 
ms); the lock mass option was enabled to improve mass accuracy. The 5 most intense 
ions from the preview survey scan were isolated (target value of 5,000 ions at a 
maximum filling time of 150 ms) fragmented by collision-induced dissociation 
(collision energy 35 %) and measured in the ion trap concurrently to full scan 
acquisition in the Orbitrap. Precursor ion charge state screening was enabled, and all 
unassigned charge states as well as singly charged peptides were rejected. The 
dynamic exclusion list was set to a maximum of 500 entries with a maximum 
retention period of 90 s and a relative mass window of 5 ppm. 
Raw data were analyzed using the MaxQuant software suite (11) (version 1.2.2.7) 
with the integrated Andromeda search engine (11) at default parameters using the IPI 
human database version 3.68 concatenated with a database containing common 
contaminants. For further analysis we removed contaminants and defined a ratio 
cutoff of 4 (Z.2.1 pull-down) and 0.25 (Z.2.2 pull-down). A complete list of all 
proteins identified is found in Supplementary Table S1. 
 
EdU replication labeling, in situ extraction and fluorescence microscopy to assay 
cell cycle dependent GFP-Z.2.2 chromatin incorporation 
C127 cells were pulse labeled for 25 min with 10 µM 5-ethynyl-2′-deoxyuridine 
(EdU, Baseclick) 48 h after transfection with GFP-Z.2.1 or -Z.2.2 plasmids, and 
immediately subjected to in situ extraction or fixation. For in situ extraction, GFP-
Z.2.2 transfected cells were washed with PBS and incubated 15 sec in 
permeabilization buffer (0.1% Triton X-100, 150 mM NaCl in PBS). Thereafter, cells 
were fixed for 10 min at room temperature with 2% formaldehyde (Sigma) in PBS 
containing 0.1% Triton X-100. Cells expressing GFP-Z.2.1 were not in situ extracted 
and were fixed with 2% formaldehyde in PBS for 10 min at room temperature. All 
washing steps after fixation were performed with 0.02% Tween20 in PBS (PBST). 
After permeabilization with 0.2% Triton X-100 in PBS for 10 min, cells were blocked 
for at least 1 h in blocking buffer (2% BSA in PBST). Before EdU-detection, cells 
were incubated 1 h with GFP-booster (Chromotek) diluted in blocking buffer. 
Incorporated EdU was detected by incubating cells 30 min in 100 mM Tris-HCl pH 7, 
4 mM CuSO4, 20 µM azide dye Alexa Fluor 594 (Invitrogen) and 50 mM sodium 
ascorbate (adapted from (12)). Cells were counterstained with 200 ng/ml DAPI in 
PBST for 10 min and mounted on microscope slides in Vectashield mounting medium 
(Vector Laboratories). 
Wide-field imaging was performed on a PersonalDV microscope system (Applied 
Precision) equipped with a 60x/1.42 PlanApo oil objective (Olympus), CoolSNAP 
ES2 interline CCD camera (Photometrics), Xenon illumination and appropriate filter 
sets. Image stacks were recorded with a z-distance of 200 nm and subjected to a 
constrained iterative deconvolution (enhanced ratio, 10 cycles, medium noise 
filtering, SoftWoRX, 3.7. imaging software package, Applied Precision).  
 
 
Expression and purification of recombinant human histone proteins in E.coli, in 
vitro octamer and mononucleosome reconstitution and MNase digestion of 
recombinant mononucleosomes 
Histones were expressed, purified and assembled into octamers as described (13). 
DNA for mononucleosome assembly was obtained from a pUC18 plasmid containing 
25 repeats of the 601 nucleosome positioning sequence (14) kindly donated by 
Daniela Rhodes. After AvaI digestion, monomeric DNA was purified by gel 
electrophoresis and electroeluted using the Elutrap system (Whatman). Assembly of 
nucleosomes was performed by salt gradient deposition (13,15). For H2A and Z.2.1 
nucleosomes, respective octamers and DNA were mixed in a 1:1 ratio; for Z.2.2 
nucleosomes, Z.2.2-H2B dimers, (H3-H4)2 tetramers and DNA were mixed in a 2:1:1 
ratio. Assembly of histones on DNA was evaluated by EMSA using 5% native PAGE 
or native 1.5% agarose gels. Incubation of mononucleosomes for 1 h at 37°C (15) did 
not change position as evaluated by 5% native PAGE (data not shown). To analyze 
the histone content of nucleosomes after assembly, the corresponding band was 
excised from native 1.1% agarose gels, nucleosomes were electroeluted using the 
Elutrap system and protein content was analyzed by 18% SDS-PAGE after Benzonase 
treatment by Coomassie staining or immunoblot. 
Equal amounts of nucleosomes (1 µg) were digested with different amounts of MNase 
(Sigma) for 10 min at 37 °C in MNase digest buffer (13.85 mM TrisHCl ph 7.5, 67 
mM KCl, 10.75% Glycerol, 1 mM DTT, 5 mM CaCl2). The reaction was stopped by 
addition of nine volumes of 5 mM EGTA. DNA was deproteinized by 
phenol/chloroform extraction, ethanol precipitated and analyzed using DNA 1000 
reagents (Agilent Technologies) with the 2100 Bioanalyzer (Agilent Technologies).  
 
Single molecule Förster resonance energy transfer (smFRET) 
Single molecule burst analysis: 
To gain information on salt dependent nucleosome stability single-molecule Förster 
resonance energy transfer (smFRET) measurements of dual labeled nucleosomes 
freely diffusing through the focal volume of a confocal microscope were performed. 
To this end a dual labeled 159 bp DNA was prepared using dye-labeled primers 
(IBA), a DNA template containing the 601 (14) sequence and six additional bases on 
each side together with dNTPs (Finnzymes) and the Phusion DNA-polymerase 
(Finnzymes) in a PCR reaction. Dye labels were at position 65 (donor dye, Tamra) 
and position 20 on the reverse strand (acceptor dye, Alexa647). A mixture of this 
labeled DNA and unlabeled DNA (molar ratio of 1:50) was used for 
mononucleosome assembly (see above). 
It is well known, that ultra-low concentrations of nucleosomes are prone to become 
instable in typical experimental geometries (16). To minimize such effects 
measurements were performed using a 1:250 mixture of double labeled to unlabeled 
nucleosomes at a total concentration of 25 nM in commercially available TE buffer 
(Sigma-Aldrich, pH 7.6) containing 10 mM DTT and 0 mM, 300 mM, 400 mM, 500 
mM, 600 mM and 700 mM NaCl, respectively. The samples were incubated at the 
respective salt concentration for 1 hour at 21°C before a drop of 20 µl was put onto 
cover slips (Marienfeld) for data collection. The cover slips were cleaned with 2% 
Hellmanex III (Hellma) and water prior to silanization for 15 min with 2% (3-
aminopropyl)triethoxysilane (Sigma-Aldrich) in Acetone, and coating with 40 mg/100 
µl polyethylene glycol (mPEG-SVA MW 5000, Laysan Bio Inc.) in ddH2O for 1 h. 
The confocal measurements were performed on a custom built experimental setup 
using pulsed interleaved excitation (PIE) (17) with lasers at 532 nm (Pico-TA- 
Picoquant, power before the objective 80µW) and 640 nm (LDH-D-C-640, Picoquant, 
power before the objective 80 µW) at a repetition rate of 26.66 MHz. The 
fluorescence was separated for polarization and color and detected on four avalanche-
photo-diodes (green channel AQRH-14, red channel AQR-16, Perkin Elmer). Photon 
arrival times were recorded using four single-photon-counting-modules 
(Becker&Hickl SPC-150) and data was processed using custom software written in 
MATLAB (MathWorks). Since the anisotropy of the molecules was not of 
importance for this study, photons of identical wavelength but different polarization 
were merged into one detector channel. Data were collected for 10 min and the 
collected photons were sorted into three different channels, namely donor detection 
after direct excitation (green), acceptor detection after direct excitation (red) and 
acceptor detection after donor excitation (fret). Labeled complexes diffusing through 
the focal volume of the microscope resulted in bursts of detected photons. An all 
photons burst search (APBS) was applied with the criteria of detecting at least 3 
photons within 500 µs with a total of at least 60 photons per burst (18). From the 
photon bursts, the Stoichiometry (S) and FRET Efficiency (E) were calculated 
(including the predetermined correction factor) according to: 
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Where GR are the red photons after green excitation, RR are the red photons after red 
excitation, GG are the green photons after green excitation and y is a factor correcting 
for the different efficiencies of the red and green detection channels (19). Multi-
molecular events were removed from the data as described below using TDS < 1 and 
TDSred-PIE < 0.6 for all complexes not showing molecular dynamics. Remaining 
donor-only and acceptor-only bursts were removed using a stoichiometry threshold (S 
= 0.15 – S = 0.55). 
Due to the chosen labeling positions on the nucleosome, closed nucleosomes have the 
donor and acceptor dyes positioned adjacent to each other leading to a high FRET 
state with an efficiency of ~80% while open or incomplete nucleosomes show a very 
low FRET signal. The fraction of closed nucleosomes was quantified for each salt 
concentration by analyzing how many of the detected fluorescence bursts have E > 
40% (Supplementary Figure S6A). The data was normalized to the fraction of closed 
molecules at 0 mM NaCl to allow for a comparison of the salt dependence for the 
three investigated samples (H2A, Z.2.1, Z.2.2).   
 
Removal of multi-molecular events 
Nucleosomes are prone to become instable at low concentrations as well as when 
interacting with surfaces. Thus in order to avoid artifacts the duration of the 
experiment has to be minimized. To address this difficulty relatively high nucleosome 
concentrations were used in the experiments to ensure that the occurrence of multi-
complex bursts is not negligible.  For a homogeneous population with only a single 
FRET species this is not a problem, however if several FRET states exist, multi-
molecule events of different species will alter the determined FRET values. 
Moreover, impurities such as complexes labeled with only donor or acceptor observed 
simultaneously with double-labeled complexes will also lead to changes in FRET 
efficiencies. However, as two independently diffusing complexes do not enter and 
exit the excitation volume exactly at the same time it is possible to differentiate these 
multi-molecular events from single molecule events and to exclude them from further 
analysis. Independently diffusing molecules involved in a multi-molecule event will 
yield different values for the mean-macro-time (i.e. the time where 50% of the 
respective photons have arrived) for all photons of a burst, as compared to that for the 
photons of one color. We therefore calculated the characteristic Time-Deviation-
Signal (TDS) defined as ( ) ( ) γ**)()1(*)( PTTDDPTTDDTDS frettotalfrettotalgreentotalgreentotal −+−+−−+−=  
(1) 
where Dx is the burst duration, Tx is the mean-macro-time, y is a factor correcting for 
the different efficiencies of the red and green detection channels and P is the 
proximity ratio given by the number of photons in the burst as P = GR/(GR+GG). 
 
In eq. 1 we compute the TDS of the green and red channels simultaneously and adjust 
the relative value to the percentage of photons detected. In addition, multi-molecule 
events containing low (0%) FRET and donor only complexes (which cannot be found 
using eq. 1) can also be determined using a PIE setup and defining: 
redtotalredtotalPIEred TTDDTDS −+−=− )(    (2) 
To demonstrate the capabilities of this analysis scheme a sample containing Z.2.1 
nucleosomes (TE pH 7.6, 0 mM NaCl) as well as impurities of donor only and 
acceptor only complexes was measured. In order to stress the discussed effects for 
this control experiment, the concentration of labeled complexes was increased to 
~150 pM. By using thresholds of TDS < 1 and TDSred-PIE < 0.6 in the TDS parameter 
space we are able to remove most of the observed trailing (i.e. events with high S and 
medium to low E) caused by multi-molecule events as well as photo-physics and 
receive a distribution showing populations of distinct FRET efficiencies and 
stoichiometries (Supplementary Figure S6B).  
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The histone variant macroH2A generally associates with
transcriptionally inert chromatin; however, the factors that
regulate its chromatin incorporation remain elusive. Here,
we identify the SWI/SNF helicase ATRX (a-thalassemia/
MR, X-linked) as a novel macroH2A-interacting protein.
Unlike its role in assisting H3.3 chromatin deposition,
ATRX acts as a negative regulator of macroH2A’s chromatin
association. In human erythroleukemic cells deficient for
ATRX, macroH2A accumulates at the HBA gene cluster on
the subtelomere of chromosome 16, coinciding with the loss
of a-globin expression. Collectively, our results implicate
deregulation of macroH2A’s distribution as a contributing
factor to the a-thalassemia phenotype of ATRX syndrome.
Supplemental material is available for this article.
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The replacement of canonical histones with histone
variants contributes to the dynamic nature of chromatin.
Due to amino acid differences and, in turn, unique post-
translational modifications, histone variants can alter nu-
cleosome structure, stability, and binding of effector pro-
teins. Histone variants have unique genomic localization
patterns, and thus specialized roles such as regulating gene
expression or chromosome segregation during cell division
(Banaszynski et al. 2010). Therefore, the differential geno-
mic incorporation of histone variants directly impacts
critical cellular functions.
The histone variant macroH2A (mH2A) is a vertebrate-
specific member of the H2A family and is unusual due to
the presence of a C-terminal macro domain (Pehrson and
Fried 1992). Two different genes encodemH2A1 andmH2A2
(H2AFY and H2AFY2, respectively), and two splice forms
of mH2A1 exist: mH2A1.1 and mH2A1.2 (Costanzi and
Pehrson 2001). mH2A is abundant in heterochromatin,
including senescence-associated heterochromatic foci
(SAHF) and the inactivated X chromosome (Xi) (Costanzi
and Pehrson 1998; Zhang et al. 2005). In vitro studies suggest
that the macro domain sterically hinders access of tran-
scription factors to DNA, while mH2A’s L1 loop produces
inflexible nucleosomes (Angelov et al. 2003; Chakravarthy
et al. 2005).
Our group has recently demonstrated a role for mH2A
isoforms in suppressing melanoma progression, and others
have linkedmH2A expression or its splice patterns to breast
and lung cancer (Sporn et al. 2009; Kapoor et al. 2010;
Novikov et al. 2011). However, the factors that regulate
the association of mH2Awith chromatin remain obscure.
Therefore, identifying regulators of the incorporation of
histone variants at distinct genomic loci is key to un-
derstanding how chromatin domains are established and
maintained and how these may go awry in disease.
A second group of factors contributing to chromatin
dynamics are ATP-dependent chromatin remodeling com-
plexes that rearrange or mobilize nucleosomes. Deregula-
tion of members of the SWI/SNF family is implicated in
various cancers and mental retardation (MR) syndromes,
including ATRX (a-thalassemia/MR, X-linked), (Wilson
and Roberts 2011). Mutations in ATRX, predominantly
found in the H3K9me3-binding ADD (ATRX–DNMT3–
DNMT3L) and/or helicase domains, are associated with
ATRX syndrome (Higgs et al. 2005; Iwase et al. 2011). This
syndrome is characterized by MR and a-thalassemia—a
loss of a-globin gene production (Higgs et al. 2005). How-
ever, the mechanisms by whichHBA (hemoglobin a) gene
repression occurs are unknown (Higgs et al. 2005).
In addition to its role in regulating gene expression,
ATRX acts in concert with Daxx to deposit the H3 variant
H3.3 specifically at telomeres (Drane et al. 2010; Goldberg
et al. 2010; Lewis et al. 2010), and ATRX deficiency results
in loss of telomere integrity (Goldberg et al. 2010; Wong
et al. 2010; Heaphy et al. 2011). However, it remains unclear
how loss of functional ATRX protein affects the global
chromatin landscape of ATRX patients, which may have
tissue-specific effects (Berube 2011).
Here, we sought to discover factors involved in regu-
lating mH2A’s chromatin association. By isolating mH2A
in its chromatin-free state, we identified ATRX as a novel
mH2A partner. Unlike H3.3, mH2A does not interact with
Daxx in chromatin-free extracts, suggesting that these two
variants interact with unique ATRX complexes. As such,
we observed a mutual exclusion between mH2A1.2 and
[Keywords: macroH2A; histone variant; ATRX; a-globin; chromatin
remodeling; histone chaperone]
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H3.3 in the nucleosome. We further demonstrate that
ATRX negatively regulates mH2A1 chromatin incorpora-
tion. Loss of ATRX results in increased mH2A1 levels at
telomeres, as well as at the a-globin locus in erythroleu-
kemic cells, concomitantwith reduced transcription of the
HBA genes. These data implicate dysregulation of mH2A’s
chromatin incorporation as a novel facet of the a-thalas-
semia phenotype of ATRX syndrome.
Results and Discussion
mH2A interacts with ATRX in a chromatin-free
cellular fraction
To identify factors involved in the regulation of mH2A
chromatin association, we reasoned they would associate
in the soluble nuclear and/or cytoplasmic fractions
(‘‘chromatin-free’’). Due to their different cellular localiza-
tion patterns (Fig. 1A; Costanzi and Pehrson 1998) and
differential mobility in chromatin, as assayed by fluores-
cence recovery after photobleaching (FRAP) analysis (Sup-
plemental Fig. 1), we hypothesized that mH2A and H2A
have unique regulatory factors. To this end, we employed
a large-scale biochemical strategy to purify chromatin-free
GFP-H2A or mH2A1.2-GFP, similar to that used for the
identification of the CENPA chaperone HJURP (Fig. 1B;
Foltz et al. 2009). Confirmation of immunoprecipitated
histones was performed by immunoblotting (Fig. 1C).
Following extensive washing and TCA precipitation of
the entire immunoprecipitated material, proteins were
resolved on a gradient gel, both lanes were excised (10
slices per lane), andmass spectrometry (MS) analysis on all
gel slices was performed (Fig. 1B; Supplemental Fig. 2A).
From the proteins retrieved (Supplemental Table 1), we
focused on factors that regulate chromatin association of
histones, including nuclear import factors (Supplemental
Fig. 2B). For example, kap114p mediates the nuclear import
ofH2A/H2B in Saccharomyces cerevisiae (Mosammaparast
et al. 2005), and accordingly, we identified the mammalian
homolog Importin 9 (Imp9) as an H2A import factor. We
validated Imp9 by immunoblots and independent MS
experiments where specific bands were excised (Fig. 1D;
Supplemental Fig. 2C,D). These data suggest that the
mechanism of histone import is evolutionarily conserved
and, importantly, validate our technical approach.
As we were interested in factors that directly regulate
chromatin association of mH2A1, we further focused on
histone chaperones (De Koning et al. 2007; Park and
Luger 2008). We identified peptides from NAP1, SET/
TAF-I, nucleolin (Ncl), and nucleophosmin (Npm) in our
MS analysis (Supplemental Figs. 2A, 3A). Some of these
factors, such asNcl andNpm,were present in both theGFP-
H2A and mH2A1.2-GFP immunoprecipitations, and we
reasoned they were general histone-interacting proteins.
Indeed, this is the case (Dunleavy et al. 2009; Gaume
et al. 2011), as confirmed by our immunoblots (Fig. 1D). We
further confirmed specificity of NAP1 for H2A by immu-
noblot (Fig. 1D), as reported (Park and Luger 2008). Due to
the lack of specificity for mH2A, these factors were unlikely
candidates for regulating its chromatin association.
Of the potential histone chaperones identified by MS,
the SWI/SNF chromatin remodeling protein ATRX inter-
acted uniquely with mH2A1.2 (Supplemental Fig. 3A).
Nineteen peptides spanning the entire ATRX protein were
identified (Supplemental Fig. 3B). We confirmed this in-
teraction using the immunoprecipitation protocol as per-
formed for MS analysis (Fig. 2A) and via an alternative
chromatin-free approach with similar results (Supplemen-
tal Fig. 3C;Mendez and Stillman 2000). Of note, we did not
detect H3 in the immunoprecipitation from either pro-
tocol, suggesting that the tagged histones in our extracts
were indeed chromatin-free (nonnucleosomal) and that the
mH2A–ATRX interaction is independent of H3 binding
(Fig. 2A). H2B peptides were detected via MS, suggesting
the presence of (m)H2A–H2B dimers.
We next examined the interaction between ATRX and
mH2A isoforms in chromatin-free extracts. ATRX interacts
with all mH2A isoforms (Fig. 2B), suggesting the interac-
tion occurs through the highly conserved H2A domain.
As expected, Imp9 preferentially associated with H2A, and
Parp1 uniquely interacted with mH2A1.1, as previously
described (Timinszky et al. 2009).We then performed reverse
coimmunoprecipitation (co-IP) experiments in HEK293 cells
transfected with GFP-tagged ATRX fragments (Supplemen-
tal Fig. 4). Using whole-cell extracts, we narrowed down the
region required for mH2A1 binding to amino acids 1–841
of ATRX (Fig. 2C). As positive controls, this fragment also
bound H3, while a construct spanning the middle region
of ATRX (800–1670) bound Daxx (Tang et al. 2004). We
next validated this interaction in chromatin-free immu-
noprecipitations (Fig. 2D). Interestingly, the N terminus
of ATRX contains an ADD domain, an HP1-binding
‘‘PxVxL’’ motif, an a-helical region, and an acid-rich motif
(B Xiang and H Li, unpubl.). It will be key to decipher
whether mH2A–ATRX binding is direct and, if so, which
domains mediate this interaction.
Figure 1. Identification of mH2A1.2 chromatin-free interacting
factors. (A) Fluorescence microscopy of HEK293 cells stably express-
ing GFP-H2A and mH2A1.2-GFP. Arrowhead indicates Xi. (B) Pro-
cedure used to isolate chromatin-free H2A- and mH2A1.2-interacting
factors. (C) aGFP immunoblot confirms expression and immunopre-
cipitation of histones in stable cell lines. (D) Immunoblots of Imp9,
Npm, and NAP1 association with GFP-H2A or mH2A-GFP isoforms.
Arrows on all aGFP blots indicate GFP-H2A (bottom) and mH2A-
GFP (top), and asterisks indicate degradation products.
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mH2A and H3.3 are in distinct ATRX complexes
While ATRX deposits H3.3 at telomeres via its interac-
tion with Daxx (Drane et al. 2010; Goldberg et al. 2010;
Lewis et al. 2010), we were unable to detect an interaction
between mH2A isoforms and Daxx via immunoblot (Fig.
3A), andDaxx peptideswere not detected in ourMS analysis
(Supplemental Table 1). However, Daxx indeed interacts
specifically with H3.3 in chromatin-free extracts (Fig. 3B).
These results suggest that H3.3 and mH2A are in distinct
ATRX complexes, distinguished by the presence of Daxx.
Based on the above, we hypothesized that mH2A1 and
H3.3 exist inmutually exclusive nucleosomes. To test this
directly, we immunoprecipitated mononucleosomes from
H2A- and mH2A1.2-Flag-tagged HeLa cells (Fig. 3C) and
performed MS analysis to determine their H3 variant
composition. While H2A-containing nucleosomes con-
tain >40%H3.3, those of mH2A1.2 contain;4% (Fig. 3D).
This suggests that distinct factors or complexes regulate
chromatin association of mH2A1 andH3.3, and we hypoth-
esized that while ATRX–Daxx deposits H3.3 into chroma-
tin, ATRX inhibits mH2A chromatin incorporation.
Loss of ATRX results in altered levels of mH2A1
in chromatin
To test this hypothesis, we probed the effects of ATRX
depletion on mH2A chromatin association. We engi-
neered HEK293 cells to stably express shRNAs targeting
ATRX or luciferase (control). We selected two shRNA
lines that induced significant knockdown (sh90 and sh92)
(Fig. 4A; Supplemental Fig. 5A) for further experiments
and ensured that mH2A levels were unaffected (Fig. 4A).
This knockdown may mimic ATRX syndrome, as pa-
tients with ATRX mutations have reduced protein levels
or decreased enzymatic activity of the helicase domain
(Berube 2011; Mitson et al. 2011).
We next inquired whether loss of ATRX altered mH2A
chromatin association. Loss of ATRX resulted in a global
increase of mH2A1 in chromatin, while total cellular
levels remained constant (Fig. 4B), implicating ATRX as
a negative regulator of mH2A’s chromatin incorporation.
Quantitative MS (qMS) analysis on histones extracted
from chromatin (Plazas-Mayorca et al. 2009) of shluc and
sh92 HEK293 cells revealed that loss of ATRX results in
;30% more mH2A1 in chromatin (Fig. 4C; Supplemental
Fig. 6). To examine the dynamics of mH2A1.2-GFP in the
absence of ATRX in vivo, we performed FRAP using stable
shRNA lines generated in HeLa1.2.11 cells (Supplemental
Fig. 5B,C). FRAP studies revealed a decrease in fluores-
cence recovery of mH2A1.2 in sh92 cells, suggesting a
more stable association of mH2A1.2 with chromatin
upon loss of ATRX (Fig. 4D).
ATRX regulates mH2A1 incorporation at telomeres
and the a-globin cluster
As mH2A1 chromatin association increased in ATRX-
depleted cells, we inquired which genomic regions are
enriched in mH2A1. Because ATRX localizes to telomeres
(Goldberg et al. 2010; Wong et al. 2010), we hypothesized
that global increase of mH2A1might, in part, be a result of
telomeric accumulation. Chromatin immunoprecipita-
tion (ChIP) followed by Southern blot demonstrated in-
creased association of mH2A1 with telomeres in ATRX
knockdown lines of HEK293 and erythroleukemic K562
cells, which express a-globin (Fig 5B; Supplemental Fig. 7;
see below). The weaker of the two ATRX knockdowns
Figure 2. ATRX interacts with mH2A isoforms in chromatin-free extracts. (A,B) Immunoblots of GFP and ATRX from chromatin-free extracts.
The absence of H3 in immunoprecipitations confirms chromatin-free interactions; see the long exposure. (B) Co-IP of GFP-H2A and all mH2A
isoforms in chromatin-free extracts for ATRX. Immunoblots for Imp9 and Parp1 demonstrate chromatin-free interactions. (C) Whole-cell
immunoprecipitations of GFP-tagged ATRX constructs (full-length, N-terminal [1–841], middle region [800–1670], and C-terminal [1670–2492]),
followed by mH2A1, H3, and Daxx immunoblots. (D) Chromatin-free co-IP of N-ATRX-GFP with mH2A1.
Figure 3. mH2A and H3.3 are in distinct ATRX complexes. Co-IPs
of chromatin-free association of H2A and mH2A isoforms (A) or H3
variants (B) with Daxx. Immunoblots detected the presence of Daxx
specifically with H3.3. (C) Ethidium bromide-stained (left) and
Coomassie-stained (right) mononucleosomes from H2A-Flag and
mH2A1.2-Flag immunoprecipitations. (D) H3 composition of H2A-
Flag and mH2A1.2-Flag mononucleosomes as analyzed by MS. The
pie chart depicts the abundance of H3.1/H3.2 (gray) and H3.3 (black)
in immunoprecipitated nucleosomes.
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(sh92) revealed >10-fold mH2A1 enrichment in K562 cells
(Fig. 5B), suggesting partial loss of function may have
significant consequences, possibly akin to the syndrome
(Berube 2011; Mitson et al. 2011). While currently unclear,
ATRX-mediated regulation of mH2A levels at telomeres
may help to ensure telomeric integrity.
Next, we queried whether loss of ATRX affects expres-
sion of the subtelomeric a-globin gene cluster on human
chromosome 16 in erythroid cells. Upon ATRX knock-
down in K562 cells (Fig. 5A; Supplemental Fig. 8A), HBA
mRNA and protein levels were dramatically reduced (Fig.
5C). Other genes in this region, including the ATRX
targetNME4 (Law et al. 2010), were also transcriptionally
decreased, while CDK8 on chromosome 13 was unaf-
fected (Supplemental Fig. 8B; Kapoor et al. 2010).
As mH2A is generally transcriptionally repressive, we
hypothesized that deregulation of mH2A nucleosome oc-
cupancy represses the HBA genes, which are silenced in
ATRXpatients by undefinedmechanisms (Higgs et al. 2005;
Berube 2011). To examine mH2A1 distribution across the
a-globin cluster, we performed native ChIP-seq in shluc
and sh92 K562 cells (Supplemental Fig. 9A). We obtained
56,540,184 reads for shluc, 67,219,237 for sh92, and
148,165,330 for input DNA using Illumina Hi-Seq (Sup-
plemental Fig. 9B). Analyses were performed on normal-
ized alignments (to the total number of alignments) to
account for the different number of reads between
samples. We found mH2A1 to be generally (1)
excluded from transcriptional start sites (TSSs)
and (2) in broad domains both upstream of and
downstream from the TSS, particularly at genes
transcribed at low levels. This supports its role as
a repressive variant and is consistent with ChIP–
chip studies (Supplemental Fig. 10A; Buschbeck
et al. 2009; Gamble et al. 2010).
While K562 cells express a-globin, levels are
lower than primary erythroblasts (D Higgs, pers.
comm.). In accordance, we observed a distinct
mH2A1 domain at the a-globin cluster in K562
cells, however, with more significant peaks of
enrichment in sh92 cells (Fig. 5D; Supplemental
Fig. 11A). These data strongly suggest that mH2A1
is enriched at this gene cluster in the absence of
ATRX. Globally, the total number of base pairs
covered bymH2A1 significant peaks is 20%higher
in sh92 cells than shluc cells. This is likely due to
mH2A1 redistribution, as only ;45% of the peaks
are shared between shluc and sh92 (Supplemental
Fig. 9B,C). Interestingly, we observed a global anti-
correlation of mH2A1 domains and ATRX peaks,
which are generally concentrated around TSSs
(Fig. 5D; Supplemental Fig 10B,C; Law et al. 2010),
suggesting that ATRX prevents mH2A1 chroma-
tin incorporation. Finally, by quantitative PCR
(qPCR) analysis of native ChIP DNA and cross-
linked ChIP DNA, we observedmarked increase at
regions in the a-globin cluster previously reported
to be mH2A1-enriched (Supplemental Fig. 11B,C;
Gamble et al. 2010). Taken together, these data
suggest that mH2A1 is specifically deposited at
the a-globin gene cluster in an ATRX-mediated
fashion.
Here, we took an unbiased approach to identify
factors that specifically associate with mH2A in
its chromatin-free state. We identify ATRX as
a negative regulator of mH2A1 chromatin incor-
poration, particularly at telomeres and the a-globin locus.
Such regulation of histone incorporation via inhibitory
factors remains relatively unexplored. A recent study
identified INO80, also an ATP-dependent chromatin re-
modeling enzyme, as a negative regulator of H2A.Z nucle-
osomal incorporation (Papamichos-Chronakis et al. 2011).
In the absence of INO80, genomic distribution of H2A.Z
is perturbed, resulting in a reduced response to tran-
scriptional changes. Whether ATRX directly interacts
with mH2A to evict this histone variant from chromatin
or inhibit its deposition remains unclear. If the interac-
tion is direct, dissecting the surfaces that mediate
binding will be important. In addition, it remains for-
mally possible that alternatively spliced or modified
forms of ATRX differentially interact with mH2A and
H3.3 (Berube et al. 2000; Garrick et al. 2004). We look
forward to future studies addressing the positive and
negative regulation of histone variants within the chro-
matin template, the factors involved, and the underlying
mechanisms.
Finally, our data point toward a novel mechanism by
which the histone variant mH2A1 is involved in the
a-thalassemia phenotype of ATRX patients. While the
ATRX–Daxx complex has been shown to deposit H3.3,
the genomic localization and function of H3.3 have yet to
be explored in the context of ATRX syndrome. Here, we
Figure 4. ATRX knockdown results in increased levels and stability of mH2A1
in chromatin. (A) shRNA-mediated knockdown of ATRX (sh90 and sh92) in
HEK293 cells results in the loss of ATRX protein and mRNA, compared with
shluc, without affecting mH2A1 mRNA. b-Actin was used for loading. (B) Loss of
ATRX results in accumulation of mH2A1 in chromatin (top panel), and the
whole-cell content remains unaffected (bottom panel). H2B was used for loading.
(C) mH2A1 immunoblot of chromatin-extracted histones analyzed by qMS. (D,
left) Quantitation of FRAP experiments indicates slower recovery of mH2A1.2-
GFP in HeLa1.2.11 cells depleted of ATRX (sh92; green line) compared with
control (shluc; blue line). (Right) Representative images of FRAP time series pre-
and post-bleach are shown.
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implicate ATRX in nucleosomal association of mH2A1,
which may be important for establishing and/or main-
taining chromatin states.
Materials and methods
Cell culture, plasmids, and shRNA
HEK293 and HeLa cells were grown in DMEM, and K562 cells were
suspension-cultured in RPMI (10% FBS, 1% penicillin/streptomycin). GFP-
tagged H2A or mH2A isoforms were expressed in HEK293 cells (pEGFP-C1
orN1, respectively), HA-tagged H3.1 andH3.3were expressed inHeLa cells
(Wiedemann et al. 2010), and Flag-tagged H2A or mH2A1.2 were infected
into HeLa cells (pQXCIP). Selection was carried out in either 800 mg/mL
neomycin or 1 mg/mL puromycin. For shRNA studies, HEK293, HeLa1.2.11,
and K562 cells were infected with lentiviral plasmids encoding ATRX
shRNAs (Open Biosystems, RHS4533-NM_000489) or luciferase shRNA
by standard procedures and grown in 1 mg/mL puromycin. GFP-tagged
plasmids of ATRX (N, mid, C, and full-length; gift of D. Picketts) were
transiently transfected into HEK293 cells.
Chromatin-free immunoprecipitation
Chromatin-free fractions were isolated essentially as described (Foltz et al.
2009). Material from large-scale chromatin-free immunoprecipitations was
glycine-eluted, TCA-precipitated, and resolved by 4%–12% gel (NuPAGE,
Invitrogen). Immunoprecipitationswere carried out with aGFP beads (Vector
Laboratories or Chromotek) for 3 h (at 250–375 mM salt). For immunoblots,
beads were washed and boiled in Laemmli loading buffer, and
proteins were resolved by PAGE.
Chromatin fractionation, histone acid extraction,
and immunoblots
Chromatin fractionation was performed as described (Mendez
and Stillman 2000). Histone acid extraction was performed as
described (Kapoor et al. 2010), with the exception that isolated
chromatin was treated with H2SO4. Immunoblots were per-
formed with the following antibodies: aGFP (Roche, 11 814
460 001), aATRX (Santa Cruz Biotechnology, sc15408), aIMP9
(Abcam, ab52605), aNap1L1 (Abcam, ab33076), aNpm (Chem-
icon, MAB4500), aH3 (Millipore, 05-928), aDaxx (Cell Signaling,
25C12), aParp1 (Active Motif, 39561), abActin (Sigma, A5316),
aH2B (Millipore, 07-371), aHemoglobin a (Santa Cruz Biotech-
nology, sc-21005), and amH2A1 (Abcam, ab37264).
LC-MS/MS and qMS
Protein identification via LC-MS/MS was carried out essentially
as described (Kaneko et al. 2010). qMS of mH2A1 was performed
as described (Kapoor et al. 2010).
Mononucleosome immunoprecipitation and MS
quantification of H3 variants
Mononucleosome immunoprecipitation and qMS of the histone
peptides were carried out essentially as described (Viens et al.
2006; Kapoor et al. 2010). In order to quantify the ratio of H3.3 to
H3.1 and H3.2, residue 31 was used (serine in place of an alanine,
respectively). All methylated and acetylated forms of the pep-
tides were considered.
cDNA isolation and qPCR
qPCR and mRNA analysis were carried out as described (Kapoor
et al. 2010). cDNA expression was normalized to GAPDH levels.
Primer sequences are provided in the Supplemental Material.
FRAP
Live-cell imaging and long-term FRAP experiments were carried out
essentially as reported (Wiedemann et al. 2010). For visualization of the
results, single-cell measurements were averaged and plotted together with
the respective standard error for every time point.
Native ChIP-seq
Native mH2A1 ChIP (Abcam, ab37264) and Input DNA were prepared
from K562 cells, and subsequent sequencing was performed using Illu-
mina Hi-Seq. See the Supplemental Material for full details.
Telomere Southern blot
DNA was isolated following mH2A1 ChIP, and telomere Southern blot
was carried out as described (Goldberg et al. 2010), with the exception that
the probe used was T2AG3 from pSty-11.
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Supplemental Figure 1 
Supplemental Figure 1. FRAP analysis of canonical H2A and mH2A isoforms. (A) Representative 
images from long-term FRAP time series of HeLa cells transiently transfected with GFP-H2A or 
mH2A-GFP isoforms. Squares of 5 µm x 5 µm within the nucleus were photobleached and 
fluorescence recovery followed for at least 5 hours. Prebleach, postbleach, and 2min, 60min, 300min 
postbleach are shown. (B) Quantitative FRAP evaluation. mH2A1 isoforms (orange and yellow) 
display a decreased recovery compared to canonical H2A (blue). mH2A2 (red) displays decreased 
recovery compared with canonical H2A and mH2A1 isoforms. In contrast, GFP alone shows full 
recovery within less than a minute (green). 
Protein H2A  
peptide 
count 
macroH2A 
peptide 
count 
Importin 4 4 19 
Importin 7 25 50 
Importin 8 3 14 
Importin 9 120 42 
KapA1 48 141 
KapA2 66 140 
KapA3 33 62 
KapA4 20 54 
KapA5 44 133 
KapA6 45 127 
KapB1 141 104 
Exportin 1 62 97 
Exportin 5 3 11 
Exportin 7 0 6 
Transportin 4 0 
Nuclear Import and Export Factors 
C 
B               
130 
95 
72 
56 
36 
28 
17 
Imp9 
ATRX 
Ncln 
 m1.2-GFP 
Npm 
  H2A-GFP 
Imp9 
NAP1 
  SET 
A 
D 
Supplemental Figure 2 
Supplemental Figure 2. H2A and mH2A1.2 associate with nuclear-cytoplasmic shuttling factors 
and chromatin-associated factors in chromatin-free extracts. (A) Proteins interacting with either 
GFP-H2A or mH2A1.2-GFP in chromatin-free extracts were resolved on 4-12% NuPAGE and silver 
stained. Each lane was cut into ten slices and MS analyzed. Chromatin-associated factors identified 
by MS are presented alongside the gel (see Fig. 1D for peptide counts). Blue characters = H2A or 
mH2A1.2-specific factors; black characters = chromatin-associated factors which interact with both 
H2A and mH2A1.2; green = GFP histones. (B) Table of nuclear-cytoplasmic shuttling factors that 
interact with H2A or mH2A1.2 in chromatin free extracts. These data were collected from MS analysis 
of the gel presented in (A) and Supplemental Table 1. (C) Chromatin-free IP and silver staining of 
proteins interacting with GFP-H2A or mH2A1.2-GFP resolved on 4-12% NuPAGE. Unique bands were 
excised and MS analyzed. Arrow indicates Imp9; molecular weight marker shown on right. (D) GFP, 
GFP-H2A or mH2A1.2-GFP IPs were resolved on 12% PAGE and IB’d for Imp9 (upper panel) or GFP 
(lower panel).  
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Supplemental Figure 3. ATRX interacts with mH2A in chromatin-free extracts. (A) Peptide counts 
of chaperones identified by MS for H2A and mH2A1.2 (See corresponding gel in Supplemental Fig. 
2A). (B) ATRX peptides identified by MS analysis in mH2A1.2 IPs from chromatin-free extracts. 
Peptides presented next to a schematic of ATRX protein with its various domains shown. Nineteen 
peptides in total were identified (15 are presented here as 4 peptides were overlapping). (C) IBs of 
GFP and ATRX from chromatin-free extracts by independent chromatin fractionation method (Mendez 
and Stillman 2000).  
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Supplemental Figure 4. Expression of ATRX deletion constructs. Fluorescent images of GFP-
tagged ATRX constructs transiently expressed in HEK293 cells. While the N-terminal construct 
expressed strongly, enrichment of mH2A1 signal observed in the N-terminal IP (Fig. 2C, D) suggests 
that this region is sufficient for binding to mH2A1.  
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Supplemental Figure 5. shRNA-mediated depletion of ATRX in 293 and HeLa1.2.11 cells. (A) 
αATRX IB of HEK 293 cells expressing five lentivirally introduced ATRX shRNAs, and control shluc. 
sh90 and sh92, used for subsequent studies, are highlighted in red; Amido black of histones shown for 
loading. (B, C) ATRX depletion in HeLa1.2.11 cells shown by IB (B) and immunofluorescence (C). 
Note presence of ATRX at telomeres. 
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Supplemental Figure 6. ATRX knockdown results in mH2A1 accumulation in chromatin. 
Comparison of an averaged full mass spectrum for the +2 charged mH2A1 peptide 
(SAKAGVIFPVGR) from sh92 ATRX knockdown (d0-labeled) and shluc control (d5-labeled) histones 
extracted from chromatin. 
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Supplemental Figure 7. Loss of ATRX results in telomeric accumulation of mH2A1. (A) One of 
two representative ChIP-telomere Southern blots for HEK293 cells shows the increased association of 
mH2A1 with telomeric chromatin in the absence of ATRX. Only sh90 was used as it induced the most 
efficient knockdown in this cell line (see Supplemental Fig. 4). (B) Biological replicate of telomere 
Southern blot in K562 cell line. mH2A1’s presence at telomeres of K562 cells is increased in the 
absence of ATRX in both sh90 and sh92 lines. Densitometry quantitation presented below each graph. 
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Supplemental Figure 8. ATRX knockdown results in reduced RNA levels of sub-telomeric 
chromosome 16 genes. (A) shRNA-mediated knockdown of ATRX (sh90 and sh92) in K562 cells 
results in the loss of ATRX mRNA, compared to shluc, without affecting mH2A1 mRNA. (B) Knock 
down of ATRX results in decreased mRNA levels of genes found in the α globin cluster of sub-
telomeric chromosome 16. Starting with the most telomere proximal, genes assayed include POLR3K, 
MPG, C16orf35, ITFG3, TMEM8A, NME4 and DECR2. Genes assayed are circled in blue in the 
UCSC browser above. CDK8 transcription (chromosome 13) is unaffected by ATRX knockdown, 
similar to mH2A1 (chromosome 5) in (A). Expression was measured relative to GAPDH and to the 
control shluc, whose expression values were arbitrarily set as 1. 
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Supplemental Figure 9. ChIP-sequencing of mH2A in shluc and sh92 K562 cells. (A) Bioanalyzer traces of 
ChIP (mH2A1) and Input DNA from MNase digested chromatin (High sensitivity DNA chip; Agilent Technologies). 
Isolated mononucleosomal DNA (arrow) was size selected for ChIP-Seq library preparation. Input (red), sh92 
(blue) and shluc (green). Peaks at 35bp and 10380bp are internal size markers. (B) Raw number of reads 
obtained by Illumina Hi-Seq, total number of alignments (Bowtie:  -m 20 -k 20 -n 2 -l 50), and alignments used for 
peak calling (MACS) for sh92, shluc and Input shown. Raw reads for the ATRX ChIP-Seq were downloaded from 
GEO (GSE22162). Also shown are the total number of peaks for sh92 and shluc (p value cutoff = 1.00e-4) and 
total number of base pairs covered by significant peaks (MACS). (C) Overlap of significant mH2A1 peaks (MACS) 
from shluc and sh92 ChIP-seq data sets (HOMER software, Heinz et al. 2010). 
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TSS/TES analysis and peak 
overlap of mH2A1 and 
ATRX. (A) Read counts 
(200bp window) normalized to 
total number of reads (counts 
per million reads), plotted 
against the distance (-5Kb, 
+5Kb), from the nearest 
annotated Transcription Start 
Site (TSS, left), and 
Transcription End Site (TES, 
right). Genes were grouped by 
expression levels to Full (all 
annotated genes), High and 
Low categories based on 
K562 RNA-Seq data from the 
ENCODE project. sh92 
(black), shluc (red), and Input 
(green). (B) Same TSS 
analysis as in (A) also 
containing ATRX (blue). Scale 
is different than in (A). (C) 
Overlap of significant mH2A1 
and ATRX peaks (MACS) in 
shluc and sh92 samples (Law 
et al. 20120; Heinz et al. 
2010). 
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Supplemental Figure 11. mH2A1 is enriched at the α globin cluster. (A) Capture of UCSC genome browser showing ~50kb 
region around α globin locus. ChIP –seq analysis of mH2A1 in K562 cells. Loss of ATRX (sh92) results in redistribution of mH2A1 
compared to control cells (shluc) as shown in Fig. 5D (shown on the X-axis genomic position in Kb; Y-axis alignment counts in 
500bp window sliding 250bp. Window counts are normalized to total number of alignments and scaled by 10^7 for mH2A1 and 
10^6 for ATRX). ChIP-seq data for mH2A1 was compared to published ATRX ChIP-seq data (Law et al. 2010). Shluc Input 
enrichment is shown for reference. Threshold line set at 35 to facilitate visualization. Regions of significant enrichment are 
indicated by black bars below the respective enrichment plots. UCSC custom tracks are shown, RefSeq gene annotation, K562 
Chromatin State Segmentation by HMM from ENCODE/Broad, Repeat elements by RepeatMasker, and Duplications of >1000 
Bases of Non-RepeatMasked Sequence are shown, respectively. Primer pairs used in B (native ChIP) and C (fixed ChIP) shown 
on top. As the HBA genes are duplicated, primer pair 6 at the TSS is presented twice. (B) Validation by qPCR of the ChIP-
sequencing library indicates enrichment of mH2A1 at regions upstream of the HBA1/2 genes. (C) ChIP via standard formaldehyde 
cross-linking and sonication demonstrates increased mH2A1 levels 1kb upstream and at TSS of the HBA1/2 genes when ATRX is 
depleted. Mock = no antibody. One of three replicates (two biological and one technical) shown. The stronger enrichment of 
mH2A1 signal in native ChIP (B) compared with formaldehyde-fixed ChIP (C) is likely due to greater antibody affinity for mH2A1 in 
the native ChIP protocol. 
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Supplemental Materials and Methods 
 
Immunofluorescence. Cells were fixed with 2% formaldehyde/PBS (Sigma Aldrich) for 10 min at room 
temperature (RT) and subsequently permeabilized with 0.5% Triton X-100/PBS for 10 min. After 
incubation in 2% BSA/PBST blocking solution (bovine serum albumin in PBS with 0.02% Tween-20) for 
1 h at RT, cells were incubated with rabbit αATRX antibody (Santa Cruz, sc15408) for 1 h at RT, and 
after washing, with goat αrabbit Alexa-488 (Invitrogen) for 30 min. Cells were post-fixed with 4% 
formaldehyde/PBST for 10 min. Counterstaining of DNA was performed with 4’,6-diamidino-2-
phenylindole (DAPI, 2.5 µg/ml; Sigma-Aldrich) and samples were mounted in Vectashield Anti-fade 
Mounting Medium (Vector Laboratories). Images were taken using a pDV wide-field epifluorescence 
microscope (Applied Precision Imaging, Inc.) equipped with a 60x/1.42 NA Plan-Apochromat oil 
objective lens (Olympus) and a CoolSnap HQ2 CCD camera (Photometrics).  
 
ChIP-qPCR and ChIP-Southern blot. ChIP in K562 cells was performed using the Magna ChIP Kit 
(Millipore) with modifications (described by the Myers Lab online protocol at Stanford University). 
Briefly, 2 x 10^7 cells were lysed (Magna ChIP Cell Lysis Buffer) and nuclei sonicated in 1ml RIPA 
buffer (1XPBS/1% NP-40/0.5% sodium deoxycholate/0.1% SDS), 4 minutes (30sec on, 30 sec off - 
Diagenode Bioruptor) to yield 500-800bp DNA fragments. Sonicated chromatin from 2x10^6 cells was 
immunoprecipitated overnight in Magna ChIP Kit Dilution Buffer at 4C with 5ug of αmH2A1 (Abcam, 
ab37264 or Millipore, 07-219), αIgG (Millipore 12-370), or no antibody control. Capture was performed 
with Millipore Magna ChIP Protein A beads for two hours at 4C. Beads were washed and reverse 
cross-linked as described by Magna ChIP Kit protocol. DNA was isolated using QiaQUICK PCR 
Purification kit. 
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ChIP-sequencing and peak calling. Chromatin from K562 cells was digested with MNase and used 
for ChIP with αmH2A1, essentially as described (Alonso et al. 2003; Hori et al. 2008). 
Mononucleosomal DNA from Input and ChIP samples were processed following Illumina standard 
library protocol with modifications to allow multiplexing. High throughput sequencing was performed 
using Illumina Hi-Seq obtaining a total of 67,219,237 reads for sh92, 56,540,184 for shluc and 
148,165,330 for Input. 100bp reads were aligned to the hg19 genome assembly (NCBI build 37) using 
Bowtie short read aligner (v 0.12.7) (Langmead et al. 2009), with the following parameters: seed of 
50bp, maximum 2 mismatches, suppression (m) = 20, and reported alignments (k) = 20. Wiggle files 
(HAFEZ, unpublished pipeline D.H.), were generated using a 500bp window sliding 250bp, counting the 
number of aligned reads (5' end of each aligned read), for both ChIP and Input samples. The number of 
alignments from each window was normalized to the total number of alignments and scaled by factor of 
10^7, to allow comparison between different samples. The MACS software (v 1.4.1) (4) was used to 
identify peaks (pvalue cutoff = 1.00e-4, shiftsize = 75) (Zhang et al. 2008). For the ATRX (Law et al. 
2010) analysis, raw reads were downloaded from GEO (GSE22162) and analyzed as described above 
(pvalue cutoff = 1.00e-5). The University of California at Santa Cruz (UCSC) genome browser was 
used to examine the distribution of sequenced tags (wiggle), on specific genomic regions. 
 
TSS/TES analysis. The relative positions of the aligned reads to the TSS/TES were generated using 
RefSeq gene annotations downloaded from the UCSC genome browser. Analysis of reads distribution 
performed with a sliding window (200bp). Reads were normalized to total number of alignments and 
presented per 10^6 reads. Gene expression classification was done based on the K562 RNA-Seq 
(RPKM) from ENCODE annotations 
(http://h.gdownload.cse.ucsc.edu/goldenPath/hg18/encodeDCC/wgEncodeCaltechRnaSeq/wgEncodeC
altechRnaSeqRawData5Rep2K562CellLongpolyaErng32x75.rpkm.gz). Gene clusters show all genes 
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(full), top and bottom 20% of genes (high and low clusters respectively). For the ATRX (Law et al. 2010) 
analysis, raw reads were downloaded from GEO (GSE22162). 
 
Analysis of overlapping regions. Significant peaks from sh92, shluc and ATRX samples generated 
using MACS were compared to find overlapping and differentially bounds peaks using Homer (v3.8.2, 
1-06-2012, Heinz et al. 2010), with mergePeaks (-d given, -venn). Venn diagrams were generated 
based on this analysis.  
 
Data deposition.  All ChIP-Seq data sets deposited to NCBI’s Gene Expression Omnibus with the 
deposition number GSE35339. 
 
ChIP and RT-PCR Primers. 
Native ChIP Primers 
-27kb Fwd : TCGTAGCCTGGGTCAGAACT, Rev : ACCCAAATGTCCATCACTGG 
-5kb Fwd : CCCTTTTTGCAGAGAGATGC, Rev : GAAGGGGAAAGGAACAGGTC 
-4kb Fwd : AGAAATAAGCTGCCGTGGTG, Rev : CATAGCCAGCAGTGTGGTTG 
-1kb Fwd : CTGGCCAAACCATCACTTTT, Rev : AGGAAGGAAGGGGTGGACT 
Fixed ChIP Primers: 
HBA1 
-1kb Fwd : TCCCCTCACCTACATTCTGC, Rev : GCCTAGAGGTCGTGGTTCAC 
Ratnakumar 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al.  
TSS : HBA1/2 primers (Law et al. 2010) 
 
RT-PCR primers: 
ATRX: Fwd: GCAACCTTGGTCGAAAGGAGT; Rev : GGCTCTGGGTGACAAATGTAG (Primer Bank)  
mH2A1: Previously described (Kapoor et al. 2010) 
HBA1: Previously described (Privitera et al. 1995) 
POLR3K, MPG, C16orf35, ITFG3, TMEM8A, NME4, DECR2: Previously described (Law et al. 2010)
Ratnakumar et al. 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Introduction
Chromatin, the storage and regulatory form of genetic informa-
tion in eukaryotes, consists of nucleosomes that are composed 
of DNA and octamers of the core histones H2A, H2B, H3, and 
H4 (van Holde, 1988). To allow changes in chromatin structure, 
which are necessary to promote different biological functions, 
several interconnected mechanisms have evolved (for review 
see Bönisch et al., 2008). Among others, these include the slid-
ing or eviction of nucleosomes by ATP-dependent chromatin 
remodeling machines (for review see Clapier and Cairns, 2009), 
posttranslational modifications (PTMs) of histone proteins 
(Strahl and Allis, 2000), and the exchange of canonical histones 
with specialized histone variants (for reviews see Pusarla and 
Bhargava, 2005; Bernstein and Hake, 2006). Histone variants 
differ in sequence and expression timing from their canonical 
counterparts and are enriched in chromatin of specific func-
tional states, ranging from DNA repair and centromere determi-
nation to the regulation of gene expression. In mammals, variants 
of the H3, H2A, and H2B families of histones have been identi-
fied whose incorporation results in nucleosomes with novel 
functional and structural properties (Suto et al., 2000; Abbott 
et al., 2001; Angelov et al., 2003; Bao et al., 2004; Gautier 
et al., 2004).
To date, five different H3 variants have been found in 
mammals: H3.1, H3.2, H3.3, H3.1t (tH3), and CENP-A. The 
centromeric H3 variant CENP-A causes changes to the nucleo-
somal structure (Black et al., 2004) and is crucial for proper 
chromosome segregation (for review see Allshire and Karpen, 
2008). tH3 is a testis-specific histone variant with a putative 
Nucleosomal incorporation of specialized histone variants is an important mechanism to gener-ate different functional chromatin states. Here, 
we describe the identification and characterization of 
two novel primate-specific histone H3 variants, H3.X and 
H3.Y. Their messenger RNAs are found in certain human 
cell lines, in addition to several normal and malignant 
human tissues. In keeping with their primate specificity, 
H3.X and H3.Y are detected in different brain regions. 
Transgenic H3.X and H3.Y proteins are stably incorporated 
into chromatin in a similar fashion to the known H3 vari-
ants. Importantly, we demonstrate biochemically and by 
mass spectrometry that endogenous H3.Y protein exists 
in vivo, and that stress stimuli, such as starvation and cellular 
density, increase the abundance of H3.Y-expressing cells. 
Global transcriptome analysis revealed that knockdown 
of H3.Y affects cell growth and leads to changes in the 
expression of many genes involved in cell cycle control. 
Thus, H3.Y is a novel histone variant involved in the regu-
lation of cellular responses to outside stimuli.
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depending on the search program used (“polyadq” or PolyA_SVM 
program), H3.X and H3.Y 3 genomic sequences of human and 
primate origins were predicted to include a conserved poly-A 
site (Tabaska and Zhang, 1999; Cheng et al., 2006). Alignment 
of human and primate H3.X and H3.Y coding sequences with 
respective human H3 variant sequences revealed a higher simi-
larity to H3.3 than to H3.2 and H3.1 (Fig. S1 C).
H3.X and H3.Y genes are predicted to encode proteins of 
146 and 135 amino acids, respectively (Fig. 1 A). Both putative 
variant proteins are highly similar to each other, with differences 
of only four amino acids in their overlapping region (89.7% iden-
tity). H3.X has an unusual long C-terminal tail with no sequence 
homology to other proteins (Fig. 1 A). H3.X and H3.Y display 
interesting changes in amino acids that are known to be posttrans-
lationally modified in H3.1, H3.2, and H3.3: serine 10 and 28, 
which are phosphorylated during mitosis (Hendzel et al., 1997) 
and immediate early gene induction (Clayton and Mahadevan, 
2003), are altered to alanine and arginine, respectively. Regions 
surrounding lysine 14, usually acetylated and found in actively 
transcribed genes (Yan and Boyd, 2006), and lysine 79, methylated 
in transcriptionally active regions (Im et al., 2003) and upon DNA 
damage (Huyen et al., 2004), are completely altered (Fig. 1 A). 
In several instances, single amino acid changes between novel 
and known H3 variants have occurred, thereby generating or 
eliminating potential PTM sites. The region surrounding aa 87–90 
is important for the chaperone-dependent chromatin incorpora-
tion of histone variants (Ahmad and Henikoff, 2002b). CAF-1 
deposits H3.1, whereas HIRA catalyzes the incorporation of H3.3 
(Tagami et al., 2004). The residues of H3.X and H3.Y in this 
region are identical to H3.3 (Fig. 1 A), leading to the hypothesis 
that these putative novel variants might be incorporated by HIRA 
in a replication-independent manner.
To assess whether both genes are expressed in human 
cells, we analyzed their RNA expression levels in a variety of 
cell lines by quantitative PCR (qPCR; Fig. 1 B). Because the 
nucleotide sequences of H3.X and H3.Y are almost identical 
(Fig. S1 A), we generated one primer set detecting both H3.X 
and H3.Y mRNAs and one additional primer set that hybridizes 
with H3.X-specific 3 sequences. We demonstrate that both H3.X  
and H3.Y genes are transcribed at low levels in the human osteo-
sarcoma cell line U2OS, with H3.Y in higher amounts than 
H3.X, but 16-fold lower than the histone variant CENP-A 
(Fig. S1 D). Minimal expression of H3.Y was detected in human 
HEK293 cells, whereas no expression was seen in HeLa as well 
as in mouse cells (negative control; Fig. 1 B). These data suggest 
that H3.X and H3.Y genes are transcribed in some human cell 
lines, albeit at low total levels.
Our observation that H3.X and H3.Y mRNAs are ex-
pressed in U2OS cells inspired us to examine RNAs from differ-
ent human tissues by qPCR. Of particular interest were human 
malignant tissues, as U2OS cells are derived from a moderately 
differentiated sarcoma of the tibia. We also chose to investigate 
several regions of the human brain and testis due to the primate-
specific appearance of H3.X and H3.Y. Interestingly, we found 
that some bone, breast, lung, and ovary tumors express low but 
significant levels of H3.X/Y mRNA (Fig. 1 C). Analyzing RNA 
from human brain areas and testis, H3.X/Y expression was 
function in chromatin reorganization during spermatogenesis 
(Witt et al., 1996). H3.1 and H3.2 sequences are distinguishable 
by just one amino acid. Although expression of both is replica-
tion dependent (Ahmad and Henikoff, 2002a), they differ in 
their cell type expression levels as well as their enrichment of 
PTMs (Hake et al., 2006). Furthermore, H3.1 has been impli-
cated in DNA damage response pathways (Polo et al., 2006) 
and is deposited into chromatin by the chaperone complex 
CAF-1 (Tagami et al., 2004), whereas H3.3 is expressed and in-
corporated into chromatin in a replication-independent manner 
by HIRA (Tagami et al., 2004). The latter variant is highly deco-
rated with modifications associated with gene transcription 
(McKittrick et al., 2004; Hake et al., 2006) and is thought to be 
involved in activating gene expression (Ahmad and Henikoff, 
2002a) and epigenetic reprogramming (for review see Santenard 
and Torres-Padilla, 2009).
Here, we describe the identification of two novel primate-
specific histone H3 variants (H3.X and H3.Y) that are transcribed 
at low levels in some human cell lines and in normal and ma-
lignant tissues. Their amino acid sequences are highly simi-
lar to each other, but differ in several functionally important 
residues from other H3 variants, e.g., S10 and S28. Transgenic 
H3.X and H3.Y proteins localize to the nucleus and are sta-
bly incorporated into chromatin. We demonstrate that endog-
enous H3.Y protein is highly expressed in some osteosarcoma 
cells. Interestingly, the number of cells expressing H3.Y is in-
creased by particular stress stimuli. Knockdown of H3.Y leads to 
diminished growth and changes in the expression of many genes 
controlling cell cycle progression. The observed presence of 
primate-specific histone H3 variants in specific human brain 
areas opens up fascinating questions about their roles in human 
cell determination and differentiation.
Results
Identification of novel H3 variant genes
Using the nucleotide sequence of human histone H3.1f  
(HIST1H3I; available from GenBank/EMBL/DDBJ under 
accession no. NM_003533), we searched the public database 
(National Center for Biotechnology Information) and identi-
fied two highly similar genes initially annotated as pseudogenes 
(Fig. S1 A). These two intron-free genes, which we named 
H3.X (GenBank/EMBL/DDBJ accession no. LOC340096) and 
H3.Y (GenBank/EMBL/DDBJ accession no. LOC391769), 
are located on human chromosome 5 (5p15.1). Further data-
base searches revealed the existence of similar genes in pri-
mate genomes (Pan troglodytes H3.X, GenBank/EMBL/DDBJ 
accession no. LOC471464; and H3.Y, GenBank/EMBL/DDBJ 
accession no. LOC471473; Macaca mulatta H3.X, GenBank/ 
EMBL/DDBJ accession no. LOC718189; and H3.Y, GenBank/ 
EMBL/DDBJ accession no. LOC718280; Fig. S1 B). Searches 
for these genes in other mammalian genomes yielded no posi-
tive hits, which suggests that they evolved in evolutionarily 
younger terms and might constitute primate-specific histones. 
Both human genes contain a sequence matching the translation 
initiation start site consensus (underline) for vertebrates (GCC-
GCCACCAUGGCG; Kozak, 1991; Nakagawa et al., 2008), and 
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were transfected into HeLa cells and, in the case of HA-tagged 
variants, at least two independent stable cell populations were 
selected. In both HA-H3.X– and HA-H3.Y–expressing HeLa 
cells, nuclear HA signals in interphase and staining of con-
densed chromatin in mitotic cells were observed by immuno-
fluorescence (IF) microscopy (Fig. 2 A). Signals were also present 
on metaphase chromosome spreads (Fig. 2 B), which suggests 
that these novel tagged H3 variants are stably incorporated into 
chromatin and constitute core nucleosomal components. Next, 
we asked if the amino acid differences between H3.X, H3.Y, 
and other H3 variants have any impact on nucleosome structure. 
Thus, we calculated in silico models of H3.X and H3.Y pro-
tein structures, using the published structure of Xenopus laevis 
H3.2 as a template (Davey et al., 2002). With these, we compu-
tationally assembled a nucleosome containing H3.X or H3.Y. 
Our data show only few differences to the published structure of 
H3.2, with an exception being the unusual C terminus of H3.X 
observed in all samples except for the thalamus. In contrast to all 
other tissues tested, H3.X mRNA could also be detected in the 
brain and testis samples (Fig. 1 C).
In conclusion, mRNAs of the novel primate-specific H3 
variants H3.X and H3.Y are not only present in human cell 
lines, but are also detected in primary cells from different 
human organs.
Tagged H3.X and H3.Y proteins are similar 
to canonical histone H3 in their nuclear 
localization, nucleosome structure,  
and exchange mobility kinetics
The detection of H3.X and H3.Y mRNA in human cells 
prompted us to investigate their protein products. We ampli-
fied their coding sequences from U2OS cDNA and cloned them 
under the constitutively active cytomegalovirus promoter in 
frame with an N-terminal HA or GFP tag. These constructs 
Figure 1. Sequence and mRNA expression analysis of novel H3 variants H3.X and H3.Y. (A) Amino acid sequence alignment of human histone variants 
H3.1, H3.2, and H3.3 with novel variants H3.X and H3.Y. Alignments were made with ClustalW Alignment (MacVector 10.0.2). Identical amino acids 
are highlighted in dark gray, similar amino acids are highlighted in light gray, and changes are set apart on a white background. The black bar indicates 
the peptide sequence used for antibody generation. Black stars mark known PTM sites in H3.1, H3.2, and H3.3. The gray star indicates an H3.3-specific 
modification site. Amino acid numbers are indicated on top. (B) qPCR analysis with cDNA from different human cell lines shows expression of H3.Y and to 
a lesser extent H3.X mRNA in U2OS cells. Primer pair H3.X+Y (dark gray) specifically recognizes H3.X and H3.Y nucleotide sequences, whereas another 
primer pair is H3.X specific (H3.X, light gray). NIH3T3 mouse cDNA was used as a negative control. Data were normalized to HPRT1 and HMBS expres-
sion levels. Controls generated without reverse transcription were used to assess amplification threshold. Error bars represent SEM of two independent 
biological experiments. (C) Expression of H3.X and H3.Y mRNA in normal and malignant human tissues. Commercially available total RNA from human 
tissues was analyzed for H3.X+Y and H3.X expression in qPCR experiments and compared with results obtained with controls generated without reverse 
transcription. The number of samples that were positive for H3.X+Y and H3.X expression (+) are indicated in brackets.
 o
n
 M
ay 9, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published September 6, 2010
JCB • VOLUME 190 • NUMBER 5 • 2010 780
that, unlike H3.1 and H3.3 (Tagami et al., 2004), these tagged 
novel variants form heterotypic nucleosomes with regard to their 
variant composition. To assess the incorporation stability of these 
novel variants, we performed FRAP experiments with GFP-tagged 
H3 variants transiently transfected into HeLa Kyoto cells, which 
were chosen because of their slow cell motility. These experi-
ments demonstrate similar dissociation kinetics for the novel GFP-
tagged H3 variants compared with GFP-H3.1 and -H3.3 (Fig. 3, 
D and E; and Fig. S2, B–D). GFP fluorescence recovery rates 
of all H3 variants were very slow (>8 h; Fig. S2, B–D) in com-
parison to GFP alone (a few seconds; Fig. 3, D and E), which is 
indicative of stable chromatin-bound immobile populations.
In summary, tagged H3.X and H3.Y protein containing 
nucleosomes are similar in their predicted structure and indis-
tinguishable from nucleosomes containing H3.1 or H3.3 in their 
FRAP mobility and chromatin-association behavior.
(Fig. 3 A). Surprisingly, this extended C-terminal tail of H3.X is 
proposed to fold into an additional -helix that fits into the free 
space of the nucleosomal core structure (Fig. 3 B, left).
Because our in silico models proposed no dramatic changes 
in nucleosomal structure for H3.Y, but some differences for 
H3.X, we asked whether H3.X and/or H3.Y are incorporated 
into nucleosomes in a cellular context and whether they exhibit 
a similar stability compared with nucleosomes containing H3.1, 
H3.2, or H3.3. Immunoprecipitation (IP) of mononucleosomes 
generated from HeLa cells expressing HA-tagged H3 variants 
using an -HA antibody confirmed the incorporation of HA-H3.X 
and -H3.Y into chromatin (Figs. 3 C and S2 A). Additionally, sil-
ver staining and immunoblots revealed that HA-H3.X and -H3.Y 
are present in nucleosomes containing all four core histones. 
Interestingly, HA-H3.X and -H3.Y containing mononucleosomes 
also contained endogenous H3 (Fig. 3 C, right), which suggests 
Figure 2. Subcellular localization of HA-H3.X and -H3.Y histone proteins. (A) Confocal imaging of stably transfected HeLa cells shows nuclear localiza-
tion of HA-H3.1, -H3.X, and -H3.Y proteins. Cells were costained with TO-PRO3 (DNA, gray, left), -HA (green, middle left), and -H3S10ph (red, middle 
right). Overlay is shown on the right (merge). The left side shows interphase and the right side shows mitotic cells, as indicated by -H3S10ph staining. 
(B) Metaphase spreads of mitotically arrested HeLa cells transfected with empty vector and HA-H3.1, -H3.X, and -H3.Y. Deconvolved wide-field images of 
chromosomes costained with DAPI (DNA, blue, left) and -HA (green, middle). Sections containing one chromosome (red arrowhead) stained with -HA 
are depicted on the far right. All HA-H3 variants are incorporated into chromosomes. Bars: (A) 5 µm; (B) 10 µm.
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Figure 3. Structure and stability of H3.X- and H3.Y-containing nucleosomes. (A) In silico homology model of H3.X (purple, left) and H3.Y (light blue, right) 
protein structures in overlay with the crystal structure of H3.2 (dark blue). (B) Crystal structure of nucleosome with H3.2 exchanged by in silico homology 
models of H3.X (purple, left) and H3.Y (light blue, right), respectively. (C) IP of mononucleosomes generated from HeLa cells transfected with empty vector, 
HA-H3.1, -H3.X, and -H3.Y shows incorporation of novel H3 variants into nucleosomes. Bioanalyzer evaluation of purified DNA after IP of MNase-treated 
chromatin (unbound and bound material) shows digestion of chromatin to mononucleosomes and their successful precipitation (left; see also Fig. S2 A for 
DNA size and quality). Silver stain of 15% SDS-PAGE with -HA IPs of mononucleosomes revealed successful binding of HA-tagged H3 variants (asterisks) 
and pull-down of core histones (top, right). Immunoblot of immunoprecipitates with -HA (red) and -H3 C-terminal (green) antibodies visualized by the 
Odyssey infrared imaging system (bottom, right). Notice that endogenous H3 is coimmunoprecipitated with all H3 variants analyzed. (D) FRAP experiments 
to evaluate nucleosomal stability of novel H3 variants using spinning disk confocal microscopy. HeLa Kyoto cells were transiently transfected with GFP, 
GFP-H3.1, -H3.3, -H3.X, and -H3.Y constructs. A small nuclear area was photobleached (box) and the recovery of the fluorescent signal was monitored 
over 1 min and up to 8 h (see Fig. S2, B–D, for long-term FRAP). Depicted is a short-term FRAP series (selected time points are shown) of GFP-tagged 
H3 variants compared with GFP alone. Bar, 5 µm. (E) Quantification of short-term FRAP experiment. Mean curves of 10–20 individual cells are shown. 
Standard deviations were very small (in the range of ± 0.02) and were omitted for clarity (for details see Fig. S2 D). All GFP-H3 variants show almost no 
recovery within the first 60 s after bleaching, which indicates that all expressed fusion protein was stably incorporated into nucleosomes. In contrast, GFP 
alone recovers to almost 100% within 5 s.
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to an increase in the percentage of cells with nuclear -H3.X/Y 
staining (unpublished data). To evaluate if starvation alone, or 
in combination with high cell density, caused this increase in 
-H3.X/Y–positive cell numbers, we either subjected U2OS 
cells to starvation or cultivated them under SO conditions. 
In three independent biological experiments, we quantified (1) 
the percentage of -H3.X/Y nuclear-stained cells by IF micros-
copy, (2) H3.X/Y mRNA levels by qPCR, and (3) H3.X/Y pro-
tein levels by immunoblot analyses. Interestingly, we observed 
an approximately sixfold increase in the number of -H3.X/Y 
nuclear-stained cells under SO conditions, whereas starvation 
alone only showed a minor effect (threefold increase; Fig. 5 A). 
In addition, we could reproducibly show, by qPCR (Fig. 5 B) 
and immunoblots (Fig. 5 C), that both H3.X/Y RNA and protein 
are up-regulated upon SO treatment compared with normally 
growing cells. We observed a stronger increase of H3.X/Y- 
than H3.X-specific amplicons (Fig. 5 B), which suggests that 
H3.Y mRNA expression is specifically affected by this partic-
ular stress condition. This was further validated by a “primer-
walk” experiment with several different primer pairs that span 
the entire H3.X or H3.Y coding sequence (Fig. S3, A–C). 
Additionally, the induced protein band observed in immunoblots 
corresponds to a protein of the size of recombinant H3.Y but not 
H3.X (Fig. 5 C). To assess the question of which factors in the 
growth medium cause the observed effect, we also analyzed 
-H3.X/Y nuclear stained cells after serum starvation and amino 
acid depletion. However, we did not observe any significant dif-
ference caused by both treatments (unpublished data).
These data show a direct correlation between -H3.X/Y 
antibody staining and the increased mRNA and protein levels due 
to SO treatment. Furthermore, they suggest that H3.Y expression, 
in particular, is positively affected by these growth conditions.
Endogenous H3.Y protein is expressed 
after SO treatment
Our experiments indicate that H3.Y expression is mostly, 
if not exclusively, induced in U2OS cells under SO conditions. 
To confirm this observation, we purified histones from HEK293, 
NIH3T3, and SO-treated and normally grown U2OS cells by 
reversed-phase HPLC (RP-HPLC; Fig. S4 A). Fractions sur-
rounding and including peaks corresponding to H3.2 and H3.3 
(peak I) and H3.1 (peak II; Fig. 6 A) were analyzed by immuno-
blots with -H3.X/Y. Specific signals were observed in frac-
tions eluting at the beginning of peak I (region A bands) and 
between peak I and II (region B bands; Fig. 6 B). Interestingly, 
region A bands correspond to proteins of the molecular weight 
of histone H3, the predicted size of H3.Y. As expected for H3.Y, 
these bands are faintly visible in normally grown U2OS cells 
and strongly enhanced in those cultured under SO conditions. 
In contrast, no such bands are present in NIH3T3 and HEK293 
cells. Region B bands are indicative of proteins of 35 kD and 
are clearly visible without any change in intensity in all human 
cell lines, but not in mouse NIH3T3 cells. Fractions correspond-
ing to region A and B bands from SO treated cells from two 
independent experiments and normally grown U2OS cells were 
analyzed by liquid chromatography tandem mass spectrometry 
(LC-MS/MS). For region B fractions, no conclusive information 
Endogenous H3.X/Y proteins are expressed 
in U2OS cells and localize to the nucleus
To characterize endogenous H3.X/Y proteins, we generated 
a monoclonal antibody against these variants (-H3.X/Y; see 
Fig. 1 A, black line, for peptide sequence). -H3.X/Y specific-
ity was tested in diverse experiments using HeLa cells stably 
expressing HA-tagged H3 variants. Immunoblot analysis of acid-
extracted histones from these cell lines revealed that -H3.X/Y 
specifically recognizes HA-H3.X and -H3.Y, but not HA-H3.1, 
-H3.2, or -H3.3 (Fig. 4 A). In IF microscopy analyses with this 
antibody, HA-H3.X and -H3.Y showed an exclusive nuclear 
staining (Fig. S2 E), which could be confirmed to be specific for 
H3.X/Y by peptide competition assays (Fig. S2 F).
To analyze the expression of endogenous H3.X and H3.Y 
proteins, we isolated total histones from different cell lines. 
As a negative control, we used mouse NIH3T3 cells and, as a 
positive control, HeLa cells expressing HA-H3.X. Immuno-
blotting of these histones with -H3.X/Y showed a faint band in 
the lane containing U2OS histones corresponding to the size of 
H3, which would be expected for H3.Y (Fig. 4 B). These data 
are consistent with our previous finding that U2OS cells ex-
press mostly H3.Y mRNA (Fig. 1 B). Next, we addressed the 
subcellular localization of endogenous H3.X and/or H3.Y in 
U2OS cells by confocal IF microscopy. -H3.X/Y shows a 
faint and dotted staining associated with the nuclear rim in all 
cells, which might be due to cross-reactivity with nuclear pores. 
Interestingly, we also noticed that few U2OS cells showed a 
strong nuclear -H3.X/Y staining, colocalizing with DNA 
(Fig. 4 C, arrowhead), which was not observed in cell lines of 
mouse or rat origin (Fig. 4 D). Some few mitotic U2OS cells, as 
well as metaphase chromosomes, also stained positive with 
-H3.X/Y (Fig. 4, E and F, respectively), which suggested that the 
observed -H3.X/Y signal marks a stable chromatin component. To 
shed light on the subnuclear localization of endogenous H3.X/Y 
in U2OS cells, we performed super-resolution (i.e., below the dif-
fraction limit of conventional optical microscopy) imaging with 
3D structured illumination microscopy (3D-SIM; Gustafsson et al., 
2008; Schermelleh et al., 2008). As depicted in Fig. 4 G, H3.X/Y 
is predominantly located outside of DAPI-dense regions, arguing 
for an association of endogenous H3.X/Y with less condensed, 
more euchromatic regions.
Nutritional- and growth-associated  
stress stimuli increase the number of 
H3.X/Y-expressing cells
Because only 0.1% of U2OS cells showed a general nuclear 
staining with -H3.X/Y, we wondered what cellular features 
distinguished these from other cells. We hypothesized that spe-
cific stress stimuli induce the nuclear -H3.X/Y staining. 
To test this assumption, we induced DNA damage with different 
treatments (UV, etoposide, and hydroxyurea) but were unable 
to detect a significant increase in the percentage of cells positive 
for -H3.X/Y staining (unpublished data). Next, we addressed 
the question of whether cell growth and nutrition could have 
an impact on H3.X/Y expression. Interestingly, induction of 
starvation and overgrowth (SO) in U2OS cells for 8 d, but not 
overgrowth alone (for details, see Materials and methods), led 
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with increasing amounts of DTT (Fig. S4 B). In contrast to 
H3.1, H3.2, and H3.3, we did not observe a change in molecular 
weight for region B bands, which suggests that these particular 
proteins are not dimers of H3.X and/or H3.Y.
Interestingly, in region A fractions, we were able to iden-
tify two peptides specific for H3.X/Y (aa 53–63 and 73–83), in 
about the protein identity could be obtained. Only one single 
peptide corresponding to H3.X/Y (aa 53–63) could be observed 
in B-type fractions, rendering the analysis of these particular 
fractions inconclusive. To eliminate the possibility that region 
B bands constitute a dimeric aggregate caused by formation of 
disulfide bonds between cysteines, we treated these fractions 
Figure 4. Detection of endogenous H3.X and/or H3.Y proteins. (A) A monoclonal antibody against H3.X/Y (-H3.X/Y) was generated by immunizing rats 
with an N-terminal peptide specific for H3.X and H3.Y (aa 9–20, see also black line in Fig. 1 A). Immunoblots of acid-extracted histones from HeLa cells 
stably transfected with empty vector, or vectors containing HA-H3.1, -H3.2, -H3.3, -H3.X, and -H3.Y. Histones from two independently selected HeLa cell 
populations expressing HA-H3.X and -H3.Y were used (#1 and #2). (A, top) Staining of the membrane with -H3.X/Y antibody shows only signals in lanes 
loaded with histones from HeLa cells expressing HA-H3.X and -H3.Y, but not in lanes containing general HA-H3 variants, which demonstrates the specificity 
of the antibody toward the novel variants in immunoblotting. (A, bottom) Equal loading was controlled by -HA staining. Note that all bands run slower, as 
expected, because of the HA tag. HA-H3.X runs even slower than all other HA-H3 variants because of its extended C-terminal tail. (B) Immunoblot analysis 
of acid-extracted histones from different cell lines with -H3.X/Y antibody. (B, top) Histones from HeLa cells expressing HA-H3.X served as positive control, 
and histones from mouse NIH3T3 cells served as a negative control. A faint signal in the lane containing U2OS histones can be seen. (B, bottom) The identi-
cal membrane was stained with Ponceau S solution before antibody incubation to control for protein loading. Dotted lines indicate that intervening lanes 
have been spliced out. (C) Confocal IF analysis of U2OS cells costained with -H3.X/Y (green), -H3S10ph (mitosis-specific, red), and TO-PRO3 (DNA, 
gray). Confocal midsections are shown. (D) Confocal IF analysis of mouse (left) and rat (right) cells costained with -H3.X/Y (green), -H3S10ph (red), and 
TO-PRO3 (DNA, gray) as negative controls. (E) Confocal IF analysis of mitotic U2OS cells costained with -H3.X/Y (green), -H3S10ph (mitosis-specific, 
red), and TO-PRO3 (DNA, gray). (F) Costaining of metaphase chromosomes derived from mitotically arrested U2OS cells with -H3.X/Y (green) and DAPI 
(DNA, blue). The boxed inlet shows enlargement of one chromosome. (G) Super-resolution 3D-SIM imaging of U2OS cells costained with -H3.X/Y (green) 
and DAPI (DNA, blue). Depicted are cells expressing low (left) and high (right) levels of H3.X/Y. Bars: (C–F) 10 µm; (G, left) 5 µm; (G, right) 0.5 µm.
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addition to the expected general H3 peptides (Figs. 6 C and S4, 
C and D). Furthermore, one peptide exclusively present in H3.Y 
but not H3.X (aa 18–28) was repeatedly detected (Figs. 6 C and 
S4 E), leading to a combined sequence coverage of 33% for 
H3.Y. Interestingly, in conjunction with unmodified H3.Y pep-
tide, we were also able to identify acetylation of lysines 18, 23, 
and 27 (Fig. S4, F and G). These PTMs are also present in the 
known H3 variants, indicating that H3.Y was a likely part of a 
nucleosome and present in chromatin fibers.
In summary, these data show that posttranslationally mod-
ified H3.Y protein is expressed in vivo, and that under stress- 
inducing conditions, more H3.Y-expressing cells are present.
Knockdown of H3.Y affects expression of 
cell cycle–related genes and cell growth
Because we could clearly demonstrate the presence of endoge-
nous H3.Y protein in human cells, we wondered about the biologi-
cal consequences of its expression. We hypothesized that the natural 
substitution of amino acids S10, K14, S28, and K79 in H3.Y and its 
preferential exclusion from DAPI-dense regions (Fig. 4 G) might 
result in gene expression changes at the sites of chromatin incor-
poration. Therefore, we used global expression arrays to examine 
a potential impact on the regulation of gene expression by H3.Y. 
We used RNAi to significantly reduce H3.Y and H3.X+H3.Y 
mRNAs and proteins. siRNAs directed against H3.Y, H3.X+Y, 
and luciferase, as control, were designed and their specificity 
verified by transfection of HeLa cells expressing HA-tagged H3.X 
and H3.Y, followed by IF analysis (Fig. 7 A). Next, we sought to 
quantitatively compare global RNA expression profiles after RNAi 
in SO-treated U2OS cells using Affymetrix Human Gene 1.0 ST 
Arrays (performed twice with independent transfections on differ-
ent days). We verified the proper knockdown of H3.Y (and H3.X) 
mRNAs by qPCR (Fig. 7 B) and observed a modest but signifi-
cant deregulation of genes when compared with control luciferase 
RNAi in global microarray analyses (Fig. 7, C and D; and Tables 
S1 and S2). Cells transfected with H3.Y-specific siRNAs showed 
293 genes up-regulated and 974 genes down-regulated. Cells 
treated with H3.X+Y-specific siRNAs had 1,106 genes up-regulated 
and 1,249 genes down-regulated (local false discovery rate 
cutoff of 0.2). To eliminate off-target and sole H3.X-specific effects 
and to focus only on H3.Y-specific responses, Venn diagrams of 
overlapping deregulated genes between H3.Y- and H3.X+Y-
 specific siRNA changes were used. They revealed up-regulation of 
73 and down-regulation of 229 shared genes (Fig. 7 C). Gene ontol-
ogy (GO) enrichment analysis of the deregulated genes classified 
shared down-regulated genes to mainly belong to cell cycle-
 controlling pathways, but also chromatin organization and meta-
bolic pathways, whereas only few GO groups of shared up-regulated 
genes could be determined (Tables S1 and S2). Because the ma-
jority of genes affected by H3.Y RNAi play a role in cell cycle 
control (mitosis), as shown by a simplified GO enrichment analysis 
(Fig. 7 D), and we previously noticed a reduction in cell number 
after H3.Y and H3.X+Y knockdown, we quantitatively determined 
cell growth of U2OS cells with reduced H3.Y mRNA and protein 
levels. Therefore, we transfected U2OS cells with different variant-
specific siRNAs and quantitatively monitored cell growth for 
96 h using the xCELLigence system (Roche). Interestingly, and in 
Figure 5. The number of cells expressing H3.X and/or H3.Y is increased 
by nutritional and proliferative stress. (A) Quantification of the percentage 
of U2OS cells positive for -H3.X/Y nuclear staining by IF analyses under 
different growth conditions. U2OS cells were stained with -H3.X/Y after 
8 d of growth under different conditions: normal, starvation, or SO. The 
percentage of cells positive for -H3.X/Y nuclear IF staining was deter-
mined (see Materials and methods for details) and plotted. A clear increase 
in the number of cells containing -H3.X/Y–positive nuclei can be seen 
after growth under SO conditions. Error bars represent SEM of three inde-
pendent biological experiments. (B) qPCR analysis of H3.X and H3.X+Y 
mRNA expression levels from U2OS cells grown under different conditions. 
From the same plates described in Fig. 5 A, cells were harvested, RNA 
was isolated, and cDNA was generated. A clear increase in H3.X+Y (dark 
gray) but not H3.X mRNA (light gray) under SO conditions can be detected, 
which is similar to the data obtained with IF analyses (Fig. 5 A). Error bars 
represent SEM of three independent biological experiments. (C) Immunoblot 
analysis of H3.X and/or H3.Y proteins isolated from U2OS cells grown 
under different conditions. From the same plates described in Fig. 5 A, 
cells were harvested, and histones were acid extracted and immunoblotted 
with -H3.X/Y antibody (top). A clear increase in a 17-kD signal can be 
seen in U2OS cells grown under different stress conditions. Recombinant 
H3.X and H3.Y proteins serve as positive controls and histones from human 
HeLa and mouse NIH3T3 cells serve as negative controls. Staining of the 
same membrane with Ponceau S solution before antibody incubation was 
performed to ensure similar loading (bottom). One representative blot from 
three independent biological experiments is shown.
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Neuronal cell subpopulations in human 
hippocampus express novel H3  
variant proteins
Encouraged by our findings that endogenous H3.Y protein 
exists in vivo and plays an essential role in cell growth and 
gene regulation, we wondered if H3.Y and/or H3.X proteins 
accordance with our global transcriptome analyses, knockdown of 
H3.Y and H3.X+Y, but not of control RNAi (luciferase), resulted 
in a significant reduction of cell growth (Fig. 7 E).
These results suggest that loss of H3.Y especially affects 
the expression of genes involved in cell cycle control, leading to 
diminished cell growth.
Figure 6. Purification and identification of endogenous H3.Y variant protein. (A) RP-HPLC section showing histone H3 peaks (see Fig. S4 A for complete 
RP-HPLC profile). Acid-extracted histones from starved and overgrown U2OS cells (Fig. 5) were separated by RP-HPLC, and histone H3 peaks (peak I, 
H3.2+H3.3; peak II, H3.1) spanning fractions 1–31 are shown. (B) Immunoblotting analyses of RP-HPLC fractions 1–30 spanning histone H3 peaks I to II 
from different cell lines under distinct growth conditions with -H3.X/Y antibody. (i) Ponceau S staining of membrane containing histone fractions from 
starved and overgrown U2OS cells to detect H3.1, H3.2, and H3.3 proteins. Immunoblots incubated with -H3.X/Y from RP-HPLC fractions from U2OS 
cells (ii), starved and overgrown U2OS cells (iii), HEK293 cells (iv), and mouse NIH3T3 cells (v). Dotted lines indicate that intervening lanes have been 
spliced out. The two anti-H3.X/Y–positive fractions are indicated with A and B. Proteins of both fractions were independently subjected to MS/MS analyses. 
(C) List of H3-, H3.X/Y-, and H3.Y-specific peptides identified by LC-MS/MS from combined band A–corresponding fractions from U2OS cells (normal and 
SO treated; see iii). Amino acids highlighted in bold are specific for H3.X and H3.Y; a bold and underlined amino acid is found only in H3.Y.
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Figure 7. Influence of H3.Y expression on global gene regulation and cell growth. (A) Specificity determination of siRNAs against novel variants. IF micros-
copy using -HA (green) and DAPI (blue) staining of HeLa cells expressing HA-H3.X and -H3.Y 4 d after RNAi treatment with indicated siRNAs. Bar, 20 µm. 
(B) qPCR analysis to verify efficient H3.X and H3.Y RNAi knockdown before global transcriptome analysis. Primer pair H3.X+Y (dark gray) specifically 
recognizes H3.X and H3.Y nucleotide sequences, whereas two other primer pairs are H3.X- (light gray) or H3.Y-specific (white). Data were normalized to 
HPRT1 and HMBS expression levels and depict fold enrichment of expression in comparison to luciferase control RNAi. Controls generated without reverse 
transcriptase were used to assess amplification threshold. Error bars represent SEM of two independent biological experiments. (C) Venn diagrams of 
genes deregulated after H3.X+Y (blue) and H3.Y (yellow) RNAi in SO-treated U2OS cells, as identified by microarray analyses of two independent experi-
ments when compared with luciferase control knockdown. Digits indicate numbers of genes significantly up- (left) or down-regulated (right) in comparison 
to luciferase control knockdown. (D) Simplified GO analysis of overlapping genes after H3.X+Y and H3.Y knockdown. Detailed GO lists are shown in 
Tables S1 and S2. Node size = total number of genes analyzed in this node (GO term/group). (E) Growth curve of U2OS cells after RNAi (red, luciferase 
control siRNA; blue, H3.X+Y siRNA; green, H3.Y siRNA). Arrows mark changes of growth medium.
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are expressed in human tissue. Based on our qPCR results 
(Fig. 1 C), and the observation that many primate-specific 
genes are expressed in the brain and reproductive organs (Tay 
et al., 2009), we chose to analyze sections of human hippo-
campus in IF (Fig. 8 A).
Interestingly, some few cells in the region above the dentate 
gyrus (DG) of the hippocampus stained positive with -H3.X/Y 
(Fig. 8 B). We determined their cellular origin by costaining with 
antibodies against neurons ( neuronal nuclei [-NeuN] and astro-
cytes ( glial fibrillary acidic protein [-GFAP]; Fig. S5). H3.X/Y 
proteins were identified in a subpopulation of neurons outside of 
the DG (Fig. 8, B and C). This finding is in accordance with our 
observation that only few U2OS cells express large amounts of 
H3.Y. Surprisingly, -H3.X/Y staining of neurons displayed an 
enrichment in certain chromatin areas, different from that observed 
in U2OS cells (Fig. 4, C and G).
In conclusion, H3.X and/or H3.Y proteins are expressed 
in a subpopulation of neurons in the human hippocampus, high-
lighting the possibility that these novel histone variants might 
have cell type–specific functions.
Collectively, our data demonstrate that the novel histone 
variant H3.Y is expressed in human cells and specialized tis-
sues, is incorporated into chromatin, is posttranslationally mod-
ified, and impacts the regulation of many genes implicated in 
cell cycle progression.
Discussion
More than 20 yr ago, the mammalian histone H3 variants CENP-A 
(Palmer et al., 1987) and tH3 (Trostle-Weige et al., 1984) were 
found. Since then several variants of the mammalian H2A family, 
such as macroH2A (Pehrson and Fried, 1992) and H2A.Bbd 
(Chadwick and Willard, 2001), have been described, but it was 
long thought that all members of the histone H3 family had been 
identified. To better understand the role of H3 variants in chromatin- 
related processes, we set out to investigate if there might be even 
more, yet unknown, H3 variants present in mammals.
H3.X and H3.Y are primate-specific 
histone genes
Using the DNA sequence of human histone H3.1 in genomic 
searches, we have now identified two novel intron-free histone 
H3 variant genes on human chromosome 5, which we named 
H3.X and H3.Y. Sequences for H3.X and H3.Y genes were, in 
addition to humans, only found in chimpanzee and macaque pri-
mate genomes; sequence information of other primate genomes 
is unfortunately not yet available. Additional Basic Local Align-
ment Search Tool (BLAST) searches in mouse, rat, and other 
genomes did not yield any positive hits, which suggests that H3.X 
and H3.Y genes are present in primates, but not in other mam-
mals or even lower eukaryotes. Both genes might be duplications 
Figure 8. H3.X/Y protein expression in 
human brain. (A) Overview IF picture of com-
mercially available human hippocampus sec-
tion stained with DAPI (DNA, gray). (B) Human 
hippocampus sections were costained with 
-H3.X/Y (red), -NeuN (neuronal marker, 
green), and DAPI (DNA, blue). The boxed sec-
tion from A is shown. Arrows indicate neuro-
nal cells with positive -H3.X/Y staining in the 
region above DG. One out of three representa-
tive stainings is shown. (C) The boxed section 
and the -H3.X/Y–positive cell marked with an 
asterisk in B are shown in higher resolution. 
Costainings with astrocyte marker antibody 
(-GFAP) are shown in Fig. S5. Bars: (A and B) 
200 µm; (C, top) 2 µm; (C, bottom) 10 µm.
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Our global microarray data imply that H3.Y influences the tran-
scription of several genes, either directly or indirectly. Interest-
ingly, loss of H3.Y led to more genes being down- rather than 
up-regulated, which suggests that H3.Y might be involved in tran-
scriptional activation of some genes. This is in accordance with 
our finding that H3.Y mainly localizes to euchromatic regions 
(Fig. 4 G). The majority of genes affected by H3.Y reduction are 
components of cell cycle– and chromatin structure–regulating 
pathways, leading to a significant impairment of cell growth. 
It is difficult to unequivocally assign a gene or group of genes as 
direct targets of H3.Y depletion, which would require the iden-
tification of genomic regions containing H3.Y on a global scale 
by chromatin IP followed by chip hybridization or sequencing. 
Unfortunately, IP of endogenous H3.Y protein with -H3.X/Y 
antibody turned out to be insufficient with standard protocols, 
and therefore more time and testing will be required to work 
out a functional ChIP protocol. It was surprising to us that the 
whole U2OS cell population was equally impaired in its cell 
growth after H3.Y knockdown although only few cells appeared 
to strongly express H3.Y protein, as shown by IF quantification 
(Figs. 4 C and 5 A). It is therefore possible that all U2OS cells 
express a minimal amount of H3.Y RNA and protein, which is 
beyond our detection limit, but nevertheless crucial for the cell 
to traverse through the cell cycle. To our knowledge, only one 
other histone variant showed a similar effect on the expression 
of cell cycle–related genes after RNAi depletion: knockdown of 
the linker histone variant H1.2 altered the expression of 2% of 
genes genome wide (most of them being repressed), including 
a relevant proportion of cell cycle–related genes (Sancho et al., 
2008). It is therefore not completely unlikely that H3.Y plays 
an important role in the regulation of genes involved in cell 
cycle control. It is tempting to speculate that the stress-related 
appearance of more U2OS cells expressing H3.Y is caused by 
continued cell proliferation or the prevention of cell death. One 
interesting observation was that knockdown of H3.Y led to 
stronger cell growth defects than combined H3.X+H3.Y RNAi. 
Because we repeatedly saw an increase of H3.X mRNA after 
H3.Y depletion, one speculative idea would be that H3.X and 
H3.Y are connected by some sort of regulatory feedback mech-
anism. It will be of great interest in future studies to shed light 
on the regulatory expression pathways of these novel variants, 
particularly in the context of cellular stress and their existence 
in neuronal subpopulations of the human hippocampus.
Materials and methods
Cell culture, cloning of H3.X and H3.Y expression constructs,  
and transfection
Human HeLa, HeLa Kyoto, HEK293, U2OS, mouse NIH3T3, and rat neuro-
blastoma cells were grown in DME medium (PAA) supplemented with 
10% FCS (Sigma-Aldrich) and 1% penicillin/streptomycin (PAA) at 
37°C and 5% CO2. Human Raji cells were cultured in RPMI-1640 medium 
(Invitrogen) supplemented with 10% FCS (Sigma-Aldrich) and 1% penicillin/ 
streptomycin (PAA) at 37°C and 5% CO2. H3.1, H3.2, H3.3, H3.Y, and 
H3.X cDNA were cloned into pEGFP-C1 (Takara Bio Inc.) and pIRES-neo 
vector (Takara Bio Inc.) containing an HA tag (a gift from H. Dormann, 
Rockefeller University, New York, NY) to generate N-terminally tagged H3 
variants after transfection into cell lines. For simplicity, we will refer to the 
EGFP-tagged constructs as GFP-tagged throughout the text. All constructs were 
sequenced (MWG-Biotech AG) to verify cloning and amplification accuracy. 
from one ancestral gene, as their sequences are highly conserved 
even in their 5 and 3 untranslated regions, with only some differ-
ences in their putative promoter sequences. Phylogenetic analyses 
of H3.X and H3.Y coding and 3 genomic sequences revealed a 
higher sequence homology to H3.3 genes than to other H3 vari-
ants, leading to the speculation that H3.X and H3.Y might be evo-
lutionary derivatives of H3.3, although they do not contain any 
introns. To our knowledge, these are the first histone genes that 
are primate specific outside of testes and likely confer specialized 
chromatin functions unique to these higher vertebrates.
H3.X and H3.Y genes are both 
transcribed, but only H3.Y protein can  
be detected in vivo
So far we have obtained evidence that H3.X and especially H3.Y 
mRNAs are present at low but significant amounts in some 
human bone, breast, lung, and ovary tumor tissues, as well as in 
testis and certain areas of the brain. Therefore, their expression 
is not only found in transformed cell lines (U2OS) but also 
in primary human tissues. Surprisingly, we were able to verify 
only the existence of H3.Y but not H3.X protein in human cell 
lines thus far. One possibility is that alternative transcription of 
H3.X may occur. Two previous annotations of the H3.X locus 
in the NCBI database predicted several introns and different 
splice sites (Fig. S3 D); however, our primer walk experiment 
and negative qPCR data using primers specific for these splice 
forms (unpublished data) provided no evidence that alternative 
H3.X transcripts exist. Based on our results, H3.X is transcribed 
only at low levels in U2OS cells, and because no protein could 
be detected thus far, it is feasible that this particular variant is a 
pseudogene without any functional consequences. Alternatively 
and more interestingly, it is also possible that its mRNA, al-
though it is present only at low levels in some cells, may have 
unknown regulatory functions and may even be influencing 
H3.Y gene expression. Future studies will hopefully shed more 
light onto a putative function of H3.X mRNA.
The number of H3.Y-expressing U2OS cells 
is increased by stress conditions
We showed that H3.Y mRNA and protein is present in some 
U2OS cells (0.1%) and that the number of cells expressing 
high levels of this novel histone variant can be increased by a 
stress response that involves nutritional starvation in combina-
tion with high cellular density. It is interesting to note that when 
calculating the amount of endogenous H3.Y mRNA per cell, we 
observe an 40-fold higher expression compared with a cell 
expressing HA-H3.Y mRNA. This suggests that once a cell re-
ceives a specific signal to start transcribing endogenous H3.Y 
or reaches a certain threshold of an unknown factor, this variant 
is expressed in extremely high amounts. It will be crucial to 
identify the physiological trigger of H3.Y expression in future 
studies to learn more about H3.Y’s cellular function.
Loss of H3.Y expression impacts 
transcriptional regulation and cell growth
To get a first glimpse on H3.Y’s potential impact on gene reg-
ulation, we knocked down H3.Y in U2OS cells using RNAi. 
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-rabbit–Rhodamine red X and -rabbit–Cy5 (Dianova, Inc.); and -rat– 
biotin (Vector Laboratories).
IF microscopy
Adherent mammalian cells were grown on coverslips, washed, fixed in 1% 
or 3.7% formaldehyde–PBS solution, permeabilized with 0.1% or 0.5% 
Triton X-100–PBS solution, and blocked with 1% BSA in 0.1% or 0.5% Tri-
ton X-100–PBS solution. After stepwise incubation with primary and then 
secondary fluorescent antibody, cells were stained with DAPI (Invitrogen) 
and mounted with a ProLong Antifade kit (Invitrogen). Samples for 3D-SIM 
were prepared on precision cover glass No. 1.5 (thickness 0.170 ± 0.005 mm; 
Carl Roth) and embedded in Vectashield mounting medium (Vector Labora-
tories). Chromosome spreads were generated as described previously 
(Hake et al., 2005). For confocal microscopy, samples were stained with 
To-Pro3 (Invitrogen) and mounted with Vectashield mounting medium (Vec-
tor Laboratories).
FRAP
For FRAP experiments, human HeLa Kyoto cells were transiently transfected 
with GFP-tagged histone H3 constructs. After 24 h, cells were seeded in 
Lab-Tek chamber slides (Thermo Fisher Scientific) and incubated for several 
hours or overnight before performing FRAP experiments. FRAP was per-
formed on a spinning disc microscope (UltraVIEW VoX; PerkinElmer) with 
an integrated FRAP PhotoKinesis accessory (PerkinElmer) assembled to an 
Axio Observer D1 stand (Carl Zeiss, Inc.). The microscope was equipped 
with a heated environmental chamber set to 37°C and CO2 perfusion set to 
5%. For photobleaching experiments, several square bleach regions with a 
size of 5 × 5 µm were positioned on selected cell nuclei within the field of 
view. Photobleaching was performed using two iterations with the acousto-
optical tunable filter of the 488-nm and the 514-nm laser line set to 100% 
transmission. To determine long-term recovery kinetics, 3D image stacks of 
8-µm height and a z distance between image planes of 1 µm were recorded 
with an initial speed of 1 frame/min for the first 10 frames, followed by 
intervals of 10 min.
Quantitative evaluations were performed with ImageJ (http://rsb 
.info.nih.gov/ij/). Lateral and rotational movements of the cell nucleus were 
corrected by image registration using the StackReg plug-in of ImageJ. Mean 
intensities over time were extracted from the total nuclear area (T). The 
background ROI outside of the cell was defined manually from the initial 
field of view. The mean gray values over time were measured, background 
subtracted, and normalized to the respective means of the last prebleach 
values. The resulting postbleach B values were then divided by the respec-
tive T value to correct for the superimposed gain or loss of total fluorescence 
during postbleach acquisition, potentially caused by newly synthesized 
GFP-histones, bleaching-by-acquisition, and flux of residual fluorescence 
from above and below the recorded optical plane.
Peptide competition
-H3.X/Y antibody was incubated for 4 h at 4°C with the following peptides 
(1 µg/ml) prior to addition to the fixed cells: biotin-coupled H3.3 unmodi-
fied, aa 22–41 (Proteomics Resource Center of the Rockefeller University); 
and H3.X/Y unmodified, aa 9–20 (Peptide Specialty Laboratories GmbH).
Immunohistochemistry
Commercially available frozen sections of human hippocampus (Biochain) 
were thawed and blocked with 0.5% BSA in 0.5% Triton X-100–PBS solution. 
After stepwise incubation with primary and then secondary fluorescent 
antibodies, cells were stained with DAPI (Invitrogen) and mounted with 
Aqua-Poly/Mount (Polysciences, Inc.). To enhance -H3.X/Y signals, samples 
were incubated with a biotin-coupled -rat antibody (Vector Laboratories), 
followed by streptavidin coupled to an Alexa 555 fluorophore (Invitrogen).
Microscopes
Unless stated otherwise, samples were kept at room temperature during 
image acquisition. Stained cells were analyzed on a microscope (Axiovert 
200M) with an EC Plan-Neofluar 40×/1.3 NA oil Ph3 (differential inter-
ference contrast [DIC] III) objective (both from Carl Zeiss, Inc.). Images 
were processed with AxioVision software (Carl Zeiss, Inc.). Confocal 
imaging was performed with a confocal microscope (LSM 510 META; Carl 
Zeiss, Inc.) equipped with an argon-ion and two helium-ion lasers using a 
Plan-Apochromat 63×/1.4 NA oil DIC or a Plan-Neofluar 40×/1.3 NA 
oil DIC objective lens (both from Carl Zeiss, Inc.). Images were processed 
with LSM 510 META software (Carl Zeiss, Inc.). Images of metaphase 
chromosome spreads were acquired using a personalDV wide-field epi-
fluorescence microscope (Applied Precision) equipped with a 60×/1.42 
NA Plan-Apochromat oil objective lens (Olympus) and a CoolSNAP HQ2 
Transfections were performed with FuGene HD (Roche) according to 
the manufacturer’s instructions. In brief, cells were incubated with the 
transfection complex for 1 d, after which selection medium containing 
600 µg/ml G-418 sulfate (PAA) was added. Stable cell lines were main-
tained in medium containing 400 µg/ml G-418 sulfate.
Expression of recombinant H3.X and H3.Y proteins in Escherichia coli
BL21-CodonPlus (DE3)-RIL bacteria (Agilent Technologies) were trans-
formed with pET-21a(+) plasmids (EMD) containing H3.X and H3.Y cDNA. 
Expression of recombinant proteins was induced by incubation with 0.1% 
IPTG (Carl Roth) overnight and controlled through SDS-PAGE analysis of 
boiled bacteria (Coomassie and immunoblot).
RNA expression analysis
Total RNA was isolated using the RNeasy mini kit (QIAGEN) according 
to the manufacturer’s instructions. Genomic DNA contaminations were re-
moved by performing an on-column DNase I digest (RNase-free DNase; 
QIAGEN). cDNA was synthesized using the ProtoScript First Strand cDNA 
Synthesis kit (New England Biolabs, Inc.), priming with random nonamers. 
qPCR analysis was performed on a LightCycler 480 (Roche) using the Light-
Cycler 480 SYBR green I mastermix (Roche). Data analysis was performed 
with the advanced relative quantification tool of the LightCycler 480 soft-
ware; results were normalized to HPRT1 and HMBS levels. H3.X and H3.Y 
primer sequences (Sigma-Aldrich) are listed in Fig. S3 C. Total RNA 
from different human tissues was commercially acquired from Applied Bio-
systems (normal lung, breast and tumor breast, and lung and ovary) and 
BioChain (tumor lung, breast, thyroid and bone, normal testis, cerebellum, 
cerebral cortex, hippocampus, thalamus, and total fetal brain).
Histone extraction and mononucleosome IP
Histones were acid extracted as described previously (Shechter et al., 
2007). In brief, nuclei were isolated by hypotonic lysis and extracted using 
0.4 M sulfuric acid. Soluble histones were precipitated with trichloroacetic 
acid and resuspended in water.
Mononucleosomes for IP experiments were generated as described 
previously (Wysocka et al., 2001), with the following changes: For cell 
lysis, 0.1% NP-40 was used instead of Triton X-100. All centrifugation 
steps before MNase treatment were performed at 3,200 g. Mononucleo-
somes were generated by digestion of chromatin with 0.25 U MNase 
(Sigma-Aldrich) for 15 min in buffer A (10 mM Hepes, pH 7.9, 10 mM 
KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol [vol/vol], 1 mM DTT, 
and protease inhibitor cocktail [Roche] plus 1 mM CaCl2) and stopped 
by the addition of EGTA (final concentration of 2 mM). Centrifugation 
was performed at 20,000 g for 20 min. Supernatants of four MNase 
digests were combined, and salt concentration was adjusted to 150 mM 
KCl. Magnetic beads (Invitrogen) were washed four times with buffer C 
(20 mM Hepes/KOH, pH 7.9, 20% [vol/vol] glycerol, 0.2 mM EDTA, 
0.2% [vol/vol] Triton X-100, 300 mM KCl, and protease inhibitor cocktail 
[Roche]). One part was evaluated for DNA size and quality using DNA 
1000 reagents (Agilent Technologies) with the 2100 Bioanalyzer (Agilent 
Technologies), another part was analyzed by immunoblotting using the 
Odyssey infrared imaging system (LI-COR Biosciences) and evaluated with 
Odyssey Software Version 2.1 (LI-COR Biosciences), and the last part was 
analyzed by silver staining.
Antibodies
To generate an antibody against H3.X and H3.Y (-H3.X/Y), a peptide 
spanning amino acids KATAWQAPRKLP of histone H3.X and H3.Y was 
synthesized (Peptide Specialty Laboratories GmbH) and coupled to BSA 
and ovalbumin, respectively. Rats were immunized subcutaneously and 
intraperitoneally with a mixture of 50 µg peptide-ovalbumin, 5 nmol CPG 
oligonucleotide (TIB MOLBIOL GmbH), 500 µl PBS, and 500 µl of incom-
plete Freund’s adjuvant. A boost without adjuvant was given 6 wk after the 
primary injection. Fusion was performed using standard procedures (Köhler 
and Milstein, 1975). Supernatants were tested by differential ELISA with the 
histone peptide coupled to BSA and an irrelevant peptide coupled to the 
same carrier. Monoclonal antibodies that reacted specifically with the pep-
tide were further analyzed in immunoblot and IF studies. -H3.X/Y clone 
8H6-2111 of rat IgG2a subclass was deployed in this study.
The following primary antibodies were used in this study: -HA (clone 
12CA5; Roche), -H3S10ph (Millipore), -H3 (C terminus; Abcam), -NeuN 
(Millipore), and -GFAP (Dako).
The following secondary antibodies were used: -rat HRP and 
-rabbit HRP (GE Healthcare); -mouse–IRDye700DX and -rabbit–
IRDye800DX (Rockland Immunochemicals, Inc.); -rat–Alexa Fluor 488, 
-mouse–Alexa Fluor 488, and streptavidin-Alexa 555 (Invitrogen); and 
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monitored over the next 4 d. To eliminate side effects caused by the lack of 
nutrients or the accumulation of waste products, growth medium was ex-
changed every day.
Microarray hybridization
Total RNA preparations were further purified with the RNeasy MinElute 
Cleanup kit (QIAGEN). 100 ng of RNA were used as starting material 
for all target preparations. RNA amplification, labeling, and hybridization 
to Human Gene 1.0 ST Arrays (Affymetrix) were performed according to 
the Human Gene 1.0 ST Array kit protocol (Affymetrix). The raw micro-
array data were processed in R/Bioconductor (http://www.bioconductor 
.org/) as follows: gene-based expression values were calculated using the 
robust multichip average (RMA) method provided by the oligo package. 
Genes that had a log2 expression value of at least 4 in at least one of the 
treatment conditions were kept for downstream analyses. Differential expres-
sion estimation was based on a moderated t statistic (limma package) with 
subsequent calculation of the local false discovery rate (lfdr; locfdr pack-
age). Genes were classified as responders by an lfdr cutoff of 0.2. GO 
enrichment analysis was performed using a hypergeometric distribution test and 
subsequent Bonferroni correction as supplied by the GOHyperGALL script 
(http://faculty.ucr.edu/~tgirke/Documents/R_BioCond/My_R_Scripts/ 
GOHyperGAll.txt). We reduced term redundancy by applying the 
GOHyperGAll_Simplify function with a P-value cutoff of 0.001.
Online supplemental material
Fig. S1 shows H3.X and H3.Y alignments, evolutionary origin, and ex-
pression level determination. Fig. S2 shows analysis of H3.X- and H3.Y- 
containing nucleosomes, and -H3.X/Y antibody specificity determina-
tion. Fig. S3 shows evaluation of human H3.X sequences and inducible 
endogenous H3.X and H3.Y gene expression. Fig. S4 shows purifica-
tion and mass spectrometrical identification of endogenous H3.Y protein. 
Fig. S5 shows H3.X/Y expression in the human hippocampus. Table S1 
shows a GO list with shared up-regulated genes after H3.Y knockdown. 
Table S2 shows a GO list with shared down-regulated genes after H3.Y 
knockdown. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201002043/DC1.
We are grateful to Ignasi Forne for technical advice concerning RP-HPLC, and 
Dietmar Martin and Kerstin Maier of the Gene Center Affymetrix Microarray 
Platform (Cramer Laboratory) for help with microarray experiments. We thank 
Axel Imhof for his remarks concerning MS data, Robert Loewe for his valuable 
advice about statistical analysis of qPCR data, and Holger Dormann for the 
pIRES-neo-HA plasmid. We are indebted to Katrin Schneider for help with FRAP 
analysis, Mariacristina Chioda and Sandra Vengadasalam for help with the con-
focal microscope, and Christiane Simon for immunohistochemistry advice. We 
thank Dirk Eick, Martin Heidemann, and Corinna Hintermair for their help with 
the xCELLigence instrument. We appreciate Antonia Jack’s, Christian Janzen’s, 
and Emily Bernstein’s critical examination of the manuscript. We thank especially 
the Hake laboratory, members of the Adolf-Butenandt-Institute, and Peter Becker, 
Stefan Jentsch, and Gunnar Schotta for constructive discussions.
This work was supported by the Deutsche Forschungsgemeinschaft 
(part of the Sonderforschungsbereich Chromatin Transregio 5) to S.B. Hake, 
H. Leonhardt, L. Schermelleh, and E. Kremmer; and by the Center for Integrated 
Protein Science Munich to S.B. Hake and H. Leonhardt. S.M. Wiedemann is a 
fellow of the Munich International Max Planck Research School for Molecular and 
Cellular Life Sciences (IMPRS-LS).
Submitted: 8 February 2010
Accepted: 11 August 2010
References
Abbott, D.W., V.S. Ivanova, X. Wang, W.M. Bonner, and J. Ausió. 2001. 
Characterization of the stability and folding of H2A.Z chromatin 
particles: implications for transcriptional activation. J. Biol. Chem. 
276:41945–41949. doi:10.1074/jbc.M108217200
Ahmad, K., and S. Henikoff. 2002a. Histone H3 variants specify modes of chro-
matin assembly. Proc. Natl. Acad. Sci. USA. 99:16477–16484. doi:10.1073/ 
pnas.172403699
Ahmad, K., and S. Henikoff. 2002b. The histone variant H3.3 marks active 
chromatin by replication-independent nucleosome assembly. Mol. Cell. 
9:1191–1200. doi:10.1016/S1097-2765(02)00542-7
Allshire, R.C., and G.H. Karpen. 2008. Epigenetic regulation of centro-
meric chromatin: old dogs, new tricks? Nat. Rev. Genet. 9:923–937. 
doi:10.1038/nrg2466
charge-coupled device (CCD) camera (Photometrics). Typically, stacks with a 
z distance of 200 nm were recorded and then subjected to a constrained 
iterative deconvolution (enhanced ratio, 10 cycles, medium noise filtering) 
using the SoftWoRx 3.7 imaging software package (Applied Precision). For 
a description about the microscopic setup used for FRAP, see the descrip-
tion for in the FRAP section. Imaging with 3D-SIM was performed with an 
DeltaVision OMX v3 prototype (Applied Precision) equipped with high-
power diode lasers with wavelengths of 405, 488 and 592.2 nm; a 100×/ 
1.4 NA Plan-Apochromat oil objective lens (Olympus); and Cascade II:512 
EM CCD cameras (Photometrics). Laser light is directed through a movable 
optical grating to generate a fine-striped illumination pattern on the sample 
plane. Image stacks with 15 images per plane (five phases, three angles) 
and a z distance of 125 nm were acquired and subjected to a compu-
tational reconstruction to obtain a high-resolution 3D dataset with a two-
fold enhanced optical resolution in all three special directions compared 
with conventional light microscopy (Gustafsson et al., 2008; Schermelleh 
et al., 2008). Immunohistochemistry samples were analyzed using a con-
focal LSM 710 microscope (Carl Zeiss, Inc.) equipped with three argon, one 
diode-pumped solid-state, one helium, and one diode laser. Images were 
acquired using an EC Plan-Neofluar 10×/0.3 NA M27, an LD C-Apochromat 
40×/1.1 W Korr M27 (water), or a LCI Plan-Neofluar 63×/1.3-mm Korr 
Ph3 M27 (water) objective lens (all from Carl Zeiss, Inc.), and Image pro-
cessing was performed with ZEN 2009 (Carl Zeiss, Inc.) software.
For downstream image processing of all microscope images, Photo-
shop (Adobe) software packages were used.
In silico modeling
To generate homology models from protein sequences, we used the I-TASSER 
server (Zhang, 2008). I-TASSER combines threading, assembly, and refine-
ment to generate 3D models. For sequences of both H3.X and H3.Y, the 
server automatically selected as a template the chain A (histone H3.2), PDB 
accession no. 1kx5. This structure was obtained using X. laevis histones 
assembled into nucleosomes with 147 bp of DNA from Homo sapiens 
(Davey et al., 2002). The model for H3.X had a C score of 0.07, and the 
model for H3.Y had a C score of 1.50. In both cases, the second-best model 
had a considerably lower C score. Datasets of the models were down-
loaded and visualized by means of the Swiss-PdbViewer (Guex and Peitsch, 
1997) and PyMOL (DeLano Scientific LLC; http://www.pymol.org).
RP-HPLC and MS/MS
Histones from U2OS, HEK293, and NIH3T3 cells were separated by 
RP-HPLC on a C4 column (250 × 4.6-mm Jupiter, 10 µm, 300 Å; Phenomenex) 
using a linear gradient of 35–53% solvent B (solvent A, 0.1% trifluoroacetic 
acid; solvent B, 99.92% acetonitrile and 0.08% trifluoroacetic acid) over 
30 min at 1.0 ml/min on a Biotech Ettan microLC (GE Healthcare). The 
H3-containing fractions were dried under vacuum and stored at 20°C. 
For mass spectrometry analysis, RP-HPLC fractions containing histones were 
resolved in 0.1 M ammonium bicarbonate and digested. Proteolytic diges-
tions were performed overnight at 37°C with sequencing grade trypsin 
(Promega). In this case, histones were chemically modified beforehand by 
treatment with propionic anhydride (Merck) to convert free amino groups of 
lysine residues to propionic amides. After digestion, samples were directly 
loaded onto a nano electrospray ionization (ESI) LC-MS/MS for protein 
identification. Each sample was first separated on a C18 reversed phase 
column via a linear acetonitrile (Sigma-Aldrich) gradient (UltiMate 3000 
system [Dionex] and an LC Packings column; 75 µm inner diameter × 15 cm, 
packed with C18 PepMap, 3 µm, 100 Å) before MS and MS/MS spectra 
were recorded on an Orbitrap mass spectrometer (Thermo Fisher Scientific). 
The resulting data were analyzed via the Mascot Software (Matrix Science) 
using a home-made database that contains the diverse H3 sequences. Frag-
ment spectra were also interpreted manually.
RNAi and growth curve
siRNAs were designed using siDESIGN Center (http://www.dharmacon 
.com/designcenter/designcenterpage.aspx; Thermo Fisher Scientific) and 
synthesized (MWG-Biotech AG). siRNAs have been prevalidated to con-
firm their targeting specificity to H3.Y or H3.X+H3.Y and to reduce the 
chance of off-target effects by BLAST searches (NCBI). The following double-
stranded siRNAs, which had differences of at least three nucleotides from 
other targets, were used. Luciferase, 5-CUUACGCUGAGUACUUCGA-3; 
H3.Y, 5-CCGCAGAGAGGGUCCUUAA-3; H3.X+Y, 5-GCGGGAAAU-
CAGAAAGUAC-3. Cells were transfected twice with siRNAs using oligo-
fectamine (Invitrogen) according to the manufacturer’s instructions. 4 d after 
transfection, cells were used for various assays. Determination of cell growth 
after RNAi was performed using xCELLigence system (Roche). Cells were 
seeded in E plates 1 d after the second siRNA transfection. Cell growth was 
 o
n
 M
ay 9, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published September 6, 2010
791Characterization of novel histone H3.Y • Wiedemann et al.
Palmer, D.K., K. O’Day, M.H. Wener, B.S. Andrews, and R.L. Margolis. 1987. 
A 17-kD centromere protein (CENP-A) copurifies with nucleosome 
core particles and with histones. J. Cell Biol. 104:805–815. doi:10.1083/ 
jcb.104.4.805
Pehrson, J.R., and V.A. Fried. 1992. MacroH2A, a core histone containing a 
large nonhistone region. Science. 257:1398–1400. doi:10.1126/science 
.1529340
Polo, S.E., D. Roche, and G. Almouzni. 2006. New histone incorporation marks 
sites of UV repair in human cells. Cell. 127:481–493. doi:10.1016/ 
j.cell.2006.08.049
Pusarla, R.H., and P. Bhargava. 2005. Histones in functional diversification. 
Core histone variants. FEBS J. 272:5149–5168. doi:10.1111/j.1742-4658 
.2005.04930.x
Sancho, M., E. Diani, M. Beato, and A. Jordan. 2008. Depletion of human histone 
H1 variants uncovers specific roles in gene expression and cell growth. 
PLoS Genet. 4:e1000227. doi:10.1371/journal.pgen.1000227
Santenard, A., and M.E. Torres-Padilla. 2009. Epigenetic reprogramming 
in mammalian reproduction: contribution from histone variants. Epi­
genetics. 4:80–84. doi:10.4161/epi.4.2.7838
Schermelleh, L., P.M. Carlton, S. Haase, L. Shao, L. Winoto, P. Kner, B. Burke, 
M.C. Cardoso, D.A. Agard, M.G. Gustafsson, et al. 2008. Subdiffraction 
multicolor imaging of the nuclear periphery with 3D structured illumina-
tion microscopy. Science. 320:1332–1336. doi:10.1126/science.1156947
Shechter, D., H.L. Dormann, C.D. Allis, and S.B. Hake. 2007. Extraction, 
purification and analysis of histones. Nat. Protoc. 2:1445–1457. 
doi:10.1038/nprot.2007.202
Strahl, B.D., and C.D. Allis. 2000. The language of covalent histone modifica-
tions. Nature. 403:41–45. doi:10.1038/47412
Suto, R.K., M.J. Clarkson, D.J. Tremethick, and K. Luger. 2000. Crystal struc-
ture of a nucleosome core particle containing the variant histone H2A.Z. 
Nat. Struct. Biol. 7:1121–1124. doi:10.1038/81971
Tabaska, J.E., and M.Q. Zhang. 1999. Detection of polyadenylation signals in 
human DNA sequences. Gene. 231:77–86. doi:10.1016/S0378-1119 
(99)00104-3
Tagami, H., D. Ray-Gallet, G. Almouzni, and Y. Nakatani. 2004. Histone 
H3.1 and H3.3 complexes mediate nucleosome assembly pathways 
dependent or independent of DNA synthesis. Cell. 116:51–61. doi:10 
.1016/S0092-8674(03)01064-X
Tay, S.K., J. Blythe, and L. Lipovich. 2009. Global discovery of primate-specific 
genes in the human genome. Proc. Natl. Acad. Sci. USA. 106:12019–
12024. doi:10.1073/pnas.0904569106
Trostle-Weige, P.K., M.L. Meistrich, W.A. Brock, and K. Nishioka. 1984. 
Isolation and characterization of TH3, a germ cell-specific variant of 
histone 3 in rat testis. J. Biol. Chem. 259:8769–8776.
van Holde, K.E. 1988. Chromatin. Springer, New York. 497 pp.
Witt, O., W. Albig, and D. Doenecke. 1996. Testis-specific expression of a 
novel human H3 histone gene. Exp. Cell Res. 229:301–306. doi:10.1006/ 
excr.1996.0375
Wysocka, J., P.T. Reilly, and W. Herr. 2001. Loss of HCF-1-chromatin associa-
tion precedes temperature-induced growth arrest of tsBN67 cells. Mol. 
Cell. Biol. 21:3820–3829. doi:10.1128/MCB.21.11.3820-3829.2001
Yan, C., and D.D. Boyd. 2006. Histone H3 acetylation and H3 K4 methylation 
define distinct chromatin regions permissive for transgene expression. 
Mol. Cell. Biol. 26:6357–6371. doi:10.1128/MCB.00311-06
Zhang, Y. 2008. I-TASSER server for protein 3D structure prediction. BMC 
Bioinformatics. 9:40. doi:10.1186/1471-2105-9-40
Angelov, D., A. Molla, P.Y. Perche, F. Hans, J. Côté, S. Khochbin, P. Bouvet, 
and S. Dimitrov. 2003. The histone variant macroH2A interferes with 
transcription factor binding and SWI/SNF nucleosome remodeling. Mol. 
Cell. 11:1033–1041. doi:10.1016/S1097-2765(03)00100-X
Bao, Y., K. Konesky, Y.J. Park, S. Rosu, P.N. Dyer, D. Rangasamy, D.J. 
Tremethick, P.J. Laybourn, and K. Luger. 2004. Nucleosomes contain-
ing the histone variant H2A.Bbd organize only 118 base pairs of DNA. 
EMBO J. 23:3314–3324. doi:10.1038/sj.emboj.7600316
Bernstein, E., and S.B. Hake. 2006. The nucleosome: a little variation goes a 
long way. Biochem. Cell Biol. 84:505–517. doi:10.1139/O06-085
Black, B.E., D.R. Foltz, S. Chakravarthy, K. Luger, V.L. Woods Jr., and D.W. 
Cleveland. 2004. Structural determinants for generating centromeric 
chromatin. Nature. 430:578–582. doi:10.1038/nature02766
Bönisch, C., S.M. Nieratschker, N.K. Orfanos, and S.B. Hake. 2008. Chromatin 
proteomics and epigenetic regulatory circuits. Expert Rev. Proteomics. 
5:105–119. doi:10.1586/14789450.5.1.105
Chadwick, B.P., and H.F. Willard. 2001. A novel chromatin protein, distantly 
related to histone H2A, is largely excluded from the inactive X chromo-
some. J. Cell Biol. 152:375–384. doi:10.1083/jcb.152.2.375
Cheng, Y., R.M. Miura, and B. Tian. 2006. Prediction of mRNA polyadenyl-
ation sites by support vector machine. Bioinformatics. 22:2320–2325. 
doi:10.1093/bioinformatics/btl394
Clapier, C.R., and B.R. Cairns. 2009. The biology of chromatin remodeling 
complexes. Annu. Rev. Biochem. 78:273–304. doi:10.1146/annurev 
.biochem.77.062706.153223
Clayton, A.L., and L.C. Mahadevan. 2003. MAP kinase-mediated phospho-
acetylation of histone H3 and inducible gene regulation. FEBS Lett.  
546:51–58. doi:10.1016/S0014-5793(03)00451-4
Davey, C.A., D.F. Sargent, K. Luger, A.W. Maeder, and T.J. Richmond. 2002. 
Solvent mediated interactions in the structure of the nucleosome core 
particle at 1.9 a resolution. J. Mol. Biol. 319:1097–1113. doi:10.1016/ 
S0022-2836(02)00386-8
Gautier, T., D.W. Abbott, A. Molla, A. Verdel, J. Ausio, and S. Dimitrov. 2004. 
Histone variant H2ABbd confers lower stability to the nucleosome. 
EMBO Rep. 5:715–720. doi:10.1038/sj.embor.7400182
Guex, N., and M.C. Peitsch. 1997. SWISS-MODEL and the Swiss-PdbViewer: 
an environment for comparative protein modeling. Electrophoresis. 
18:2714–2723. doi:10.1002/elps.1150181505
Gustafsson, M.G., L. Shao, P.M. Carlton, C.J. Wang, I.N. Golubovskaya, W.Z. 
Cande, D.A. Agard, and J.W. Sedat. 2008. Three-dimensional resolution 
doubling in wide-field fluorescence microscopy by structured illumina-
tion. Biophys. J. 94:4957–4970. doi:10.1529/biophysj.107.120345
Hake, S.B., B.A. Garcia, M. Kauer, S.P. Baker, J. Shabanowitz, D.F. Hunt, and 
C.D. Allis. 2005. Serine 31 phosphorylation of histone variant H3.3 is 
specific to regions bordering centromeres in metaphase chromosomes. Proc. 
Natl. Acad. Sci. USA. 102:6344–6349. doi:10.1073/pnas.0502413102
Hake, S.B., B.A. Garcia, E.M. Duncan, M. Kauer, G. Dellaire, J. Shabanowitz, 
D.P. Bazett-Jones, C.D. Allis, and D.F. Hunt. 2006. Expression pat-
terns and post-translational modifications associated with mammalian 
histone H3 variants. J. Biol. Chem. 281:559–568. doi:10.1074/jbc 
.M509266200
Hendzel, M.J., Y. Wei, M.A. Mancini, A. Van Hooser, T. Ranalli, B.R. Brinkley, 
D.P. Bazett-Jones, and C.D. Allis. 1997. Mitosis-specific phosphoryla-
tion of histone H3 initiates primarily within pericentromeric hetero-
chromatin during G2 and spreads in an ordered fashion coincident 
with mitotic chromosome condensation. Chromosoma. 106:348–360. 
doi:10.1007/s004120050256
Huyen, Y., O. Zgheib, R.A. Ditullio Jr., V.G. Gorgoulis, P. Zacharatos, T.J. Petty, 
E.A. Sheston, H.S. Mellert, E.S. Stavridi, and T.D. Halazonetis. 2004. 
Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand 
breaks. Nature. 432:406–411. doi:10.1038/nature03114
Im, H., C. Park, Q. Feng, K.D. Johnson, C.M. Kiekhaefer, K. Choi, Y. Zhang, 
and E.H. Bresnick. 2003. Dynamic regulation of histone H3 methylated 
at lysine 79 within a tissue-specific chromatin domain. J. Biol. Chem. 
278:18346–18352. doi:10.1074/jbc.M300890200
Köhler, G., and C. Milstein. 1975. Continuous cultures of fused cells secret-
ing antibody of predefined specificity. Nature. 256:495–497. doi:10 
.1038/256495a0
Kozak, M. 1991. An analysis of vertebrate mRNA sequences: intimations of trans-
lational control. J. Cell Biol. 115:887–903. doi:10.1083/jcb.115.4.887
McKittrick, E., P.R. Gafken, K. Ahmad, and S. Henikoff. 2004. Histone H3.3 is 
enriched in covalent modifications associated with active chromatin. Proc. 
Natl. Acad. Sci. USA. 101:1525–1530. doi:10.1073/pnas.0308092100
Nakagawa, S., Y. Niimura, T. Gojobori, H. Tanaka, and K. Miura. 2008. 
Diversity of preferred nucleotide sequences around the translation ini-
tiation codon in eukaryote genomes. Nucleic Acids Res. 36:861–871. 
doi:10.1093/nar/gkm1102
 o
n
 M
ay 9, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published September 6, 2010
 
Supplementary information for:
Identification and characterization of two novel
primate-specific histone H3 variants, H3.X and H3.Y
J Cell Biol. 2010 Sep; 190 (5): 777-791
 
Characterization of novel histone H3.Y • Wiedemann et al.
T
H
E
 J
O
U
R
N
A
L
 O
F
 C
E
L
L
 B
IO
L
O
G
Y
S1
JCBSupplemental material
Wiedemann et al., http://www.jcb.org/cgi/content/full/jcb.201002043/DC1
Figure S1.  H3.X and H3.Y alignments, evolutionary origin, and expression level determination. Alignments were made with ClustalW Alignment (Mac-
Vector 10.0.2). (A) Nucleotide alignment of human H3.1f (available from GenBank/EMBL/DDBJ under accession no. NM_003533), H3.X (accession 
no. LOC340096), and H3.Y (accession no. LOC391769) genes. Identical nucleotides are highlighted in dark gray and changes are set apart on a white 
background. Nucleotide numbers are indicated on top. (B) Amino acid alignment of human (H. sapiens), chimpanzee (P. troglodytes), and macaque 
(M. mulatta) H3.X and H3.Y proteins. Note that M. mulatta H3.X protein contains a stop (asterisk) at position 136, but the following nucleotides would 
code for an H3.X-specific C-terminal tail. Identical amino acids are highlighted in dark gray, similar amino acids are highlighted in light gray, and 
changes are set apart on a white background. Amino acid numbers are indicated on top. The dotted line separates the results of H3.X and H3.Y proteins. 
(C) Phylogenetic tree of H3.X and H3.Y from different species. Coding nucleotide sequences of different histones from human (Hs), chimpanzee (Pt), and 
macaque (Mm) were aligned using ClustalW Alignment (MacVector 10.0.2). Evolutionary relationships were determined using the neighbor-joining tree-
building method based on the Kimura 2 parameter with gamma correction off. Numbers indicate bootstrap probabilities. (D) qPCR analysis with cDNA 
from U2OS cells. Primer pairs for H3.X+Y (dark gray; specifically recognizes H3.X and H3.Y nucleotide sequences) and CENP-A (white) were used. 
Data were normalized to HPRT1 and HMBS expression levels. Controls generated without reverse transcription were used to assess amplification threshold. 
Error bars represent SEM of two independent biological experiments.
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Figure S2.  Analysis of H3.X- and H3.Y-containing nucleosomes and -H3.X/Y antibody specificity determination. (A) Evaluation of DNA size and qual-
ity after MNase IP (bound material, see also Fig. 3 C). Purified DNA after MNase IP was separated and analyzed using a 2100 Bioanalyzer (Agilent 
Technologies). Shown are the electropherograms of bound DNA material. Peaks left and right (15 and 1,500) indicate marker DNA measured in base 
pairs. Peaks labeled with asterisks show base pair length of precipitated DNA after MNase IP. (B) FRAP experiment to evaluate nucleosomal stability of 
novel H3 variants in vivo. HeLa Kyoto cells were transiently transfected with GFP and GFP-H3.1, -H3.3, -H3.X, and -H3.Y constructs. Live cell imaging 
was performed with confocal spinning disk microscopy. A small nuclear area was photobleached (box) with a focused laser beam, and the recovery of 
the fluorescent signal was monitored over 8 h. Mean projection of the 3–4 central image planes is shown. Many cells underwent cell division during or 
at the end of the time series (e.g., arrows pointing to daughter cells), which indicates the general viability of the cells. (C) Quantitative evaluation of mean 
GFP signal recovery after photobleaching relative to fluorescence intensity before bleaching. Mean curves of 13–25 individual cells are depicted for each 
construct. For clarity, error bars are omitted here (see D for details). Note that the FRAP curves start at a higher initial postbleach value than the short-term 
FRAP curves depicted in Fig. 3 E as a consequence of the mean projections of image stacks at each time point. (D) Quantification of mean GFP signal 
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recovery after photobleaching relative to fluorescence intensity before bleaching is shown. Depicted are the mean curves for GFP-H3.1 (dark blue, n = 13), 
GFP-H3.3 (red, n = 15), GFP-H3.X (purple, n = 18), and GFP-H3.Y (green, n = 25). Error bars indicate respective standard deviations. Note that subtle 
differences in recovery curves are within the dynamic range and that no statistically significant differences in FRAP recovery rates between novel and known 
H3 variants could be detected. (E) IF microscopy of HeLa cells stably expressing HA-H3.X and -H3.Y costained with DAPI (DNA, blue, left) and -H3.X/Y 
(green, middle). Merged pictures are shown on the right. (F) Peptide competition experiment to evaluate epitope specificity of -H3.X/Y antibody. -H3.X/Y 
was preincubated with peptides (1 µg/ml) corresponding to aa 9–20 of H3.X/Y (bottom) or a control peptide corresponding to aa 22–41 of H3.3 (top), 
then used for IF microscopy with HeLa cells stably expressing HA-H3.X (green, middle). DAPI (blue, left) stains DNA, and merged pictures with antibody 
stainings are shown on the right. Insets show enlargements of two cells, highlighting the H3.X/Y sequence–specific loss of antibody signal (bottom). 
Bars: (B) 10 µm; (E) 5 µm; (F) 50 µm.
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Figure S3.  Evaluation of human H3.X sequences and inducible endogenous H3.X and H3.Y gene expression. (A) qPCR analysis of H3.X and H3.Y mRNA 
expression in U2OS cells under different stress conditions using different primer pairs (“primer-walk”). Three primer pairs specific for H3.X+H3.Y (dark 
gray) and two primer pairs specific for H3.X (light gray) and H3.Y (white) were used. Shown is the result from one of our three biological replicates (Fig. 5). 
(B) qPCR generated amplicons of each primer pair. (C) List of H3.X+Y-, H3.X-, and H3.Y-specific primer pair sequences. (D, top) Scheme depicting the dif-
ferent transcripts that have been annotated in the NCBI database for the human H3.X locus over the last years. (D, bottom) Alignment of NCBI predicted 
H3.X protein sequences. Identical amino acids are highlighted in dark gray, similar amino acids are highlighted in light gray, and changes are set apart 
on a white background. Amino acid numbers are indicated on top.
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Figure S4.  Purification and identification of endogenous H3.Y protein. (A) RP-HPLC profile of acid-extracted total histones from starved and overgrown 
U2OS cells. Histones corresponding to different peaks are indicated. The box marks the section of H3 peaks shown in Fig. 6 A. (B) Evaluation of -H3.X/Y 
region B bands (Fig. 6 B) by immunoblotting under reducing conditions. To test the possibility that the -H3.X/Y region B band protein is a dimer of H3.Y 
and/or H3.X, proteins of these fractions were treated with increasing amounts of DTT and analyzed in immunoblots with -H3.X/Y. Pooled peak I and II 
H3 fractions contained H3 dimers that were reduced to monomers after treatment with 250 and 500 mM DTT, whereas the -H3.X/Y band B proteins did 
not change running behavior after the same treatment. (C–G) MS/MS spectra of peptides specific for novel H3 variants. NanoLC ESI MS/MS analysis of 
propionylated and trypsin-digested proteins found in RP-HPLC fractions corresponding to region A bands from U2OS SO experiment No. 1 (Fig. 6 B, iii). 
MS/MS spectra of the doubly charged precursor ions at m/z 745.44 (C), 606.83 (D), 654.90 (E), 640.88 (F), and 647.90 (G). Boxes on the right show 
the specific b and y ions after fragmentation.
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Figure S5.  H3.X/Y expression in the human brain. Commercially available human hippocampus sections were costained with -H3.X/Y (red), -NeuN 
(neuronal marker, green), -GFAP (astrocyte marker, white), and DAPI (DNA, blue). One out of three representative stainings is shown. For further costain-
ings of human hippocampus, see Fig. 8. Bars, 20 µm.
Table S1. GO list with shared up-regulated genes after H3.Y knockdown
GOBPID P-value Odds ratio Exp count Count Size Term
GO:0032274 0.000 166.667 0 2 5 Gonadotropin secretion
GO:0042523 0.000 166.667 0 2 5 Positive regulation of tyrosine phosphorylation of Stat5 protein
GO:0046884 0.000 166.667 0 2 5 Follicle-stimulating hormone secretion
GO:0042522 0.000 99.983 0 2 7 Regulation of tyrosine phosphorylation of Stat5 protein
GO:0042506 0.000 83.312 0 2 8 Tyrosine phosphorylation of Stat5 protein
GO:0060986 0.001 62.473 0 2 10 Endocrine hormone secretion
Comprehensive GO list of combined genes significantly up-regulated upon H3.Y and H3.X+Y RNAi in comparison to luciferase control RNAi (see the Venn diagram in 
Fig. 7 C for the number of overlapping genes). Count, actual number of responders found in the node; Exp Count, number of responders expected (entering the term 
by chance); GOBPID, GO identified in the biological process domain (numbers are identifiers based on the GO database released by the Gene Ontology Consortium; 
http://www.geneontology.org/); Size, total number of genes analyzed in this node (GO term/group).
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Table S2. GO list with shared down-regulated genes after H3.Y knockdown
GOBPID P-value Odds Ratio Exp Count Count Size Term
GO:0000280 0.000 6.951 3 20 248 Nuclear division
GO:0007067 0.000 6.951 3 20 248 Mitosis
GO:0048285 0.000 6.710 4 20 256 Organelle fission
GO:0000087 0.000 6.653 4 20 258 M phase of mitotic cell cycle
GO:0051301 0.000 5.937 4 22 318 Cell division
GO:0000279 0.000 5.515 5 22 340 M phase
GO:0022403 0.000 4.767 6 24 428 Cell cycle phase
GO:0007049 0.000 3.538 12 35 864 Cell cycle
GO:0000278 0.000 4.671 6 24 436 Mitotic cell cycle
GO:0071103 0.000 9.106 2 13 122 DNA conformation change
GO:0022402 0.000 4.019 8 27 571 Cell cycle process
GO:0006323 0.000 9.123 1 11 102 DNA packaging
GO:0007059 0.000 10.287 1 10 83 Chromosome segregation
GO:0006261 0.000 11.797 1 9 66 DNA-dependent DNA replication
GO:0065004 0.000 9.327 1 9 81 Protein–DNA complex assembly
GO:0000075 0.000 8.952 1 9 84 Cell cycle checkpoint
GO:0006334 0.000 9.422 1 8 71 Nucleosome assembly
GO:0051276 0.000 3.453 7 20 470 Chromosome organization
GO:0006260 0.000 4.924 3 13 213 DNA replication
GO:0031497 0.000 8.856 1 8 75 Chromatin assembly
GO:0009066 0.000 21.496 0 5 22 Aspartate family amino acid metabolic process
GO:0034728 0.000 8.475 1 8 78 Nucleosome organization
GO:0006270 0.000 20.300 0 5 23 DNA replication initiation
GO:0009067 0.000 29.070 0 4 14 Aspartate family amino acid biosynthetic process
GO:0051726 0.000 3.772 4 14 295 Regulation of cell cycle
GO:0006259 0.000 2.988 7 19 508 DNA metabolic process
GO:0000070 0.000 12.588 0 5 34 Mitotic sister chromatid segregation
GO:0006996 0.000 2.203 18 35 1,311 Organelle organization
GO:0000819 0.000 12.168 0 5 35 Sister chromatid segregation
GO:0051318 0.000 19.372 0 4 19 G1 phase
GO:0009086 0.000 43.353 0 3 8 Methionine biosynthetic process
GO:0006333 0.000 5.579 2 8 114 Chromatin assembly or disassembly
GO:0006082 0.000 2.841 7 18 502 Organic acid metabolic process
GO:0007091 0.000 16.139 0 4 22 Mitotic metaphase/anaphase transition
GO:0007093 0.000 10.425 1 5 40 Mitotic cell cycle checkpoint
GO:0007094 0.000 30.961 0 3 10 Mitotic cell cycle spindle assembly checkpoint
GO:0045841 0.000 30.961 0 3 10 Negative regulation of mitotic metaphase/anaphase transition
GO:0008652 0.000 9.599 1 5 43 Cellular amino acid biosynthetic process
GO:0031570 0.000 9.118 1 5 45 DNA integrity checkpoint
GO:0007076 0.000 27.089 0 3 11 Mitotic chromosome condensation
GO:0071174 0.000 27.089 0 3 11 Mitotic cell cycle spindle checkpoint
GO:0009309 0.000 6.867 1 6 70 Amine biosynthetic process
GO:0044283 0.000 3.415 4 12 275 Small molecule biosynthetic process
GO:0016043 0.001 1.813 33 51 2,371 Cellular component organization
GO:0006555 0.001 24.077 0 3 12 Methionine metabolic process
GO:0071173 0.001 24.077 0 3 12 Spindle assembly checkpoint
GO:0019752 0.001 2.682 7 17 498 Carboxylic acid metabolic process
GO:0043436 0.001 2.682 7 17 498 Oxoacid metabolic process
GO:0010948 0.001 12.098 0 4 28 Negative regulation of cell cycle process
GO:0007346 0.001 4.575 2 8 137 Regulation of mitotic cell cycle
GO:0031577 0.001 21.667 0 3 13 Spindle checkpoint
GO:0045839 0.001 21.667 0 3 13 Negative regulation of mitosis
GO:0051784 0.001 21.667 0 3 13 Negative regulation of nuclear division
GO:0042180 0.001 2.614 7 17 510 Cellular ketone metabolic process
GO:0000097 0.001 19.696 0 3 14 Sulfur amino acid biosynthetic process
Comprehensive GO list of combined genes significantly down-regulated upon H3.Y and H3.X+Y RNAi in comparison to luciferase control RNAi (see the Venn diagram 
in Fig. 7 C for the number of overlapping genes). Count, actual number of responders found in the node; Exp Count, number of responders expected (entering the term 
by chance); GOBPID, GO identified in the biological process domain (numbers are identifiers based on the GO database released by the Gene Ontology Consortium; 
http://www.geneontology.org/); Size, total number of genes analyzed in this node (GO term/group).
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